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Summary 
 
This thesis has developed to explore a specific intervention in a core context.  
That context is the transition of stroke from hospital to home and from acute 
illnesses to chronic disease.  This includes the change from a rehabilitation focus 
on the physical effects and complications of stroke (during in patient stroke unit 
care) to the psychological, emotional and social consequences of stroke as well 
as the risk of recurrence. 
Specifically it focuses on an intervention in two key problem areas.  The first is 
the risk of stroke or transient ischaemic attack (TIA) recurrence and risk factor 
modification through lifestyle change.  The second is the area of psychosocial 
problems  post  stroke.    Both  these  areas  may  be  addressed  by  a  single 
intervention, and it is that potential intervention that is evaluated in detail in 
this thesis.  Other problem areas such as functional recovery and interventions 
to affect this are set in context, but not specifically covered here.   
Chapter  One  highlights  the  association  in  the  literature  between  the  well 
documented social and psychological consequences of stroke and longer term 
health outcomes for patients.  We can see from the literature that there is a 
strong  association  between  depression  and  worse  outcomes  in  terms  of 
rehabilitation,  reduced  cognitive  functioning  and  increased  mortality.    In 
addition  patients  with  poor  social  support  or  poor  family  functioning  are 
recognised to  have  a  longer  length  of hospital  stay  and  poorer  rehabilitation 
profile.  Patients who have a poor understanding of their illness are less likely to 
comply  with  treatment  advice  or  re attend  for  further  treatment.    There  is 
therefore a setting for evaluating an intervention that might seek to impact the 
emotional, informational and social needs of patients post stroke. 
Chapter Two describes a randomised controlled trial of a Stroke Nurse Specialist 
intervention in a behaviour modification programme.   This trial was intended to 
address  the  risk  of  Transient  Ischaemic  Attack  (TIA)  or  Stroke  recurrence  by 
aiming to improve the information needs of post stroke and TIA patients, hoping 
to  improve their compliance,  lifestyle  modification and  ultimately  risk  factor 4 
control.    The  primary  outcome  was  the  proportion  of  patients  who  achieved 
control of all their modifiable risk factors (e.g. smoking, hypertension, diabetes 
and hypercholesterolaemia) according to predetermined criteria.  No significant 
difference was seen between the groups for the primary outcome (proportion 
achieving  risk  factor  control:  Experiment  46.4%  Vs  Control  41.7%,  p=0.34).  
Differences  were  seen  between  the  groups  in  the  reduction  in  systolic  blood 
pressure  (Experiment   9.2mmHg,  SD  23.3  Vs  Control   1.0mmHg,  SD  22.4, 
p=0.04).  In addition patients in the experimental  group were more likely to 
express satisfaction with aspects of liaison and information provision. 
Chapter Three evaluates the effects of the short term behaviour modification 
intervention  (detailed  in  Chapter  Two)  at  over  three  years  after  initial 
enrolment.  Rates of follow up of the initial cohort were lower than the initial 
study (50% compared to 94%).   No significant difference exists at three years 
between the intervention and control groups for the primary outcome of risk 
factor control. Differences were observed between the groups for the rates of 
admission to nursing homes (Experiment 0 Vs Control 5, p=0.02), however the 
small size of this follow up sample limits the conclusions that can be drawn from 
this result. 
Chapter  Four  attempts  to  set  the  randomised  controlled  trial  evaluated  in 
Chapters  Two  and  Three  in  the  context  of  other  outpatient  rehabilitation 
interventions  and  tries  to  establish  if  there  is  comparability  between  the 
interventions and even combinability for subsequent meta analysis.  This process 
identifies several core themes:  
·  Physical fitness training after stroke, 
·  Occupational therapy after stroke, 
·  Multidisciplinary rehabilitation post stroke,  
·  Information provision and education post stroke and 
·  Psychological and social support. 5 
In  addition,  several  trials  targeting  intervention  aimed  at  carers  only  were 
identified. 
Chapter Five describes a systematic review and meta analysis of Stroke Liaison 
Worker trials – that is trials that evaluated a healthcare worker or volunteer who 
provided social support, information and liaison with the patient after discharge.  
This includes the trial described in Chapter Two.  Individual patient data meta 
analysis was conducted of 16 trials evaluating 18 interventions.  Meta analysis 
did not demonstrate any benefit of Stroke Liaison Workers compared to usual 
care for the primary outcomes of subjective health status or extended activities 
of daily living.  In addition there was no benefit from Stroke Liaison Worker on 
the  outcomes  of  death,  institutionalisation,  mental  health  or  dependence.  
Patients were more satisfied that someone had really listened to them.  Carers 
were more satisfied that they had received enough information about the causes 
of stroke, that they had enough information about recovery, that someone had 
really  listened,  and  that  they  did  not  feel  neglected.  Subgroup  analysis  by 
patient dependence at recruitment revealed that patients with mild to moderate 
dependence had reduced dependence in the intervention group (OR 0.60, 0.44 – 
0.83, p=0.002) as well as a reduction in death or dependence (OR 0.55, 0.39 – 
0.78, p=0.0008). 
In Chapter Six I was keen to evaluate whether the interventions in the literature 
and the framework for combining and evaluating them could be mapped onto 
existing  services  in  Scotland.    This  was  done  through  a  questionnaire  of  the 
Scottish Stroke Nurses Forum.  This identified 58 Stroke Liaison Workers from 
around Scotland who identified themselves as providing the services described 
using  the  review criteria  in  Chapter  Five.    These  nurses  identified  that  their 
commonest requests for help relate to psychological or emotional issues.  62% of 
respondents believed that their role was effective for all their patients. 
In conclusion, Stroke Liaison Workers result in greater satisfaction with certain 
aspects of service provision but do not appear to result in changes to patient 
subjective health, extended ADL or carer subjective health.  Subgroup analysis 
suggests that patients with mild to moderate dependence may benefit.  Overall 
there  does  not  appear  to  be  evidence  of  effectiveness  for  this  complex 
intervention when applied to all patients or carers. 6 
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extraction.    I  was  responsible  for  contacting  the  authors,  organising  the 
Collaborators Meeting, data collection, data checking and analysis. 
Chapter Six: Identifying Stroke Liaison Roles in Scotland 
I was responsible for the original design of the questionnaires, data collection 
and analysis.  Professor Lorraine Smith provided advice on questionnaire design. 18 
Glossary and List of Common Abbreviations 
AAP  Adelaide Activities Profile (a measure of extended activities 
of daily living) 
ADL      Activities of daily living 
Barthel  Barthel  Scale  of  daily  living  index  (a  measure  of 
dependence) 
BDI      Beck Depression Inventory (a measure of depression) 
BP      Blood Pressure 
CABG      Coronary Artery Bypass Graft 
CCTR      Cochrane Controlled Trials Register 
CPD      Cigarettes per day  
CSI  Carer  Strain  Index  (a  measure  of  carer  subjective  health 
status) 
CVA      Cerebrovascular Accident 
CES D  Centre for Epidemiological Studies – Depression Score (a 
measure of depression) 
COOP  Dartmouth Primary Care Co operative Information Project 
Charts (a measure of subjective health) 
EADL      Extended activities of daily living 
EuroQOL    (a measure of subjective health) 
FAC  Functional  Ambulatory  Categories  (a  measure  of 
dependence) 19 
FAI  Frenchay Activities Index (a measure of extended activities 
of daily living) 
FIM      Functional Index Measure (a measure of dependence) 
FSO      Family Support Organiser 
FSW      Family Support Worker 
GDS      Geriatric Depression Scale (a measure of depression) 
GHQ  General  Health  Questionnaire  (a  measure  of  subjective 
health status).  It has several forms including the shortened 
forms GHQ12, and GHQ28 
HADS  Hospital Anxiety and Depression scale (a measure of mental 
health including separate sections relating to depression and 
anxiety) 
HbA1c     Haemoglobin A1c 
Hope and Acceptance Scale  (a measure of mental health) 
IADL  Instrumental Activities of Daily Living (a measure of 
dependence) 
LHS      London Handicap Scale (a measure of dependence) 
MRS      Modified Rankin Scale (a measure of dependence) 
McMaster Family Assessment Device Global Function Scale – Mastery Scale  
  (a measure of social support and family functioning with separate sub 
  domains) 
Medical Coping Modes  (a measure of mental health) 
Mental Adjustment to Stroke Scale  (a measure of subjective mental health) 20 
MI      Myocardial Infarction 
mmHg     Millimetres of Mercury 
MS      Multiple Sclerosis 
NHP  Nottingham Health Profile (a measure of subjective health 
status) 
Nottingham EADL  Nottingham Extended Activities of Daily Living Scale 
OARS SR   Older Americans Resources and Services – Social Resources (a 
measure of social support) 
OARS ADL  Older Americans Resources and Services – Activities of Daily 
Living (a measure of physical dependence) 
OARS Physical Health  Older  Americans  Resources  and  Services  –  Physical 
Health (a subjective measure of physical health) 
OARS Economic Resources Older  Americans  Resources  and  Services  –  Economic 
Resources (a measure of economic strain) 
OR      Odds Ratio 
Pound Satisfaction Scale  A satisfaction questionnaire of stroke services 
Questionnaire on Resources and Stress (a measure of subjective health) 
QOL      Quality of Life 
RBG      Random Blood Glucose 
RCT      Randomised Controlled Trial 
REI      Recovery Efficacy Index (a measure of subjective health) 
Rivermead Mobility Index  (a measure of mobility and dependence) 21 
RNLI  Reintegration to Normal Living Index (a measure of 
subjective health) 
RSS      Received Social Support (a measure of social support) 
SCQ  Sense of Competence Questionnaire (a measure of subjective 
mental health) 
SF36  Short  Form  36  (a  measure  of  subjective  health  status, 
including sub domains for mental and physical health etc.) 
SFSW      Stroke Family Support Worker 
SLW      Stroke Liaison Worker 
SMD      Standardised Mean Difference 
SNS      Stroke Nurse Specialist 
Social Functioning Examination (a measure of social support and social 
functioning) 
SSSL D  Social  Support  List  –  Discrepancies  (a  measure  of  social 
support) 
TIA      Transient Ischaemic Attack 
WMD      Weighted Mean Difference 22 
Chapter One:  
Returning to the community 
Introduction 
Stroke is recognised as a global concern.  Worldwide in 2005, the World Health 
Organisation estimated that stroke accounted for 5.7 million deaths (9.9% of all 
deaths)(1).  It is also widely accepted that stroke is a major cause of disability 
and handicap, with an incidence in the United Kingdom of 3 to 5 per 1000 in 
people aged 45 to 84 (2).   
There have been major developments in the field of stroke research over recent 
years with increasing numbers of randomised controlled trials registered with 
the Cochrane Controlled Trials Register (www.cochrane.org).  In addition there 
has been an expansion in secondary research with greater numbers of Cochrane 
reviews published (3).  This evidence has accumulated over time as research has 
continued to evaluate better ways to deliver therapy or services.  Much of this 
research has had a focus on pharmacological interventions for stroke with the 
majority  of  randomised  controlled  trials  on  the  Cochrane  Controlled  Trials 
Register evaluating pharmacological interventions.  Additionally there has been 
a growth of evidence regarding inpatient interventions (such as organised stroke 
unit care) (4).  In response to the growing evidence base for inpatient stroke 
interventions  there  have  been  the  growth  of  guidelines  (5 7)  and  the 
development  of  policy  at  national  level  (8)  as  well  as  declarations  of  stroke 
strategy at international level (9). 
These developments are encouraging and should continue to improve outcomes 
for stroke patients and their families.  Large areas of stroke care however lack a 
firm evidence base (10;11).  In particular trials of rehabilitation and longer term 
community support remain an evolving area.  In the absence of robust evidence 
from  controlled  clinical  trials,  recommendations  regarding  growing  service 
developments  are  being  made  (12).    The  scale  of  post  stroke  problems  and 
community  support  require  that  health  care  providers  develop  services  and 
interventions  to  meet  these  needs.    Much  of  this  work  may  be  based  on 
presumed best care and remains unevaluated. 23 
 
The  majority  of  people  survive  their  stroke,  but  a  third  to  a  half  remain 
functionally dependent after one year (13;14). This is associated with significant 
psycho social problems for both patients and their carers, which may also occur 
independent  of  physical  disability  (15 17).  The  burden  of  such  problems  may 
increase as a result of demographic change and reductions in age specific stroke 
case  fatality  (18;19).    Importantly,  carers  form  a  significant  part  of  stroke 
patients support networks providing care (20).  To date, little research appears 
to  have  addressed  the  needs  of  this  significant  group  and  the  impact  of 
interventions on carers remains unknown (21). 
Living with Stroke 
For many stroke patients, the real challenges and difficulties may only become 
apparent when they return to the community from a hospital after suffering a 
stroke.    It  is  at  this  point  that  an  individual’s  impaired  activities  become 
translated into reduced participation (handicap) and many limits to role related 
responsibilities  are  unearthed.    For  many  patients,  a  stroke  may  have  real 
financial, relationship, and mental health ramifications that become apparent 
on returning to the community, and are simply not addressed during inpatient 
rehabilitation.    The  prevalence  of  significant  problems  post  stroke  has  been 
documented in the literature.  Stroke may cause significant physical, emotional 
and social difficulties for both patients and their families for years after stroke 
(22;23).
  The prevalence of emotional difficulties post stroke has been estimated 
to  be  between  19  and  62%  (24 26).    Depression,  for  instance  after  stroke  is 
frequent (27) as is social inactivity (28).  Social isolation and impaired social 
interaction  are  estimated  to  be  present  for  18     46%  of  patients  (23;28 30).  
Patients seek services and support from healthcare and social services, and this 
is cited as a concern for 13   77% of patients.  For example transfer of care was 
identified as a problem in more than 33% of cases and in some contexts was as 
high as 100% (15;31 33).   
Post stroke quality of life has been identified in one series as being strongly 
associated with perceived emotional support, depression and functional abilities 
(34).  The same study found that family relationships were a main source of 
satisfaction with life. 24 
 
Resources and Threats 
The long term outcome for stroke patients appears to depend on a recognised 
number of resources and threats.  Patients with adequate resources appear to 
suffer fewer negative consequences of stroke, whilst real threats to a positive 
long term  outcome appear  to  be  recognisable  and quantifiable.    These  could 
broadly be described as being inversely related.  When patient’s resources are 
low, a correlation appears to exist with a poorer outcome.  Several key areas of 
resource  and  threat  appear  to occur  repeatedly  in  the  stroke literature  (See 
Figure 1.1). 
Family and Social Support 
Social support is a broad term that encompasses a wide range of relationships 
and social networks.  It has been defined as: 
“The feeling of being loved and cared for, valued and esteemed, and 
able to count on others should the need arise” (35) 
For the majority of stroke patients this might be seen as the key role that an 
immediate  family  network  might  provide.    For  patients  without  immediate 
family, the definition might appropriately be expanded to include a wider circle 
of relationships. 
Stroke  patients  generally  experience  a  decline  in  their  social  activity  after 
stroke as well as a reduction in their social network (28). 
A number of studies have sought to identify and quantify social support and its 
impact on stroke patients.  These studies have then sought to correlate social 
support with defined outcomes. 
Social support and poor outcomes 
Social  support  has  been  found  to  be  important  in  influencing  healthcare 
outcomes (36).  Patients with poor social support networks are said to have an 
increased mortality after both cardiovascular disease and malignancy or a worse 25 
recovery  from  cardiovascular  illness  (37 39).    Lower  social  support  is  also 
associated  with  poorer  adjustment  to  illness  or  bereavement  (40 42)  and 
increased carer burden and depression (43).  
Stroke can be considered as having a significant impact on existing social support 
networks.  For a significant proportion of stroke patients who live at home with 
their families, stroke can have profound influences on families and carers (29) 
including  impacts  on  emotional  health  (23),  relationships  and  functioning 
(30;44). 
In addition to this stroke patients with lower social support were found to have a 
slower recovery from stroke (45), and were more likely to experience a longer 
length of stay in hospital (46). 
Studies have shown that families with poor family functioning were less likely to 
comply  with  treatment  decisions  and  less  able  to  help  patients  with 
rehabilitation efforts (47). Indeed family function in one series proved a better 
predictor of patient length of stay than many typical clinical predictors of stroke 
outcome (46). 26 
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Figure 1.1: Resources and Threats: Hypothesis 27 
Social support networks and good outcomes 
Potential  beneficial  effects  of  social  support  have  been  observed  in  several 
studies and include a reduced risk of mortality (37;38;48 50).  Beneficial effects 
have  been  observed  on  recovery  from  serious  illness  such  as  cardiovascular 
disease (51 54)
 including myocardial infarction (55 58) and optimising treatment 
outcomes in other chronic conditions such as arthritis (59;60) and cancer (61 
63).  In addition patients with good social support have been shown to have 
improved recovery from operations (64).  They are said to have enhanced self 
esteem and improved survival in some cancers (39) and in hospital contexts to 
show  less  distress  than  patients  with  lower  social  support  levels  (65).    In  a 
context  of  neurological  rehabilitation  and  adjustment,  spinal  injury  patients 
with  higher  reported  levels  of  social  support  admitted  to  fewer  medical 
problems and claimed to better adjusted to their spinal injury (42).   
Carers  themselves  also  appear  to benefit  from  wide  social  support  networks.  
Carers  of  Multiple  Sclerosis  (MS)  patients  with  higher  levels  of  social  support 
reported lower levels of perceived caring burden (40).  Carers of Alzheimer’s 
disease patients with social support were less  likely to have depression (43).  
More generally social support appears to mediate the effects of carer burden on 
caregiver’s mental health (66).   
The correlation between social support and poor outcome after stroke has been 
made in a number of population surveys.  One survey of post stroke patients in 
China found that there was a positive correlation between strong social support 
networks and a patient’s functional ability.  The positive association of social 
support on mental health was non significant (67).   
Others found that positive outcomes for functional status, depression and social 
status were significantly associated with higher levels of social support in the 
first six months of recovery after stroke (68).  Only functional status alone was 
improved  when  adjustments  were  made  for  initial  stroke  severity  and  it  was 
suggested that in severely impaired patients that high levels of family support 
are associated  with  progressive  improvements  in  functional  status  early  after 
stroke (68).  This finding has been replicated elsewhere (45;69).
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Social  functioning  appears  to  have  been  improved  by  social  support  in  some 
studies.  One  randomised  trial  of  specialist  nurse  support  found  that  mildly 
disabled  stroke  patients  had  improved  social  functioning  when  compared  to 
controls (70).  Another found that social support was associated with improved 
relationships  with  professionals,  and  improved  quality  of  community 
relationships  early  after  stroke,  although  the  effect  was  not  sustained  (71). 
Others have reported that social support mediates the impact of handicap over 
quality of life (72). 
Family  function  may  be  improved  on  several  domains  by  a  combination  of 
education and social work input for carers of stroke patients who also noted 
improved carer knowledge and patient adjustment compared to controls (73).  
Interventions targeted at carers have also shown improved carer confidence in 
knowledge, improved use of coping strategies and increased social support (74).  
Others  have  shown  improved  problem  solving  skills,  reduced  depression,  and 
improvements in social functioning, mental health and reduced limitations due 
to emotional health (75).  One study of a family support worker demonstrated 
reduced  anxiety  and  hassles  in  the  carers  of  stroke  patients,  and  whilst  not 
demonstrating a consistent effect for patients, showed improved satisfaction in 
both groups (76).  These effects are echoed in another study of family support 
organisers  that  showed  improved  mental  health,  reduced  pain,  improved 
physical function, improved general health perception and quality of life as well 
as improved satisfaction for carers of stroke patients (32). 
 
Mental Health 
Estimates of the rates of depression after stroke vary and are reported to affect  
between 25 and 79% (24).  Most would place the incidence at over 25% in the 
first year (25).  Much of this variation may arise from differences in diagnostic 
classification; however, the prevalence of low mood seems well recognised.   
Mental health and poor outcome 
In  an  older  population,  depression  and  mental  health  problems  have  been 
reported to be associated with greater impairment of quality of life than many 29 
chronic physical diseases (26).  In older people depressive illness is associated 
with  greater  morbidity  and  dependency  (77).    This  includes  increased  use  of 
drugs and alcohol, greater use of healthcare resources and poorer compliance 
with treatment recommendations (77).  The association between medical co 
morbidity  and  depression  suggests  that  medical  co morbidity  may  be  more 
influential as a cause or factor in depression than social isolation itself (78). 
In  cardiovascular  disease,  depression  post  myocardial  infarction  (MI)  is 
recognised as a cause of increased mortality, where in one study the risk was 
more than twice that of non depressed patients (79).  This increased risk has 
even  been  noted  to  exist  for  patients  with  mild  depressive  symptoms  not 
traditionally thought to be at risk (80).  Analysis of patterns of ischaemia in 
depressed patients has shown that patients with mild to moderate ischaemia 
exhibit an increase in ischaemic episodes both during mental stress testing and 
during normal life. This has been thought to be a potential explanation for the 
increased mortality in this group (81).  An association has been found between 
depression  and  sedentary  behaviour  as  well  as  smoking,  though  depression 
remained  an  independent  predictor  of  mortality,  incompletely  explained  by 
these risk factors (82).  Depression also proves a reliable predictor of quality of 
life up to 12 months after a myocardial infarction (83) and may be a factor in 
compliance with cardiac rehabilitation (84) 
Depression prior to surgery has been found to be associated with increased six 
month  morbidity  in  patients  undergoing  coronary  artery  bypass  graft  (CABG) 
surgery including re hospitalisation, increased surgical pain and failure to return 
to  normal  activities  (85).    In  a  separate  series  depression  predicted  post 
operative  angina  recurrence  (86).    One  study  found  that  the  presence  and 
severity  of  depression  was  likely  to  independently  influence  the  type  of 
revascularisation  procedure  performed,  with  fewer  depressed  patients 
undergoing CABG (87). 
There is still controversy in the literature as to whether post stroke depression is 
caused by the stroke lesion itself, or by the patient’s psychological response to 
illness (88).  Regardless of the causes of post stroke depression, it is known that 
depression  may  impede  rehabilitation  (89;90),  reduce  physical  and  cognitive 
function (91) and create additional stress for carers (92). 30 
A survey conducted among 51,119 US veterans with ischaemic stroke found the 
prevalence  of  depression  to  be  5%  within  three  years.    Other  mental  health 
diagnoses were equally prevalent at 4% within three years of stroke onset.  Both 
post stroke depression and other mental health diagnoses were associated with 
an increased mortality rate (OR 1.13, 95% CI 1.06 1.21) (93).  This effect was 
independent of other chronic conditions.  This increased mortality rate has been 
reported  elsewhere  in  the  literature  (94)  and  is  not  fully  explained  by  an 
increased risk of suicide (95). 
Patients with mood disorders reported a reduction in the quantity and quality of 
relationships  as  a  result  of  difficulties  with  personal  and  social  adjustment 
(96;97). 
Carers are also at high risk of mood disorders as a result of caring for patients 
after stroke, and as a consequence experience impaired social function (15;17).
 
Mental health and positive outcomes 
From the correlation between poor mental health and poorer outcome it might 
be suggested that “good” mental health might offer a protective effect against 
these hazards.  However a difficulty arises in the definition of “good” mental 
health.  In simple terms, it might be defined as the absence of psychopathology.  
Viewed in this light “good” mental health could be said to be associated with 
improved  morbidity,  dependency  and  quality  of  life  in  older  patients  when 
compared to patients with poor mental health (24;77 81).   
Some studies have shown that patients who remain depressed tend to remain 
physically  disabled,  whilst  those  whose  depression  improves  demonstrate  a 
reduction in disability (98;99).  
Some have tried to define good mental health as the psychosocial resources of 
mastery,  self efficacy  and  social  support,  noting  that  these  factors  were 
responsible  for  a  significant  part  in  the  buffering  of  psychological  distress  in 
response to chronic medical conditions (100).     
Likewise for caregivers, psychological coping strategies have been identified as 
potential mediators of the impact of caring on caregiver mental health (66). 31 
Using the criterion of good mental health as the inverse of poor mental health, it 
could be argued that good mental health status is associated with protection 
from  poor  cognitive  function,  improved  physical  recovery  (91),  improved 
rehabilitation  (89;90),  improved  mortality  (93)  and  improved  quantity  and 
quality of social relationships (96;97).  However, more specifically, some have 
suggested that particular models of psychological resource (such as increased 
efficacy  and  control,  enhanced  problem  solving  and  cohesive  family  systems) 
might have a beneficial effect on an individuals and a family’s recovery from 
stroke (101).  Proof of a causal effect however has not been demonstrated with 
these models of psychological theory. 
Information and Knowledge 
Providing information for patients and carers is considered a key part of services 
for  patients  and  carers  (12;102).      Educational  interventions  in  healthcare 
settings  can  be  complex  and  need  evaluated  in  carefully  designed  trials 
(103;104).    There  is  complexity  in  translating  change  from  education  into 
outcomes and this complexity (as illustrated in Figure 1.2) may be the reason for 
the limited results of many patient education trials (105). 
Poor information and outcomes 
Patients  with  a  poor  understanding  of  their  illness  are  less  likely  to  express 
satisfaction with their health care, less likely to comply with treatment advice, 
less likely to re attend for further treatment and less likely to improve (106). 
One survey of stroke patients and carers found that over one third of patients 
and nearly two thirds of carers would have wished more information about the 
illness (107).  A quarter of patients and nearly two thirds of patients and carers 
respectively had to ask for more information.  The reasons patients and carers 
gave for being unable to get more information were the busyness of hospital 
staff, staff unavailability or lack of knowledge and the use of medical jargon 
that was too difficult to understand (108).   
Patients whose caregivers had little knowledge of stroke were more likely to be 
at  risk  of  sub optimal  home  care  (109).    Likewise  lack  of  knowledge  or 
information  about  their  condition  are  said  to  exacerbate  patients’  physical 32 
limitations  and  emotional  distress  (110).    This  perceived  lack  of  information 
following discharge was directly correlated with expressed dissatisfaction with 
care for both carers and patients (108).  Patients living in the community also 
express  dissatisfaction  with  the  information  they  had  received  about  stroke 
disease (33) and continued to have unanswered questions up to two years after 
stroke (111). 33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Hierarchy of Levels of Education 
Adapted  from  Kirkpatrick  (104;105).    The  complexity  of  evaluating  an 
educational intervention on behavioural change can be seen in the assessment of 
that change – as you seek to ascend the outcomes of education, the number of 
potential  confounders  and  the  lack  of  reliable  objective  measures  limit  or 
reduce the power of the conclusions about the intervention. 
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Good information and outcomes 
Educational programmes for children and adolescents with asthma have been 
shown to improve lung function, reduce absenteeism from school, and reduce 
visits to accident and emergency departments (112).   
Some nurse led interventions have been shown to be helpful in improving health 
related behaviour in individuals at high risk of coronary heart disease, including 
improved  dietary  intake,  increased  exercise,  reduced  smoking  and  temporary 
improvements in systolic blood pressure (113).  In patients with coronary heart 
disease,  educational  interventions  have  shown  improved  diet,  exercise 
prophylactic drug use and health status (114).  Five year follow up of this cohort 
even suggested a non significant reduction in mortality in the intervention group 
(115;116).  Others have shown additional benefits on health status, reduced role 
limitations from physical problems, and reduced worsening of chest pain and 
fewer hospital admissions (117).  A review of disease management programmes 
for coronary heart disease that have included patient education and risk factor 
management  showed  non significant  reductions  in  mortality  and  recurrent 
myocardial infarction, whilst showing significant improvements in drug use and 
hospitalisations (118). 
More  generally,  advice  on  dietary  salt  intake  has  been  shown  to  enable 
hypertensive patients to maintain a lower blood pressure after the withdrawal of 
antihypertensive therapy and reduce the long term risk of cardiovascular disease 
(119;120).  Additionally advice on the reduction of dietary fat when maintained 
for  two  years,  showed  potential  benefits  in  reduction  in  mortality  and 
cardiovascular events (121). 
Outwith  vascular  disease,  training  Multiple  Sclerosis  (MS)  sufferers  in  coping 
skills has been shown to improve their methods of coping, overall satisfaction, 
and satisfaction with family and socio economic status (122). 
Good knowledge of stroke by stroke carers may improve the quality of discharge 
home  from  hospital  (109).    Patients  and  carers  who  feel  they  have  received 
adequate information are apt to feel more satisfied with the quality of their 
care – especially the information provision aspects of it (32;76;123;124)  35 
Services 
The interface between informal support in the community (carers and family) 
and formal community support (community care) becomes key to the support of 
many patients with chronic conditions.  Community services can be defined as 
assistance with care giving tasks, in home assistance, and adult day care, Meals –
on Wheels and support groups as well as benefits and financial support (125). 
In one qualitative study, comparison was made between health service provision 
and  community  or  social  care  provision.    Many  older  patients  identified  that 
although  a  contact  point  was  more  readily  identifiable  for  healthcare,  users 
were more likely to take an active role in accessing and choosing social services 
than healthcare (126).  This was often despite an apparent lack of necessary 
healthcare provision.  Similarly in another study, elderly patients on discharge 
were more than twice as likely to access community home care or nursing care 
than  they  were  to  visit  their  General  Practitioner  (127).    Elderly  patients 
appeared to value social services and to consider them more accessible than 
healthcare. 
Poor access to resources and outcomes 
A survey of carers of elderly or minority group patients have shown that 51 67% 
of caregivers were in need of one or more community service (including financial 
needs), and that being in need, they were deemed at risk whilst providing care 
giving services themselves (128).  The lack of choice, access and at risk status of 
those who needed social welfare but could not obtain it has also been identified 
in the qualitative literature (126).  
In a stroke context, poor knowledge of stroke services and benefits is noted to 
be associated with emotional problems and increased physical limitations (129).  
Patients  in  the  community  have  expressed  dissatisfaction  with  the  level  of 
information they have received about stroke services and information regarding 
benefits (15;32;33).  
Good access to resources and outcomes  
Caregivers  of  Alzheimer’s  patients  in  a  qualitative  study  identified  that 
community services were associated with the  benefits of renewal, increased 36 
knowledge  and  a  sense  of  community  (125).    In  addition  they  perceive  their 
relative (the patient) to benefit.  Older patients in particular appear to value 
social  service  support  and  are  more  likely  to  express  satisfaction  with  social 
services than with primary health care (130).  
There  is  an  increasing  body  of  evidence  on  the  effectiveness  of  outpatient 
therapy  post stroke  and  services  available  to  community  dwelling  stroke 
survivors.  Therapy based outpatient services for instance have been shown to 
reduce deterioration and improve the function of activities of daily living (131).  
Physical fitness training after stroke has been described as increasing strength 
and  cardiovascular  fitness  after  stroke  (132),  and  information  provision  and 
education may benefit both patients and carers (133).  In addition to medical 
and therapy based services, a growing range of locality based social services and 
financial support are available for patients and carers (134). 
Carers 
A Carer has been defined as: 
“the person, other than a healthcare professional, perceived by the 
patient or family as normally being most responsible for day to day 
decision making and care (32).”  
Definitions of carers in the literature for older patients, not surprisingly is very 
similar and equally broad: 
“family  caregivers  are  relatives  or  friends  of  an  older  person  who 
provide,  arrange  or  oversee  services  that  the  older  person  needs 
because of functional disabilities or health needs (135).”  
Definitions of carers are therefore context specific and not permanent and are 
defined by relationship to the patient. 
Approximately  5.2  million  people  in  the  UK  are  estimated  to  be  providing 
informal care in England and Wales according to the 2001 Census (136).  Informal 
carers  provided  care  that,  if  costed,  would  cost  the  government  millions  of 
pounds  each  year.    At  any  one  time  0.5%  of  the  UK  population  are  disabled 
stroke survivors who are dependent on the help of a carer to perform community 37 
activities, domestic activities or personal activities of daily living (137).  Carers 
therefore  form  an  integral  part  of  a  patient’s  support  network  and  may 
significantly impact the welfare of patients, but form a vulnerable population in 
their own right. 
Carers’ needs 
A review of the literature suggests that carers have perceived needs that are 
independent of a patient’s needs and yet are related to their ability to care for 
the patient.  Carers consistently describe needs for information (111;128;138 
141) and they may seek means to acquire that information if it is not provided 
(139).  Information was found in one series to be protective against poor carer 
outcome  (141).    Additionally  caregiver  training  has  been  suggested  to 
independently predict a positive outcome for carers at 3 months (140).  Social 
support for carers independent of patients has been identified as important and 
in one series, social support for a carer was associated with improved caregiver 
life  satisfaction  (142).    Caregivers  also  describe  needs  for  support  from 
community services and in one series between 52 and 67% of clearly identified 
needs were not being met (128). 
Risks for Carers 
Depression is noted to be frequent in carers when compared to matched controls 
(143) with an estimated frequency of anywhere between 34 and 52% (144).  A 
number  of  observational  studies  have  tried  to  establish  risk  factors  for 
depression or other markers of poor outcome in carers.  Consistently identified 
factors  across  many  studies  appear  to  be  patient  dependence 
(15;92;140;144;145),  cognitive  impairment  (92;144;146;147),  behaviour 
problems in the patient (92;144;147) and emotional problems in the patient such 
as depression (15;25;144;147). 
Outcomes for Vulnerable Carers 
Carers who are depressed represent a concern not only in terms of their own 
health risk, but also in their ability to care for a dependent friend or relative.  
Depressed carers have been shown to provide poorer standards of caring and, 
are less able to help the patient in rehabilitation (148).  In addition, in a cohort 
of carers followed for four years, caregivers who registered increased levels of 
carer strain had a 63% higher mortality rate than comparable non caregivers (RR 38 
1.63, 95% CI 1.0 to 2.65).  Carers who did not show signs of caregiver strain had 
no significant increase in mortality (149). 
Protective Resources for Carers 
In addition to identifying the risk for carers, a number of studies have identified 
potential protective elements that might be exploited in intervention studies.  
One study identified that carers with a higher perceived self efficacy and greater 
satisfaction  with  social  support,  experienced  less  strain  and  better  mental 
health  (147).    Another  reported  that  carer  training  was  associated  with  a 
positive  carer  outcome  at  3  months  post  stroke  (140).    Others  noted  that  a 
carers ability to cope was enhanced by information as well as positive coping 
strategies (141).   
Interventions for Carers 
These positive associations which suggest a protective effect should offer real 
hope  of  the  development  of  an  intervention  to  improve  outcomes  for  this 
vulnerable population.  A number of different types of interventions have been 
developed and evaluated in trials.  These types of intervention have included 
education  and  information  provision  in  the  form  of  written  or  electronic 
materials (150;151), group educational classes (74;152 155), counselling (73;156 
158), practical caregiver training (21) and liaison (32;70;123).  In Chapter Four I 
will  examine  where  the  emerging  randomised  controlled  trials  for  carers  sit 
within  the  wider  context  of  community  stroke  rehabilitation  trials.    The 
interventions that involve liaison, information provision and social support for 
patients and carers in combination are evaluated in a meta analysis of Stroke 
Liaison Worker trials in Chapter Five.  39 
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From association to intervention 
(See Figure 1.3) 
No matter how strong an association may appear between risk and outcome, any 
intervention  (even  ones  that  perfectly  mirror  favourable  and  protective 
elements in the natural world) must be evaluated in appropriately conducted 
randomised controlled trials to ascertain their effectiveness.  Trials evaluating 
therapy based on social interventions face a number of potential limitations that 
can  introduce  the  risk  of  bias.    These  can  include  selection  bias,  where  the 
patient or carer group recruited does not reflect a generalisable population or 
recruits subjects whose motivation or incentives may be related to personality or 
other factors that will influence the outcomes.  In addition, therapy trials are at 
risk of performance bias where interventions are not standardised or consistently 
delivered.    Ideally  these  trials  need  to  be  appropriately  blinded,  particularly 
where the intervention is complex and the outcome measures may be open to 
bias.    Blinding  complex  interventions  involving  health  care  personnel  is 
potentially difficult (159) but blinding of outcome assessment is usually possible.  
The assessment of these potential interventions will be developed in depth in 
subsequent chapters in this thesis. 41 
Chapter Two:  
The  Impact  of  Stroke  Nurse  Specialist  Input  on 
Risk  Factor  Modification:  A  Randomised 
Controlled Trial 
Introduction 
One  of  the  consistent  challenges  facing  stroke  services  is  in  the  provision  of 
appropriate  education  and  support  for  stroke  patients  and  their  carers 
(107;108;110;160;161).
    Research  has  sought  to  establish  the  effectiveness  of 
various educational interventions on different aspects of patient’s and carer’s 
health  and  well  being  (162;163).    Trials  looking  at  the  impact  of  specific 
education interventions on patients and caregivers knowledge about stroke have 
demonstrated an improved level of knowledge (164;165).  However most have 
failed to show an impact on emotional outcomes (164;166 168), perceived health 
status  (164 166;169),  physical  function  (164;168)  or  health  behaviour  (165).   
Some  trials  have  observed  improvements  in  family  functioning  (164),  pain, 
physical function, mental health (170) and satisfaction with information received 
(164;167), although this was not universal.  
We know that interventions with an educational or counselling component can 
be  effective  to  encourage  smoking  cessation  (171 174),
  lower  blood  pressure 
(175 177),  achieve  modest  reductions  in  cholesterol  (178;179),  and  promote 
weight loss (180).  Educational interventions in a cardiac patient population have 
demonstrated  a  measurable  impact  on  blood  pressure,  exercise,  diet  and 
mortality (181).  Despite evidence that inadequate provision of information has 
adverse  consequences  on  compliance  with  secondary  prevention  and 
psychosocial outcomes (160), evaluation of the impact of education on physical 
outcomes is lacking in stroke disease.   
We  describe  a  single  blind  randomised  controlled  trial  of  a  nurse  providing 
health education and counselling for patients with stroke or transient ischaemic 
attack (TIA), and its effects on risk factors, satisfaction, mood and perceived 
health status. 42 
 
Subjects and Methods 
Pilot work and statistical power 
We  undertook  an  initial  survey  of  the  case notes  of  51  consecutive  patients 
attending our stroke and TIA clinic.  We focussed on the more easily measurable, 
significant  modifiable  risk  factors  (blood  pressure,  smoking,  cholesterol  and 
diabetes).  The average number of risk factors per patient was three.  Of these 
patients,  only  20%  had  achieved  complete  risk  factor  control  by  the  time  of 
discharge from secondary care.  We defined risk factor control as risk factor 
results  that  fell  within  the  recommended  treatment  range  according  to  the 
contemporary  national  and  local  treatment  guidelines  (Table  2.1).    We 
estimated we would need to recruit 89 patients per group to show an increase in 
the proportion of patients whose risk factors were “on target” from 25% to 50% 
with 80% power at the 5% significance level.  The control group rate of 25% is 
supported by our pilot work and on other trial data (170;179;182;183). 
We  then  conducted  a  Randomised  Controlled  Trial  to  assess  the  impact  of  a 
nurse specialist led, health education intervention.  Our primary outcome was an 
increase in collective risk factor control (or the proportion of patients with all 
their  risk  factors  controlled).  Secondary  outcomes  were  improvement  in 
individual  risk  factors,  clinical  outcomes  (death,  further  cerebrovascular  or 
other vascular events, hospitalisation), perceived health status (184), Geriatric 
Depression  scores  (185;186)  and  satisfaction  scores  using  previously  validated 
stroke service questionnaires (187).  Local ethical approval was obtained for the 
study. 
Inclusion and exclusion criteria 
All  patients  with  a  diagnosis  of  TIA  or  stroke,  cerebrovascular  disease  or 
amaurosis  fugax,  with  any  major  modifiable  risk  factor,  (blood  pressure, 
smoking,  cholesterol,  and  diabetes)  were  eligible.    Patients  with  cognitive 
impairment  (defined  as  an  Abbreviated  Mental  Test  score  <5)  were  excluded 
(188).  Patients with communication difficulties were not excluded unless, in the 
opinion  of  a  Speech  and  Language  Therapist  they  were  felt  unable  to 
comprehend the information given or effectively consent to involvement. 43 
Randomisation 
Patients were enrolled following the completion of their standard investigations 
and treatment.  After giving informed consent, randomisation was performed by 
opening a sequentially numbered opaque envelope available within the clinic.  
These were generated by the use of computer generated random numbers in 
repeating blocks of six, organised by someone uninvolved in the study.  Baseline 
characteristics demonstrate the similarity of the two groups at randomisation 
(Table 2.2). 
Study participants 
208 patients were recruited at their final visit to the stroke clinic or geriatric 
medical day hospital.  Details of the patient recruitment are illustrated in Figure 
2.1.  Three patients were entered twice in error, both times to the treatment 
group.  These subjects were analysed on their initial data only and subsequent 
data were excluded from the analysis.  One patient in the control group was 
later  found  to  be  ineligible  based  on  information  unavailable  at  the  time  of 
enrolment.  For the purposes of assessment and data analysis, this patient has 
been included on an intention to treat basis.  The diagnostic classifications of 
both groups are illustrated in Table 2.2. 
Intervention 
Patients  randomised  to  control  services  received  usual  care,  which  included 
generic  risk  factor  advice  from  medical  staff  as  well  as  the  Stroke  Nurse 
Specialist (SNS).  Treatment group patients were reviewed at monthly intervals 
by the SNS for additional input, which encouraged empowerment with behaviour 
modification and treatment compliance.  These reviews were conducted within 
the hospital premises as an outpatient consultation; patients were interviewed 
and  given  individual  counselling  on  lifestyle  changes  and  the  importance  of 
secondary prevention.  Additional open questions gave patients the opportunity 
to  bring  up  other  subjects  as  the  patient  felt  appropriate.    The  average 
consultation length was approximately 30 minutes.  Patients received on average 
three counselling sessions with the SNS.  All verbal information was backed up by 
written information that was selected by the SNS as relevant to the individual 
patient.  Personalised patient held records were also given to patients, detailing 
their risk factors, and the recommended risk factor targets.  This record was 44 
updated at each visit, and was considered a key part of the intervention.  The 
SNS did not routinely attempt to contact the patient’s GP or hospital specialist 
in order to influence prescribing.  Where a risk factor (e.g. blood pressure) was 
deemed to be at unacceptable levels, patients were encouraged to consult their 
GPs with that information.  General Practitioners of both treatment and control 
group  patients  were  informed  of  the  study  by  letter,  and  of  the  form  of 
intervention.  At the end of the study, a letter summarising the patient’s risk 
factors as well as our recommended risk factor targets was sent to the GPs of all 
the patients (treatment and control groups).  
Follow up and / outcome measures 
All patients were followed up at completion of the study on average 5.3 (SD 1.5) 
months after enrolment by a researcher blinded to the patients’ randomisation 
category.    Assessments  included  the  EuroQOL  (184)
  perceived  health  status 
questionnaire,  Geriatric  Depression  Score  (185;186)  and  a  validated  stroke 
services  satisfaction  questionnaire  (187).    Three  patients  who  were  enrolled 
twice in error were not reviewed after the second enrolment. 
Analysis 
Data  were  entered  by  the  principal  investigator  and  analysed  using  SPSS  for 
Windows version 10.0.  Continuous homogeneous variable data were analysed 
using independent T tests.  Where normality tests were not satisfied, data were 
analysed  using  and  Mann Whitney  U/Wilcoxon  Sum  Rank  test  non parametric 
methods.    Categorical  data  were  analysed  using  the  c2  test.    Analysis  of 
covariance with a general linear model (Ancova) was applied where necessary to 
adjust for differences in baseline variables.  
 
Results 
Primary analysis 
Cumulative  risk  factor  control  was  defined  as  the  number  of  patients  whose 
major,  modifiable  risk  factors  were  within  national  or  local  guidelines.    The 
number of controlled risk factors per patient is illustrated in Table 2.3.   Analysis 45 
by  c2  and  Mann Whitney  U  non parametric  testing  failed  to  demonstrate  a 
statistically  significant  difference  between  the  two  groups.    (Percentage 
controlled 46 %, 95% CI 39 – 54 Vs 42 %, 95% CI 35 – 49, p= 0.36).  (Tables 2.3 and 
2.4) 
Secondary Analysis – Individual Risk Factor Control and Clinical Outcomes 
The initial (planned) analysis of individual risk factors appeared to demonstrate 
a statistically significant reduction in systolic blood pressure in the treatment 
group compared to control ( 9.2mmHg, 95% CI  15.0 to  3.5 Vs  1.0mmHg, 95% CI 
 6.3 to 4.3, p=0.04).  However the experimental group appeared to have higher 
baseline  systolic  blood  pressures  (156.2mmHg,  95%  CI  150.7  –  161.7  vs. 
151mmHg, 95% CI 146.0 to 156.3, p=0.19), and achieved only marginally lower 
mean systolic blood pressures at follow up than the control group (148.0mmHg, 
95%  CI  142.0  to  154.0  vs.  150mmHg,  95%  CI  144.5  to  155.6,  p=0.62).    The 
possibility exists that this result reflects regression to the mean.  Analysis using a 
general linear model (Ancova) to adjust for baseline BP did not suggest that the 
result could be fully explained by regression to the mean.  However analysis with 
adjustment  for  baseline  BP  indicated  that  the  difference  between  groups  in 
systolic blood pressure drop was less marked ( 7.8mmHg, 95% CI  13.1 to  2.6 Vs 
 2.2mmHg  7.1 to 2.7, p=0.13). 
Changes in diastolic blood pressure ( 2.1mmHg, 95% CI  5.7 to 1.5 Vs  1.2mmHg, 
95% CI  4.5 to 4.5, p= 0.71), reported smoking number ( 1.6 cigarettes per day, 
95% CI  5.1 to 1.8 Vs  0.4cpd, 95% CI  3.7 to 2.8, p= 0.61), serum cholesterol ( 
0.96mmol/L, 95% CI  1.2 to 0.7 Vs  0.87mmol/L 95% CI  0.9 to 1.1, p=0.63), 
random blood glucose (+0.92mmol/L, 95% CI  1.9 to 3.7 Vs +0.89mmol/L, 95% CI 
 1.8 to 3.6, p= 0.99) and HbA1c ( 0.25%, 95% CI Vs  0.78 ± 2, p=0.20) did not 
reach statistical significance. 
Other clinical outcomes 
Analysis  of  clinical  outcomes  between  the  groups  did  not  demonstrate  any 
significant  difference  in  clinical  events  not  leading  to  admission  (P=0.28)  or 
admissions (P=0.56).  There were no deaths in either group during the time 
course of the trial. 46 
Medication score 
Patients were asked to recall their current medications.  This list was compared 
to  a  General  Practitioners  record  of  the  patients  prescribing  at  the  time  of 
review.  A medication score was given as a percentage correct recall of relevant 
secondary prevention medication.  There was non significant difference noted 
between the two groups (Intervention 71% correct, 95% CI 62 to 80 Vs Control 
79% correct, 95% CI 70 to 88, p=0.24). 
Perceived Health Status (EuroQOL) 
Patients were asked to rate their perceived health status (EuroQOL) at baseline 
and at follow up.  There was no significant difference between the groups at 
baseline  or  follow  up  when  analysed  using  a  c
2  test  for  the  separate  health 
categories (mobility, self care, usual activities, pain or anxiety and depression).   
Comparison  of  perceived  health  scale  (percentage)  by  independent  T test 
showed a non significant increase in the treatment group in the EuroQOL visual 
analogue scale (3.5% increase, 95% CI  0.9 to 7.9 Vs 1% increase, 95% CI  3.3 to 
5.3, P=0.43). 
Depression score (Geriatric Depression Score) 
There  was  no  statistically  significant  difference  between  the  groups  in  the 
Geriatric Depression Scale (4.26, 95% CI 3.56 to 4.95 Vs 5.06, 95% CI 4.38 to 
5.73, P=0.11).  When predefined cut offs are used, there were no differences in 
those with a “probable” diagnosis of depression (GDS > 5) between the groups 
(30 Vs 37, p=0.43) or those with a diagnosis of “definite” depression (GDS >10) (5 
Vs 10, p=0.29). 
Stroke services satisfaction questionnaire 
Patients were asked to complete a stroke service satisfaction questionnaire at 
follow up.  There were significant differences between the groups for several of 
the categories (Table 2.5).  Patients in the treatment group were more likely to 
express satisfaction that they had been able to talk to someone (p=0.03), and 
that they knew who to contact if required (p=0.03).  They also expressed greater 
satisfaction with the information they had received, both about the causes of 
stroke (p=0.02) and about their risk factors (p=0.01). 47 
Discussion 
Studies examining healthcare workers who typically provide education, liaison 
and social support (these studies are described in more detail in Chapter 5 under 
the  umbrella  title  of  Stroke  Liaison  Worker)  have  varied  in  their  target 
population,  interventions  and  outcome  measures.    Most  have  assessed  the 
impact  of  educational  or  counselling  based  interventions  on  functional, 
emotional  and  educational  outcomes  (164;166;167;189).      These  studies  have 
tended not to look at the physical outcomes of health education interventions 
(162;165),  or  have  shown  disappointing  outcomes  with  respect  to  risk  factor 
modification (190). 
The  intervention  in  this  randomised  controlled  trial  appeared  to  be  well 
tolerated, with drop out rates in the treatment group being very similar to the 
control group.  
Overall there was no significant difference between the groups in terms of the 
proportion  of  patients  who  had  achieved  100%  control  of  their  risk  factors.  
There was a very small and non significant difference between the groups that 
favoured the intervention group.  The reason for the lack of a more significant 
result may reflect a type II statistical error, which would be most likely to be 
due to under powering.   
The  unexpected  improvement  in  risk  factor  control  in  the  control  group  is 
surprising when compared to previous studies which gave a more disappointing 
picture of risk factor control (191).   
It may be that part of the reason for improvement in the control group may be 
due to a smaller number of risk factors in the series than in the pilot survey.  It 
may be easier to gain 100% control of all of a patient’s risk factors if they only 
have one or two risk factors to control (compared to three or four).  In addition, 
hypercholesterolaemia was the most frequent risk factor in both groups.  It is 
ordinarily amenable to statin therapy in contrast to other drug therapy, lifestyle 
or dietary modification which were the mainstay of treatment in much of the 
comparable literature. 48 
There was a non significant trend to improvement in systolic blood pressure in 
the intervention group, when adjusted for baseline systolic blood pressure.  It 
might  be  postulated  that  a  reduction  as  early  as  three  months  may  reflect 
improved concordance in addition to lifestyle and dietary changes since it is well 
established  that  patients  with  chronic  conditions  (such  as  hypertension)  may 
take as little as half of their prescribed medication (192).   
Studies show that many people with stroke are dissatisfied with the content and 
quality  of  information  given  to  them  (160).    Patients  who  feel  inadequately 
informed  seem  to  be  less  satisfied  with  the  care  they  have  received,  less 
compliant with medical advice and suffer poorer outcomes (193;194).  Improving 
patient’s satisfaction with the level of information they have received and the 
level of health professional contact may be key to addressing these problems.  
Patients  in  the  intervention  group  were  statistically  more  likely  to  express 
satisfaction that they had been able to talk to someone about the problems they 
were  having  and  that  they  knew  who  to  contact  should  they  have  further 
problems relating to their stroke or TIA.  In terms of the information patients 
received,  patients  in  the  intervention  group  were  more  satisfied  with  the 
amount of information they had received about the causes and nature of their 
illness and about their risk factors.  These findings are not surprising given the 
nature of the intervention, and reflect other trial evidence (164;167). 
In conclusion, nurse specialist led education with tailored risk factor advice and 
patient held documentation was well tolerated.  This form of intervention did 
not result in significant improvements in risk factor control, and this may reflect 
under powering.  Patients in the intervention group were more satisfied with the 
amount of information they received, and expressed satisfaction that they felt 
they had someone that they could contact with regard to their stroke disease.  
Further research in this area is warranted since optimisation of risk factors is 
vital for long term health outcomes. 49 
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Table 2.1: Modifiable Risk Factor Targets 
Risk Factor  Target  Guideline 
Blood Pressure  <140/85  National* 
Smoking  Complete Cessation  National
† 
Cholesterol  <5.0  Local 
Diabetes  Random Glucose <8 
HbA1c <7.5 
Local 
*British Hypertension Society Guidelines 1999 (195) 
†Scottish Intercollegiate Guidelines Network 1997 (196) 51 
Table 2.2: Summary of Baseline Characteristics 
  Experiment  Control  p Value 
% (n=100)  % (n=105) 
Mean age  64  66  0.25 
Sex (Male)  54 (54)  49.5 (52)  0.68 
 
     
Diagnosis       
Transient Ischaemic Attack  29.0 (29)  25.7 (27)  0.18 
Stroke  61.0 (61)  64.8 (68)  0.18 
Cerebrovascular Disease  2.0 (2)  3.8 (4)  0.16 
Amaurosis Fugax  4.0 (4)  3.8 (4)  0.21 
Transient Global Amnesia  2.0 (2)  0.0 (0)  0.13 
Retinal Artery Occlusion (embolic)  2.0 (2)  1.9 (2)  0.36 
Modifiable Risk Factors       
Smoker  36.0 (36)  40.0 (42)  0.55 
Number of Cigarettes per day  13  13  0.99 
Hypertensive  66.0 (66)  73.3 (77)  0.26 
Systolic BP (mmHg)  156.2  151.1  0.19 
Diastolic BP (mmHg)  83.4  80.0  0.18 
Diabetic  25.0 (25)  24.8 (26)  0.97 
Random Blood Glucose (mmol/L)  10.73  9.94  0.57 
HbA1C (%)  7.54  7.89  0.58 
Hypercholesterolaemia  79.0 (79)  75.2 (79)  0.52 
Total Cholesterol (mmol/L)  5.8  5.7  0.66 
       
Other Risk Factors       
Previous TIA  18.0 (18)  10.5 (11)  0.12 
Previous stroke  12.0 (12)  21.9 (23)  0.06 
Atrial Fibrillation  2.0 (2)  3.8 (4)  0.45 
         
Number of Modifiable Risk 
Factors 
1  22.0 (22)  24.8 (26)  0.64 
  2  49.0 (49)  40.0 (42)  0.20 
  3  29.0 (29)  32.4 (34)  0.60 
  4  0.0 (0)  2.9 (3)  0.09 
For categorical variables, the Chi
2 statistic has been used. 
For continuous variables the Student’s t test has been used. 
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Table 2.3: Number of Controlled Risk Factors at Follow up 
  Experiment 
(n=94) 
Control 
(n=98) 
p Value 
% (n)  % (n) 
None  28.7 (27)  31.6 (31)  0.79 
1  46.8 (44)  46.9 (46)  0.98 
2  20.2 (19)  20.4 (20)  0.97 
3  4.3 (4)  1.0 (1)  0.16 
4  0.0 (0)  0.0 (0)   
“All  relevant  risk 
factors controlled” 
46.4 
(95% CI 39.1 – 53.7) 
41.7 
(95% CI 34.7 – 48.7) 
0.34 
For categorical variables, the Chi
2 statistic has been used. 
The number of risk factors controlled within the study population expressed as 
numbers of risk factors that fall within the guidelines laid out in Table 1.   
 
 
 
 
 
 
 
Table 2.4: Secondary Outcome Measures including Change in 
Individual Risk Factors 
Variable 
  
Experiment  Control  Student’s 
t-test 
       
Blood Pressure control       
Systolic BP  (mmHg)  -9.2 (SD 23.3, n=64)  -1.0 (SD 22.4, n=72)  P=0.04* 
Diastolic BP  (mmHg)  -2.1 (SD 15.1, n=64)  -1.2 (SD 13.8, n=72)  P=0.71 
         
Diabetic control        
RBG  (mmol/L)  0.9 (SD 5.7, n=23)  0.9 (SD 7.4, n=24)  P=0.99 
HbA1c  (%)  -0.3 (SD 0.7, n=17)  -0.8 (SD 1.5, n=17)  p=0.20 
         
Cholesterol  (mmol/L)  -1.0 (SD 1.1, n=75)  -0.9 (SD 1.2, n=73)  p=0.63 
         
Smoking No  (cpd)  -1.6 (SD 11.5, n=33)  1.1 (SD 8.1, n=37)  P=0.56 
         
EuroQOL*  (%)  3.5 (SD 20.9, n=94)  1.0 (SD 22.4, n=97)  p=0.43 
         
*Bonferroni correction for multiple comparisons; p=0.2853 
 
Table 2.5: Satisfaction with Stroke Services 
Question  Experiment  Control  Pearson 
Chi-
Square  Strongly Agree 
%(n=94) 
Strongly Agree 
%(n=98) 
I  have  been  treated  with  kindness  and 
respect by staff at the hospital.  84% (79)  78% (76)  P=0.252 
The staff attended well to my needs when 
I was at the hospital.  78% (73)  75% (73)  P=0.255 
I was able to talk to the staff about any 
problems I might have had.  75% (70)  57% (56)  P=0.027 
I have received all the information I want 
about the causes and nature of my illness.  70% (66)  51% (50)  P=0.022 
The  doctors  have  done  everything  they 
can to make me well again.  76% (71)  66% (65)  P=0.360 
I am satisfied with the outpatient services 
provided by the hospital.  75% (70)  65% (64)  P=0.080 
I have received enough information about 
my risk factors for stroke.  71% (67)  54% (53)  P=0.010 
Somebody  has  really  listened  and 
understood my needs and problems since I 
attended the hospital. 
 
68% (64)  60% (59)  P=0.212 
I am satisfied with the amount of contact I 
have  had  with  the  hospital  since  I  have 
attended. 
 
73% (69)  62% (61)  P=0.166 
I  have  had  enough  emotional  support 
since I attended the hospital.  60% (56)  48% (47)  P=0.233 
I know whom to contact if I have problems 
relating to my TIA/stroke.  71% (67)  52% (51)  P=0.034 
I am happy with the amount of recovery I 
have made. 
 
59% (55)  55% (54)  P=0.928 
I  was  given  all  the  information  I  needed 
about the  allowances or services I might 
need. 
53% (50)  44% (43)  P=0.436 
Satisfaction expressed as the percentage that strongly agree with the statements. 
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Chapter Three:  
3  Years  On:  Does  Behaviour  Modification  Affect 
Post Stroke Risk Factor Control? 
 
Introduction 
Stroke recurrence is well documented and studies have suggested that rates are 
higher than was initially expected; a 5 year recurrence rate of up to 16% has 
been quoted (197).   As we have examined in Chapter Two, significant progress 
has been made in secondary prevention (198 201), however, evidence is lacking 
with regards to the best methods to promote medication adherence and modify 
health behaviour (202;203).  This is despite considerable evidence accumulating 
in cardiovascular disease regarding both behaviour  modification (114;115;204 
208) and multiple simultaneous risk factor interventions (208).  In addition little 
is known about persistence with secondary prevention measures in stroke or TIA 
patients.  It is reasonable to assume that compliance in the “real world” might 
not reflect that recorded in randomised controlled trials (203). 
We describe a three year follow up study of a short term intervention (outlined 
in Chapter Two) to promote behaviour modification and encourage medication 
concordance. 
The original randomised controlled trial evaluated the impact of a three month 
nurse led behaviour modification program that included counselling on lifestyle, 
risk factors and medication concordance post stroke or TIA (209).  Patients were 
randomised to the intervention for three months, or usual care.  Those in the 
intervention  group  were  given  counselling  and  written  information  regarding 
their  individual  risk  factors,  risk  factor  targets  and  medication.  Despite  not 
achieving  a  global  improvement  in  risk  factors,  there  was  a  statistically 
significant reduction seen in systolic blood pressure at follow up. Patients were 
significantly more satisfied with stroke services – specifically about information.  
We sought to establish if these benefits were maintained in the longer term. 55 
 
Methods 
All contacts from the original study (n=205) were reviewed and cross checked 
with hospital records to exclude those who had died in the interim.  In addition, 
General Practitioners were contacted to confirm a patient’s status.  All living 
contacts  were  then  sent  a  letter  inviting  them  to  participate  in  a  follow  up 
program.  General Practitioners were also informed of the study.  The letter to 
patients was followed two weeks later by a telephone call to invite them to 
participate, and making an appointment at the day hospital facility.  Where this 
was not practical, a home visit was arranged.  Where patients did not attend, 
they  were  contacted  a  second  time  by  telephone  to  offer  them  one  further 
appointment. 
We sought to contact, where possible, every member of the original cohort and 
to avoid loss to follow up.  Where patients did not respond to the letter and 
could not be contacted by telephone, General Practitioners were contacted to 
determine  if  the  patient  had  died  or  moved  and  for  details  of  forwarding 
addresses where available.  Residents of Nursing Homes were not contacted.  No 
residents of nursing homes were recruited to the original study. 
On attendance, the purpose of the study was explained and written consent was 
obtained.  Assessment reviews were conducted by three researchers blinded to 
the  original  patient  allocation.    Details  of  patient  randomisation  from  the 
original study were held on a database that was not accessed until all patient 
reviews had been completed.  
Details  of  the  four  main  modifiable  risk  factors  were  documented.  Blood 
pressure was recorded and smoking history documented. Blood was taken for 
cholesterol measurement and random blood glucose in all patients irrespective 
of their previous history of diabetes or hypercholesterolaemia.  Serum HbA1c 
was recorded in all previously established diabetics.  
Patients  were  asked  to  report  whether  they  had  further  cerebrovascular  or 
cardiovascular events in the interval period.  In addition admissions to hospital 
and  their  cause  were  recorded.    Patients  were  asked  to  fill  in  a  EuroQOL 56 
questionnaire to record perceived health status, a Geriatric Depression Scale and 
a follow up questionnaire on satisfaction with stroke services.   
Medication concordance was documented.  This was assessed in several ways; 
1.  Patients  were  asked  to  bring  all  of  their  current  medication  and 
comparison was made to the repeat prescription for inconsistencies. 
2.  Medication packaging was also checked for any “out of date” medication. 
3.  Patients  were  also  asked  whether  they  considered  themselves  to  be 
compliant with therapy. 
Persistence  with  therapy  was  evaluated  by  comparing  medication  details  at 
follow up, with those documented at completion of the initial study.  
On  completion  of  the  study,  General  Practitioners  were  informed  of  the 
patient’s risk factor status and targets were once again reinforced.   
Data  were  analysed  using  SPSS  version  13.    Dichotomous  data  were  analysed 
using the χ
2 statistic.  Continuous variables were analysed by an independent 
samples T test.  Local ethics committee approval was obtained. 
 
Results 
The mean length of follow up was 3.6 years (SD 0.43).  Of the 205 patients 
enrolled in the initial study, 102 patients attended for follow up (Figure 3.1). 
Reasons for non attendance are documented (Table 3.2).  Twenty five patients 
had died since the completion of the initial study (11 intervention/14 control, 
p=0.39).    All  intervention  patients  in  the  initial  study  were  living  within  the 
community. At time of follow up 5 patients from the control group were resident 
in a nursing home, though no patients from the intervention group had been 
admitted to a care facility. 57 
Risk factor control 
The  primary  outcome  was  collective  risk  factor  control.  Risk  factors  were 
controlled  if  within  local  or national  guidelines.  Table  3.1  demonstrates  that 
there was no significant difference in the percentage of controlled risk factors 
between groups. In addition there was no significant difference in control of the 
four  main  modifiable  risk  factors  (diabetes,  smoking  status,  cholesterol  and 
blood pressure). 
There was no significant interval change in risk factor control between the initial 
and follow up studies. Overall collective risk factor control was suboptimal in 
the initial study and disappointingly there was no significant improvement three 
years on. These results match others described in the literature at 2 years (210). 
The  difference  in  systolic  blood  pressure  documented  in  the  initial  study, 
appears not to have been maintained. 
Clinical outcomes 
Clinical events were self reported. There was no attempt to confirm evidence of 
self reported events or admissions. More than one cerebrovascular event was 
reported by several patients. The total number of strokes was similar between 
groups (Table 3.1); however the total number of reported TIA’s was higher in the 
intervention group. One patient in the intervention group reported 10 possible 
TIA’s  in  the  interval  between  studies.  No  objective  confirmation  of  these 
reported symptoms was possible in this study. The actual number of patients 
with recurrent events between groups was similar and therefore this does not 
reach  statistical  significance.  Ischaemic  heart  disease  episodes  were  more 
frequent in the control group but this was not statistically significant. 
Admission rates differ between groups, the number of admissions was higher in 
the control group, though this was largely due to non vascular aetiology. 
Medication persistence 
Details of ongoing prescription of three secondary prevention medications were 
documented and compared with the initial study data (Table 3.3). Persistence 
was similar in both groups. Despite apparent differences in reported compliance 
and the presence of expired medication between groups, this does not reach 
statistical significance. 58 
Perceived health status 
Overall there was no significant difference between perceived health status and 
Geriatric Depression Score between groups. The number of clinically depressed 
individuals determined by a cut off score of 5 or more on the short form of the 
GDS was greater in the control group (Table 3.1); however this did not reach 
statistical significance. 
Patient  satisfaction  with  stroke  services  was  evaluated  using  a  series  of 
questions on a Likert scale, as per the initial study. Overall satisfaction was high, 
however there was no significant difference in questionnaire scores as shown in 
Table 3.4. Also highlighted are the previously positive questions in the initial 
study. 59 
 
Discussion 
It appears that brief intervention with respect to behaviour modification and risk 
factor control has no long term benefit. This study may be one of few carried 
out showing long term outcomes in post stroke patients; however there are a 
number of important limitations. Firstly, in terms of study size, both the initial 
and follow up studies were largely underpowered and therefore the results have 
to  be  cautiously  interpreted.  It  is  unlikely  that  anything  other  than  major 
differences between groups would be detected and many results in this paper 
could represent a type II statistical error.  
Attrition is inevitable at long term follow up. Attrition bias, where one group of 
patients systematically drop out of follow up is an important risk in behaviour 
modifications. Almost the entire cohort (94%) attended for follow up during the 
initial study and had a clear understanding of what was involved. It could be 
assumed  that  patients  who  have  been  poorly  compliant  with  education  and 
therapy may not be willing to attend for follow up, where their poor compliance 
since the initial study could be exposed. Follow up rates between groups were 
comparable. 
The  estimation  of  recurrent  vascular  events  in  this  study  was  based  on  self 
reporting and no formal confirmation was possible. The apparent difference in 
reported TIAs in the intervention group may be due to increased awareness of 
symptoms following education, or a heightened level of anxiety.  
The gold standard assessment of medication concordance is by electronic or pill 
counting  methods  (211).  We  sought  to  use  multiple  methods  in  this  study  to 
assess adherence behaviour that were felt to be simple and objective. 
Medication  persistence  was  reassuringly  high  in  this  study.  Both  groups  had 
similar high levels of persistence with therapy at follow up; this may explain the 
similarities in risk factor control. This may simply reflect the fact that patients 
who  participate  in  studies  are  more  motivated  and  our  results  may  not  be 
generalisable.   Persistence  with  secondary  prevention  therapies,  in particular 
antithrombotic therapy, has been shown to be similarly high in other short term 60 
studies (212 214). However, in comparison to our study, other evidence suggests 
that  persistence  falls  with  time,  in  particular  with  antihypertensive  therapy 
(215;216). 
A  potential  confounding  factor  for  patients  in  the  Glasgow  area  is  the 
introduction of a chronic disease management programme since the initial study. 
Primary care teams aim to review all patients with a diagnosis of a stroke every 
six months, aiming to address secondary prevention, assess rehabilitation needs 
and provide education. This programme is independent of the study and it is 
likely that both the intervention and control group have undergone review.    
The difference between the two groups in terms of rates of institutionalisation 
raises interesting questions. These differences may be due to chance alone in a 
small study sample. However, it may be related to real clinical differences in 
stroke  recurrence  or  cognitive  decline.  Nursing  Home  residents  were  not 
approached for inclusion in the follow up study for ethical reasons; therefore we 
were  unable  to  determine  the  reason  for  admission.  A  disabling  stroke  and 
cognitive  impairment  secondary  to  vascular  disease  are  common  causes  of 
admission  to  a  Nursing  Home.  In  addition,  cognition  was  not  evaluated  as  a 
clinical outcome in this study. 
 Satisfaction  with  stroke  services  remained  high  within  this  study  population; 
however  the  significant  difference  between  groups  has  not  been  maintained 
long term.  In  the  initial  study,  patients  in  the  intervention  group  felt  more 
satisfied  with  the  information  provided  to  them  about  stroke  disease,  risk 
factors and who to contact in the event of problems. These results have also 
been replicated in a more recent study of short term follow up (217). Further 
work is required with regards to the most effective method in providing ongoing 
education  over  a  longer  time  frame;  it  may  be  that  that  chronic  disease 
management programmes have a role to play.   
It  is  clear  that  management  of  risk  factors  remains  suboptimal.  Overall 
collective risk factor control is poor and it is interesting that it remains very 
similar to results at completion of the initial study. It is disappointing that no 
significant  improvements  have  been  made  in  the  interim  despite  recent 
developments. 61 
Despite this study’s limitations it remains one of the few studies that describe 
the realities of risk factor control in a real world setting over a long time period 
(210). It is the intention of education and behaviour modifying interventions to 
improve  longer  term  compliance  and  satisfaction  and  therefore  further  long 
term research is required. 62 
 
 
 
 
 
Figure 3.1: Trial Flow 
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Table 3.1: Outcome data 
  Intervention 
   (n=49) 
Control 
(n=53) 
Significance 
 
Risk factor control       
 % of controlled risk factors  52% (SD 31.0)  56% (SD 35.4)  p=0.53 
       
 Systolic BP (mean)  143 (SD 18.8)  139 (SD 21.6)  p=0.38 
 Diastolic BP (mean)  74 (SD 10.3)  74 (SD 12.2)  p=0.74 
 Cholesterol  4.3 (SD 1.2)  4.5 (SD 0.9)  p=0.23 
 Diabetic control       
       Random Glucose (mean)  8.1 (SD 5.7)  7.1 (SD 3.5)  p=0.31 
       HbA1c (mean)  8.0 (SD 1.9)  7.5 (SD 1.5)  p=0.43 
 Cigarettes per day (mean)  13 (SD 7.7)  14 (SD 9.2)  p=0.73 
       
Clinical events       
Recurrent Cerebrovascular events  25(n=7)  13(n=6)  p=0.78 
(No. of patients)       
Total number of TIAs  23  10   
Total number of CVAs  2  3   
       
 Ischaemic heart disease events  2  6  p=0.27 
 (No. of patients)       
        
Total No. of admissions (all cause)  13  22  p=0.31 
Vascular admissions  7  11  p=0.69 
         
Perceived Health Status       
 EuroQOL (% score)  62% (SD 20.0)  60% (SD 20.5)  p=0.73 
 Geriatric Depression Score(mean)  3.6 (SD 3.3)  4.3 (SD 4.2)  p=0.36 
 Depressed (by cut-off)  11  16  p=0.49 
       
For categorical variables, the Chi
2 statistic has been used. 
For continuous variables the Student’s t test has been used. 
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Table 3.2: Reason for Non-attendance 
  Intervention 
(n) 
Control 
(n) 
Pearson Chi-
Square  
 
Death  11  14  p=0.39 
Institutionalisation  0  5  p=0.02 
(Death or institutionalisation)  11  19  p= 0.09 
       
Refused-Unwell  1  0  p=0.31 
Refused-No reason   19  11  p=0.09 
Not contactable  20  22  p=0.84 
 
 
 
 
 
 
Table 3.3: Persistence with Therapy 
  Intervention 
%,(n/N) 
Control 
%,(n/N) 
Significance 
 
Persistence with therapy          
   Antiplatelet  95% (44/46)  89% (44/50)  p=0.28 
   Antihypertensive  97% (36/37)  95% (41/43)  p=0.81 
   Statin  88% (32/36)  89% (39/44)  p=0.92 
       
Expired medication (packaging)       
   “yes”  13% (4/32)  6% (2/34)  p=0.42 
            
“Do you always take your 
medicines?” 
     
   “yes”  78% (29/37)  92% (36/39)  p=0.10 
For categorical variables, the Chi
2 statistic has been used. 
For continuous variables the Student’s t test has been used. 
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Table 3.4: Satisfaction with Stroke Services 
Question           % Strongly Agree               
Intervention 
(49) 
Control 
(52) 
Pearson 
Chi 
Square 
I have been treated with kindness 
and respect by staff at the hospital. 
78% 
(38/49) 
 
75% 
(39/52) 
 
p=0.52 
 
The staff attended well to my needs 
when I was at the hospital. 
74% 
(36/49) 
 
75% 
(39/52) 
 
p=0.59 
 
I was able to talk to the staff about 
the problems I might have had.* 
68% 
(30/44) 
 
71% 
(35/49) 
 
p=0.78 
 
I have received all the information I 
want about the causes and nature of 
my illness.* 
53% 
(25/47) 
 
50% 
(26/52) 
 
p=0.54 
 
The doctors have done everything 
they can to make me well again. 
55% 
(26/47) 
 
67% 
(35/52) 
 
p=0.25 
 
I am satisfied with the outpatient 
services provided by the hospital. 
54% 
(26/48) 
 
62% 
(32/52) 
 
p=0.29 
 
I have received enough information 
about my risk factors for stroke.* 
47% 
(22/47) 
 
59% 
(30/51) 
 
p=0.17 
 
Somebody has really listened and 
understood my needs and problems 
since I attended the hospital. 
48% 
(19/40) 
 
 
58% 
(26/45) 
 
 
p=0.61 
 
 
I am satisfied with the amount of 
contact I have had with the hospital 
since I have attended. 
55% 
(26/47) 
 
 
50% 
(25/50) 
 
 
p=0.66 
 
 
I have had enough emotional 
support since I attended the 
hospital. 
52% 
(14/27) 
 
50% 
(17/34) 
 
p= 
0.97 
 
I know whom to contact if I have 
problems relating to my 
TIA/Stroke.* 
43% 
(21/49) 
 
42% 
(22/52) 
 
p=0.98 
 
I am happy with the amount of 
recovery I have made. 
57% 
(28/49) 
 
52% 
(27/52) 
 
p=0.68 
 
I was given all the information I 
needed about the allowances or 
services I might need. 
33%  
(8/24) 
42% 
(14/33) 
p=0.59 
Satisfaction expressed as the percentage that strongly agree with the statements. 
*Previously positive questions 
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Table 3.5: Change in Secondary Outcomes Over Study Period 
Variable  Time   Experiment  Control  Significance 
       
Blood Pressure control       
Systolic BP  3 Months  -9.2 (SD 23.3, n=64)  -1.0 (SD 22.4, n=72)  P=0.04 
(mmHg)  3 Year  -8.5 (SD 24.9, n=33)  -10.6 (SD 25.5, n=41)  p=0.73 
  Interval  
(3 Years –  
3 Months) 
1.8 (SD 26.5, n=32)  -8.3 (SD 25.1, n=43)  p=0.10 
         
Diastolic BP  3 Months  -2.1 (SD 15.1, n=64)  -1.2 (SD 13.8, n=72)  P=0.71 
(mmHg)  3 Year  -2.5 (SD 16.0, n=33)  -4.7(SD 15.9, n=41)  p=0.55 
  Interval  -3.8 (SD 11.0, n=32)  -5.2 (SD 14.0, n=43)  p=0.64 
         
Diabetic control        
RBG  3 Months  0.9 (SD 5.7, n=23)  0.9 (SD 7.4, n=24)  P=0.99 
(mmol/L)  3 Year  0.8 (SD 13.8, n=8)  -0.2 (SD 7.4, n=9)  p=0.85 
  Interval  -1.2 (SD 11.0, n=9)  -0.9 (SD 7.1, n=10)  p=0.95 
         
HbA1c  3 Months  -0.3 (SD 0.7, n=17)  -0.8 (SD 1.5, n=17)  p=0.20 
(%)  3 Year  -0.6 (SD 2.4,n=8)  -0.5 (SD 1.8, n=8)  p=0.93 
  Interval  0.0 (SD 2.0, n=9)  0.0 (SD 1.5, n=8)  p=0.99 
         
Cholesterol  3 Months  -1.0 (SD 1.1, n=75)  -0.9 (SD 1.2, n=73)  p=0.63 
(mmol/L)  3 Year  -1.4 (SD 1.25, n=41)  -1.3 (SD 1.1, n=40)  p=0.51 
  Interval  -0.4 (SD 1.0, n=40)  -0.2 (SD 1.0, n=39)  p=0.47 
         
Smoking No  3 Months  -1.6 (SD 11.5, n=33)  -0.4 (SD 8.1, n=37)  P=0.61 
(cpd)  3 Year  -1.6 (SD11.1, n=15)  1.08 (SD 9.5, n=12)  p=0.51 
  Interval  0.8 (SD 9.3, n=15)  1.0 (SD 9.1, n=12)  p=0.96 
         
EuroQOL*  3 Months  3.5 (SD 20.9, n=94)  -1.0 (SD 22.4, n=97)  p=0.43 
(%)  3 Year  -4.0 (SD 22.9, n=49)  -5.7 (SD 17.4, n=53)  p=0.68 
  Interval  -7.4 (SD 18.9, n=49)  -5.3 (SD 18.8, n=51)  p=0.56 
         
GDS†  Interval  -0.2 (SD 1.9, n=0.49)  -0.6 (SD 3.8, n=51)  p=0.57 
  (3 Years –  
3 Months) 
     
         
 Minus values indicate a reduction in the appropriate measure. 
*Higher scores indicate a higher quality of life score. 
†Higher (positive scores) indicate a greater likelihood of depression. 
For categorical variables, the Chi
2 statistic has been used. 
For continuous variables the Student’s t test has been used. 67 
 
 
 
 
 
Chapter Four:  
Outpatient  Rehabilitation  Services After  Stroke: A 
Descriptive Analysis of the Randomised Trials 
Introduction 
Complex interventions, defined as those made up of  “various interconnecting 
parts”,  encompass  the  majority  of  healthcare  interventions  especially  in  the 
context of rehabilitation (218). Ideally rehabilitation trials should follow the MRC 
framework  for  complex  interventions,  which  recognises  the  challenge  of 
developing, describing and researching complex interventions (219). It proposes 
that their development and testing should follow a series of phases (Figure 4.1).  
 
Figure 4.1: MRC Framework for Complex Interventions
Theory: explore relevant theory and 
best choice of hypotheses 
Modelling: identify components of an 
intervention and underlying 
mechanisms of effect 
Exploratory trial: develop a feasible 
protocol for a definitive trial 
Definitive randomised trial: 
adequately powered testing of 
defined intervention 
Long-term implementation: establish 
that intervention can be widely 
applied 
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The basic sciences underpinning rehabilitation are not well developed and the 
underlying  pathophysiological  rationale  for,  and  intention  of  a  rehabilitation 
intervention are often not clear.  Traditionally rehabilitation trials have been 
developed from an intuitive belief about what may be effective, and most trials 
of  such  interventions  have  not  had  sufficient  statistical  power  to  provide 
definitive  conclusions.    Because  individual  trials  are  often  small,  conclusions 
about  the  effectiveness  of  rehabilitation  interventions  are  often  based  on 
systematic reviews of all the randomised trials.  
In  the  area  of  outpatient  stroke  rehabilitation,  the  number  of  randomised 
controlled trials has increased considerably in recent years (220).   Classifying 
these  separate  interventions  however  presents  some  challenges.    Firstly,  the 
nature  of  stroke  rehabilitation  is  broad,  ill defined  and  multi faceted  (221). 
Secondly,  a  wide  variety  of  outpatient  rehabilitation  services  have  been 
developed  which  address  different  aspects  of  stroke,  including  impairment, 
disability  (activities),  handicap  (participation)  and  mood  status.    Finally, 
rehabilitation services rarely operate in isolation and a variety of comparison 
treatments have been used as controls.   
In the absence of a framework for characterising rehabilitation interventions we 
wished  to  find  a  method  of  identifying  and  classifying  trials  of  stroke 
rehabilitation  in  the  community.    We  therefore  sought  to  develop  a  simple 
classification  system  which  categorises  interventions  by  simple  descriptive 
characteristics to assist in the comparison of similar studies. 
Methods 
 
Identifying Trials 
We  set  out  to  identify  all  randomised  controlled  trials  of  outpatient 
rehabilitation interventions for stroke patients which had been compared with 
normal care. The definition of outpatient rehabilitation was derived from the 
World Health Organisation definition of rehabilitation (221); “a problem solving 
and  educational  process  aimed  at  reducing  the  disability  and  handicap 
experienced by someone as a result of a disease”.  Rehabilitation was therefore 
considered to be any intervention delivered by a “rehabilitation worker” which 69 
aimed to reduce disability or handicap after stroke.  This definition excluded 
drug and surgical interventions and trials of alternative systems of care (e.g. 
home versus hospital based rehabilitation).  Additionally we narrowed our search 
to exclude trials that treated only a specific impairment (e.g. treatments for 
upper limb spasticity) or a specific subgroup of patients (e.g. depressed post 
stroke patients only, or specific ethnic groups only (222)).  Thus the focus of this 
classification  was  at  the  outset  to  describe  interventions  delivered  to  the 
majority of stroke patients or carers in a community setting.  The classification 
of  trials  of  systems  of  care  or  specific  treatments  for  impairments  has  been 
attempted elsewhere [www.effectivestrokecare.org]. 
We searched the Cochrane Controlled Trials Register (8993 trials, search date 
September  2005).    In  addition,  we  searched  the  reference  lists  of  Cochrane 
reviews of outpatient interventions (25;131 133;223;224). Further (unpublished) 
trials were identified by communication with trialists (225 227). 
Selecting Trials:  
Trials for inclusion were identified using the following criteria: 
A randomised controlled trial, recruiting only stroke patients or carers, which 
evaluated an intervention  provided by  a  rehabilitation  worker  (in  comparison 
with no routinely provided intervention), which aimed to reduce some aspect of 
disability or handicap and was carried out in an outpatient setting (i.e. home, 
clinic, day hospital). 
Data collection:  
Trial characteristics were obtained from the available published and unpublished 
sources and recorded in a database.  The method of classifying interventions was 
derived from methods previously discussed at a collaborators’ meeting of the 
Outpatient  Trialists  Collaboration  (228).    This  used  a  simple  Delphi  process 
(229;230)  to  develop,  collect  and  categorise  data  in  an  iterative  process  in 
collaboration with trialists from working in the area.  Each trial intervention was 
described using this classification including the following details: 
Trial identifiers (centre, publication year, contact trialists) 70 
Who provided the intervention (profession or discipline) 
Domains  of  the  intervention  –  these  were  categorised  into  one  of  four 
subcategories; 
1.  Behavioural  –  interventions  which  focus  on  problem  solving  and 
adaptation through the active participation of both therapist and patient 
to  bring  about  changes  in  task orientated  behaviour  (e.g.  walking, 
activities of daily living).  This could incorporate some adaptation of the 
physical environment. 
2.  Psychological  –  interactions  between  rehabilitation  worker  and  patient 
which  focus  on  problem  solving  and  adaptation  through  psychological 
interventions and changes in the patient’s thought or perspective.  This 
could address emotional needs or symptoms and include activities such as 
counselling. 
3.  Informational  –  interventions  which  focus  on  problem solving  and 
adaptation though the provision of information (usually about the disease 
and its consequences). 
4.  Social – interventions which focus on problem solving and adaptation by 
addressing  social  needs  and  influencing  the  social  environment.    This 
frequently involves liaison with other staff or services. 
Delivery  of  the  intervention  –  whether  the  intervention  was  provided  on  an 
individual  or  group  basis  and  whether  it  was  prescriptive  in  delivery  or 
customised to the individual patient. 
1.  Intensity of the intervention – expressed as the total number of treatment 
sessions per month and the duration of the intervention. 
2.  Timing  of  the  intervention;  whether  provided  “early”  (at  hospital 
discharge or similar time after stroke) or at a later stage after stroke (6 
months or more). 71 
3.  Patients/Carers;  whether  the  intervention  was  delivered  to  patients 
and/or carers, or simply to carers alone. 
4.  Intention of the intervention – were the main and intermediate intentions 
of the intervention (e.g. to reduce disability by improving mobility).  This 
should be reflected in the primary outcome measure used in a trial. 
Where  trials  had  more  than  one  intervention  arm,  each  independent 
intervention was classified separately. 
 
Numerical Taxonomy:  
Once standardised information from the original trials had been obtained, we 
carried out a simple numerical taxonomy cluster analysis (231).  Each individual 
trial  intervention  was  examined  for  its  similarity  to  each  of  the  other  trial 
interventions  by  calculating  a  similarity  index  (i.e.  the  proportion  of 
characteristics which were shared by the two interventions under comparison).  
Five characteristics which the collaborative group (228) had previously judged to 
be  important  in  determining  the  nature  of  an  intervention  were  selected  to 
calculate the similarity index: 
1.  Staff  providing  the  intervention  –  categorised  as  physiotherapy, 
occupational therapy, nursing, psychology or volunteer staff. 
2.  Main  domain  of  the  intervention  –  categorised  as  behavioural, 
psychological, informational or social (see Data Collection above). 
3.  Minor  domain(s)  of  the  intervention  –  i.e.  other  characteristics  which 
were present in the intervention but not considered to be the main focus 
of the intervention. 
4.  Method of delivery – categorised as individual or group, customised to the 
individual or prescriptive. 
5.  Intention  of  the  intervention  –  categorised  as  focussing  on  either 
disability or handicap. 72 
 
A  similarity  index  was  calculated  as  the  proportion  of  the  above  five 
characteristics  which  were  shared  by  two  interventions.    The  maximum 
similarity  index  was  1.0.  A  numerical  taxonomy  dendrogram  (231)  was  then 
developed by first grouping together interventions with a similarity index of 1.0, 
and then those of 0.8, then 0.6 etc. until all interventions were linked at some 
level. 
 
Results 
 
8993  titles  were  reviewed  in  the  Cochrane  Controlled  Trials  register.    In 
addition,  155  Cochrane  reviews  and  protocols  were  searched.  A  total  of  149 
trials  were  initially  identified  and  assessed  for  inclusion;  76  were  excluded 
because  they  were  non randomised,  not  targeted  at  stroke  patients,  were 
focussed  on  a  subgroup  of  patients  or  a  specific  impairment,  had  an  active 
intervention  in  the  control  group,  or  did  not  aim  to  reduce  disability  or 
handicap.  (See Figure 4.2) 
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Figure 4.2: Selection of Trials for Inclusion 
 
The process of trial identification and assessment for potential analysis.
8993 Titles in Cochrane 
Controlled Trials 
Register 
155 Cochrane Reviews 
and Protocols 
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·  Subgroup of Stroke 
patients only 
·  Active control group 
·  Not aiming to 
reduce disability or 
handicap 
73 Trials  
(82 Interventions) 
149 Trials assessed 
Contact with trialists 
2 Unpublished trials 74 
 
73  trials  were  finally  selected  as  relevant  for  inclusion,  which  studied  82 
different  interventions  (70;71;71;123;152;153;225 227;232 234;234 239;239 
241;241 245;245 254;254;255;255;256;256;257;257 274;274 300).    We  obtained 
information for 72 trials and limited information regarding 1 trial (301). 
Data were complete for the majority of trials.  Tables 4.1 4.5 outline the basic 
characteristics of the identified randomised trials.  A wide range of approaches 
to delivering outpatient rehabilitation interventions have been or are currently 
being tested.  Most trials recruited a relatively mixed group of patients at the 
time of hospital discharge. 
The numerical taxonomy is displayed in Figure 4.3 and shows several clusters of 
trials which can be characterised under several themes: 
Multidisciplinary rehabilitation after stroke 
This  title  includes  a  broad  range  of  studies  that  generally  evaluated  the 
intervention  of a team  of therapists  providing  multidimensional  rehabilitation 
post  stroke.    They  were  focused  primarily  on  providing  customised  input  in 
behavioural domains with the aim of reducing disability.  The group overall had a 
similarity index of >0.8, differing predominantly in the staff who provided the 
intervention.    This  group  had  a  moderate  similarity  (<0.6)  with  occupational 
therapy based rehabilitation programmes.  They differed from the occupational 
therapy group in the staff who provided the intervention and the intention of 
the intervention (disability Vs handicap).  They had a low similarity index with 
other groups (<0.4).  Within this broad group it is apparent that there are two 
further  distinct  groups  that  deliver  multidisciplinary  interventions  but  with 
differences that are not distinguished on the basis of this classification alone. 
a.)  Early  Supported  Discharge;  These  trials  evaluated  a  team  of  therapists 
providing  a  multidimensional  rehabilitation  programme  immediately  on 
discharge from hospital.  While broadly similar in the timing of the intervention, 
the  co ordination  of  these  services  is  often  more  directly  integrated  with 
inpatient care and in some contexts begins there. 75 
b.) Post Stroke Rehabilitation; These trials generally evaluated the impact of 
input  in  a  behavioural  domain  early  after  stroke,  providing  customised 
interventions with the aim of reducing disability.   The trials had a similarity 
index  of  <0.8,  differing  only  in  the  staff  who  provided  input  or  whether 
interventions  were  customised  or  prescriptive.  Whereas  early  supported 
discharge services had a greater degree of overlap or dovetailing with hospital 
services, post stroke rehabilitation trials were distinct services. 
Occupational Therapy after Stroke;  
These were interventions provided by occupational therapists with the aim of 
reducing handicap and were delivered in a behavioural domain in a generally 
customised fashion.  They have a similarity index of 0.8 – 1.0.  Studies differed 
only in whether the intervention was customised or prescriptive and aimed to 
reduce disability or handicap.  This group of studies had a similarity index of 0.6 
to the Early Supported Discharge Trials and the Post Stroke Rehabilitation group 
as shown above. 
Physical Fitness after Stroke;  
This  group  of  studies  typically  evaluated  interventions  provided  by  a 
physiotherapist late after stroke providing a prescriptive exercise intervention 
intended to improve physical performance or fitness.  The trials had similarity 
index of <0.8 to each other.  They differed significantly from the other groupings 
having a low similarity index of 0.2. 
Social and Psychological Support;   
This grouping covers a more diverse range of studies with a similarity index of 
<0.6.  Typically they evaluate services provided by a nurse, volunteer or social 
worker who provides social support, information and liaison with other services 
aiming  to  reduce  aspects  of  handicap,  especially  improving  quality  of  life  or 
reducing  depression.    Differences  between  studies  existed  in  the  healthcare 
worker  who  delivered  the  intervention,  the  domain  of  the  intervention  (e.g. 
psychological  or  social)  and  whether  the  intervention  was  prescriptive  or 
customised.  This group showed only moderate similarity to other groups (0.4).   76 
Information Provision;  
This  disparate  group  of  trials  generally  evaluated  information  delivered  by 
differing team members at different stages post stroke with different intentions 
(e.g.  improving  knowledge,  mood  or  subjective  health  status).    Overall  they 
have a similarity index of 0.6. 
Discussion 
 
The  main  aim  of  this  was  to  identify  and  classify  the  characteristics  of 
outpatient  rehabilitation  services  for  stroke  patients  after  discharge  from 
hospital.  We therefore focussed on those randomised trials which have tested 
the null hypotheses that the routine intervention by a “rehabilitation worker” 
for  stroke  patients  outwith  hospital  is  no  more  effective  than  no  routine 
intervention.  We did not include trials examining alternative services to hospital 
care  (e.g.  “hospital  at  home”)  although  we  did  include  services  designed  to 
accelerate discharge from hospital. 
Before discussing the implication of this analysis, it is important to acknowledge 
some  of  the  methodological  limitations.    Because  the  basic  sciences 
underpinning rehabilitation are not well established, we have sought to develop 
a classification based on superficial characteristics.  For example who was doing 
what to whom, where, how often and with what intent?  This descriptive method 
may not take into account important components of the intervention. 
Secondly, the analysis described here was developed initially by the Outpatient 
Trialists Collaboration through an iterative process, drawing on their collective 
experience.  As such it might be said to be in part data driven.  The choice of 
different characteristics might well have produced a different clustering.   
The grouping of trials in this taxonomy may not exactly match the choice of 
trials  for  the  Cochrane  reviews  previously  mentioned,  but  bears  a  great 
resemblance.  This similarity is unlikely to be coincidental as these methods of 
classification were initially employed by the Outpatient Trialists Collaboration in 
order  to  identify  areas  for  the  development  of  Cochrane  reviews  and  has 
informed that process.  Similarly, trials that are clustered in the taxonomy may 
not  be  included  in  the  Cochrane  reviews.    This  may  occur  where  based  on 77 
additional information not included in this analysis the reviewers have concluded 
that  the  trial  does  not  meet  the  review  inclusion  criteria.    It  is  hoped  that 
despite  these  limitations,  this  methodology  for  classifying  outpatient 
interventions may prove useful in informing future reviews. 
The current classification does suggest that three major themes emerge from 
these trials.  Firstly there are the “physical rehabilitation” services which are 
typically delivered by either physiotherapists, occupational therapists or a multi 
disciplinary team.  These tend to focus on the physical aspects of disability and 
handicap, and as a whole provide intensive therapy. 
The  second  of  the  themes  concerns  what  might  simply  be  termed  the 
“psychological impact” of stroke.  This more diverse grouping is unified by its 
intention to impact some aspect of the social, psychological or informational 
needs of stroke patients and improve their quality of life or mood. They include 
the use of education, counselling, liaison and social support and are generally 
less intense than physical rehabilitation interventions. 
A separate category is beginning to emerge in stroke rehabilitation trials and it is 
those trials that seek specifically or exclusively to impact on carers after stroke.  
Because  of  the  broad  inclusion  criteria  of  this  analysis,  they  have  not  been 
excluded  where  they  did  not  intervene  with  stroke  patients,  but  have  been 
marked with an asterisk in the dendrogram to indicate where they sit within this 
analysis.  These trials represent a growing area of stroke rehabilitation research 
and may represent the next generation of both primary and secondary research. 
In conclusion, we have identified a heterogeneous group of outpatient stroke 
rehabilitation  services  which  have  been  tested  within  randomised  controlled 
trials  and  provided  a  simple  taxonomy  of  their  content.    Most  of  these 
interventions can be fitted into one of three descriptive themes.  We believe 
that this can form the basis for future discussion and research, informing the 
gaps in primary and secondary research. 
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Table 4.1: Therapy Based Rehabilitation and Family Support Trials 
 
Intervention 
Ref 
Staffing  Domain  Delivery  Timing  Intention 
Physio  OT  Nursing  SW  Other  Major  Minor  Customised  Prescriptive  Early  Late  (Target) 
Therapy Based Rehab                            
Copenhagen  (272)  ●          B  S,I  ●    ●    Disability, ADL 
Hong Kong 95  (273)  ●          B,S  I  ●    ●    Disability, Mood 
Kansas  (274)  ●          B      ●  ●    ADL, Mobility 
London (intens) 81  (275)  ●  ●        B    ●    ●    ADL 
London (convent) 81  (302)  ●  ●        B    ●    ●    ADL 
Vancouver 91  (278)    ●        B, S    ●      ●  Leisure 
London 00  (277)  ●  ●      Med and 
SLT 
B, I  S  ●    ●    Disability, ADL 
                           
Family Support/Carers                            
Toronto 92  (71)    ●        S      ●    ●  Social Support 
Groningen  (258)      ●      I, S  Psy    ●  ●    Carer strain 
Alabama  (75)      ●      S, Psy      ●  ●    Caregiver strain, 
Social functioning,  
Mood 
London 04  (21)  ●  ●  ●      B  I    ●  ●    Carer strain, 
Patient ADL,  
Dependence 
B – Behavioural, I – Information, Psy – Psychological, S - Social 81 
Table 4.2: Physical Fitness Training Trials 
Intervention 
Ref 
Staffing  Domain  Delivery  Timing  Intention 
Physio  OT  Nursing  SW  Other  Major  Minor  Customised  Prescriptive  Early  Late  (Target) 
Physical Fitness 
Training 
                          
Duncan 98  (274)  ●  ●        B    ●    ●    ADL, Mobility 
Cuviello-Palmer 88  (282)  ●          B      ●  ●    Mobility, Fitness 
Dean 00  (284)  ●          B      ●  ●    Mobility, Fitness 
Glasser 86  (285)  ●          B      ●  ●    Mobility 
Inaba 73  (286)  ●          B      ●  ●    Strength 
Kim 01  (287)  ●          B      ●    ●  Strength, Mobility 
Pohl  02 (treadmill)  (288)  ●          B      ●    ●  Mobility 
Potempa 95  (289)  ●          B      ●    ●  Fitness 
Tiexeira 99  (291)  ●          B      ●    ●  Fitness, Strength 
Pohl  02 (physio)  (288)  ●          B    ●      ●  Mobility 
Young 92  (303)  ●          B,I    ●    ●    Disability, ADL 
Werner 96  (304)  ●  ●        B  S  ●      ●  Disability, ADL 
Yokokawa 91  (301)  ●          B, I    ●      ●  Fitness, Mood 
Wade 92  (221)  ●          B  I  ●      ●  Mobility, ADL 
B – Behavioural, I – Information, Psy – Psychological, S - Social 82 
Table 4.3: Information Provision and Early Supported Discharge Trials 
Intervention  Ref  Staffing  Domain  Delivery  Timing  Intention 
Physio  OT  Nursing  SW  Other  Major  Minor  Customised  Prescriptive  Early  Late  (Target) 
Information Provision                            
Birmingham 93  (248)      ●      I    ●    ●    Knowledge, Mood 
Seattle  (73)    ●    ●    I  S,B    ●  ●    Knowledge, Family function 
Minneapolis  (153)  ●  ●  ●      I  S,B    ●    ●  Depression / Mood 
Newcastle 99  (152)    ●  ●  ●    I  S, B    ●  ●    Subjective Health status 
Knowledge 
Birmingham 92  (251)          ●  i      ●  ●    Knowledge 
Bradford 03  (155)  ●  ●  ●      I  S,B    ●  ●    Knowledge, Handicap 
                           
Early Supported 
Discharge 
                          
Stockholm  (269)  ●  ●    ●  ●  B  S  ●    ●    ADL / Disability 
Newcastle  (267)  ●  ●    ●  ●  B    ●    ●    ADL / Disability 
Adelaide  (259;261)  ●  ●    ●  ●  B  I  ●    ●    Disability 
Belfast  (264)  ●  ●      ●  B    ●    ●    Disability 
London  (305)  ●  ●      ●  B    ●    ●    Disability / ADL 
Manchester  (265)  ●  ●  ●    ●  B    ●    ●    Disability 
Montreal  (266)  ●  ●  ●    ●  B    ●    ●    Disability 
Oslo  (268;306)  ●  ●  ●      B    ●    ●    Disability 
Trondheim  (270)  ●  ●        B  I,S  ●    ●    Disability / ADL 
Akershus  (262)  ●        ●  B    ●    ●    Disability / Length of Stay 
Bangkok  (263)      ●    ●  B    ●    ●    Disability 
B – Behavioural, I – Information, Psy – Psychological, S   Social 83 
Table 4.4: Occupational Therapy Trials 
Intervention  Ref  Staffing  Domain  Delivery  Timing  Intention 
Physio  OT  Nursing  SW  Other  Major  Minor  Customised  Prescriptive  Early  Late  (Timing) 
OT                            
Cardiff 95  (233)    ●        B,S  I  ●    ●    ADL 
Glasgow 00  (234)    ●        B,S    ●    ●    ADL, Disability 
Netherlands 01  (237)    ●        B    ●    ●    ADL 
Nottingham 95 (Leisure)  (276)    ●        S, B    ●    ●    Leisure, Disability 
Nottingham 95 (ADL)  (276)    ●        B,S    ●    ●    Disability, Leisure 
Nottingham 96  (239)    ●        B,S    ●    ●    ADL 
Nottingham 97  (307)    ●        B,S    ●    ●    ADL 
Nottingham 99  (241)    ●        B,S    ●    ●    ADL 
Total 01 (LEI)  (245)    ●        B,S    ●    ●    Disability, Handicap 
Total 01 (ADL)  (245)    ●        B,S    ●    ●    Disability, Handicap 
Vancouver 89  (246)    ●        B    ●    ●    ADL, Satisfaction 
Nottingham 01  (232)    ●        B,S,I    ●      ●  Dependence, ADL 
Ontario 83 (A)  (244)    ●        B    ●    ●    ADL 
Ontario 83 (B)  (244)    ●        B      ●  ●    ADL 
Ontario 83 (C)  (244)    ●        B      ●  ●    Disability 
Hong Kong 01  (308)    ●        B      ●  ●    ADL 
Hong Kong 04  (236)    ●        B      ●  ●    ADL 
Nottingham 00  (242)    ●        B,S      ●  ●    Disability, Handicap 
Mount 00  (309)    ●        B      ●  ●    ADL 
B – Behavioural, I – Information, Psy – Psychological, S   Social 84 
Intervention  Ref  Staffing  Domain  Delivery  Timing  Intention 
Physio  OT  Nursing  SW  Other  Major  Minor  Customised  Prescriptive  Early  Late  (Target) 
SLW                            
Adelaide  (300)      ●      S,I    ●    ●    QOL / EADL 
Glasgow 04  (298)      ●      I,B    ●    ●    Risk Factor Control / QOL 
Melbourne (SHIPS)  (299)      ●      S,I  B  ●    ●    ADL / QOL 
Chicago   (310)      ●      S,I  P  ●    ●    Mood / Strain 
Utrecht  (297)      ●      I  B    ●  ●    Satisfaction / QOL / Mood 
Bradford 96  (70)      ●      S,I  B    ●  ●    EADL 
Preston  (295)      ●      S,i      ●  ●    EADL 
Indianapolis  (311)      ●      B  P    ●  ●    ADL 
Rhode Island  (226)        ●    P,I  S    ●  ●    QOL/EADL 
Edinburgh 97  (255)        ●    S,I  P  ●    ●    EADL 
Melbourne 84  (254)        ●    S  P,I  ●      ●  Institutionalisation/ Disability 
Boston  (293)          ●  p  I,s  ●    ●    ADL 
Mansfield  (123)          ●  P,I  S  ●    ●    Mood / EADL 
Liverpool (Psych)  (227)          ●  P,I  S  ●    ●    QOL / Mood 
Leeds House 00 (Psych)  (279)          ●  P  I  ●    ●    EADL 
Oxford  (32)          ●  S,I    ●    ●    QOL / EADL 
Liverpool (FSO)  (227)          ●  S,I  P  ●    ●    QOL / Mood 
London  (296)          ●  S,I  P  ●    ●    EADL 
Philadelphia  (257)          ●  S,P  I  ●    ●    EADL/ QOL/ Participation 
Leeds House 00 
(Volunteer) 
 
(279) 
        ●  S,I    ●    ●    EADL 
Table 4.5: Stroke Liaison Worker Trials 
B – Behavioural, I – Information, Psy – Psychological, S   Social 85 
Chapter Five:  
Meta-analysis  of  Stroke  Liaison  Workers  for 
Patients and Carers. 
 
Introduction 
 
As we have seen in Chapter One, for many patients stroke is associated with 
significant  psychosocial  problems  for  both  patients  and  carers.    These 
include depression anxiety, reduced social networks, information needs and 
dissatisfaction  with  the  diversity  in  service  provision.    These  might  be 
considered the psychosocial complications of stroke that affect not only the 
patient  but  also  their  social  network  and  carers.    As  we  have  seen  in 
Chapter  One  a  potential  result  of  these  psychosocial  problems  is  an 
association  with  increasing  social  isolation,  depression,  poor  health  and 
increased mortality (22;23;45 47;89 91;94;96;97).   
 
Support  following  discharge  from  hospital,  information  about  stroke  and 
available resources, and practical help have been identified by patients and 
carers as services that they would value (312).   In Chapters Two and Three 
we evaluated an intervention with a predominantly educational component 
that  attempted  to  target  the  informational  needs  associated  with  poor 
compliance  and  its  associated  problems.        This  appeared  to  result  in 
improved satisfaction with components of information provision and liaison.  
However, these results did not appear to be maintained at three years post 
intervention (Chapter Three). 
 
As we have seen in Chapter Four, a number of similar studies exist in the 
context of outpatient services for stroke and TIA.  These interventions as 
yet have not been evaluated in a systematic review of their effectiveness.  86 
The nurse secondary prevention study in Chapter Two appears to fit into this 
group of fairly diverse interventions.  What unites these interventions is that 
they are intended for a broad group of stroke patients and the aim of the 
intervention  is  to  improve  some  aspect  of  rehabilitation  in  its  broadest 
form.  Where they differ is primarily in the profession that provides the 
intervention,  or  in  the  primary  recipient  of  the  intervention  (patient  or 
carer). 
 
While some studies did report positive effects of these interventions (32), 
none were found to have a significant impact on psychological outcomes or 
quality of life.  This may have been due to small sample size and type II 
statistical  error.    Meta analysis  of  similar  studies  offers  the  potential  to 
overcome type II statistical errors that have resulted from underpowered 
individual studies (313). 
 
Whilst  it  is  well  recognised  that  there  are  associations  between  the 
psychosocial  problems  post  stroke  and  worsened  clinical  outcomes 
(89;91;94;97),  developing  an  intervention  for  these  problems  becomes 
problematic.    It  is  dangerous  to  assume  that  association  is  the  same  as 
causation.    The  absence  of  a  clear  underlying  pathophysiology  for  many 
rehabilitation  interventions  means  that  we  remain  uncertain  as  to  the 
mechanisms  of  some  problems  post  stroke  (such  as  depression)  and 
therefore uncertain as to the mechanisms of an intervention (such as social 
support or counselling).  As a result there has been the testing of a number 
of “black box” interventions in randomised controlled trials, which it has 
been hoped might “happen upon” a mechanism for effective interventions 
into real problems.  Many of these trials are underpowered to detect a real 
clinical benefit and therefore in combining these studies in meta analysis we 
are most likely to see if they are truly effective.  For many areas of stroke 
care it is this process of secondary research that has provided coherent and 
conclusive  evidence  where  individual  trials  have  been  disappointing  or 
conflicting (131;223;314).   
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Criticism of meta analysis often centres around its combining of trials and 
the  perceived  risk  that  it  combines  differing  studies  (313).    The  risk  of 
combining  irreconcilably  different  trials  is  best  addressed  by  careful 
attention to the methods of the review.  In addition it is important that the 
participant group included in the review are carefully described in advance.  
These safeguards can be achieved through the pre planned classification of 
trials for inclusion, careful attention to the types of intervention, careful 
description of the comparisons (i.e. what are the control group to receive) 
and  perhaps  more  fundamentally  to  the  methods  of  the  trial  (e.g. 
randomised  controlled  trial  versus  controlled  trial  or  interrupted  time 
series) (313).    This assessment must also include a method of trial quality 
assessment to determine the potential risks of bias within a trial or a review 
process  (313;315).    These  quality  features  include  the  methods  of 
randomisation,  the  efforts  to  provide  allocation  concealment,  and  the 
attention to other factors such as blinding and intention to treat analysis 
(313). 
 
 
Before attempting a review of these trials we need to consider which are 
combinable and what descriptives we would give to the intervention.  On 
reviewing  the  group of  studies  in  more  detail,  it  becomes  apparent  that 
there  are  additional  similarities  not  described  by  our  taxonomy  process 
(Chapter Four).   
 
1.  The  intervention  evaluated  in  these  trials  is  a  multifaceted 
intervention.  That is the intervention has several distinct areas of 
focus  that  differentiate  them  from  the  trials  of  (for  example) 
information provision alone.  Specifically, the trials appear to provide 
aspects  of  information  provision,  liaison,  and  social  support  in 
combination.  The degree to which they provide all three may vary, 
however  it  becomes  apparent  that  they  provide  a  comprehensive 
intervention.  The overall intention of these interventions might be 
described as aiming to return patients and carers to normal roles. 88 
 
2.  The participants in each of these trials can be broadly divided into 
four groups: 
 
a.  Those interventions that solely address patients and evaluate 
patient outcomes. 
b.  Those that address and evaluate patient and carer outcomes 
together. 
c.  Those  that  address  only  caregivers  and  evaluate  caregiver 
outcomes. 
d.  Those  that  evaluate  an  intervention  for  a  subset  of  stroke 
patients only (e.g. depressed patients).  
 
It is easy to see that combining trials that evaluate patients and those 
that  evaluate  only  caregivers  raises  problems  of  incompatible 
populations and outcomes.  Additionally trials that evaluate a sub 
population of patients (such as depressed patients post stroke) cannot 
provide  generalisation  to  a  general  stroke  population  or  permit 
combination  with  trials  that  attempt  to  address  that  entire 
population.    The  two  remaining  groups  that  offer  some  hope  for 
combination in a review process therefore are those that evaluate 
patient  outcomes  alone  or  those  that  evaluate  patients  in 
combination  with  caregivers.    This  could  offer  some  potential 
additional information about the interventions effects on caregivers.   
 
3.  The methods of studies considered for this review process has been 
implied in our previous chapter on a taxonomy of trials.  Randomised 
controlled trials provide the best available method for evaluating an 
intervention without the introduction of systematic bias.  Combining 
randomised controlled trials provides the least risk of bias within a 
meta analysis. 
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In summary a stroke liaison worker can be defined as a healthcare worker 
whose  aim  is  to  help  return  patients  and  their  carers  to  normal  roles. 
Typically  they  provide  emotional  and  social  support  and  information  to 
stroke patients and their families and liaise with services with the aim of 
improving aspects of participation and quality of life for patients with stroke 
and/or their carers (316). This multi faceted role distinguishes stroke liaison 
workers from interventions whose aim is to treat a single problem such as 
improving activities or knowledge (e.g. trials of information provision). A 
stroke liaison worker may be a health or social care professional, or be from 
the voluntary sector. Such services have been evaluated under a range of 
different names, such as 'social work' (254;281), 'specialist nurse support' 
(70), 'stroke family care worker' (76), and 'stroke family support organiser' 
(32). For the purposes of this review, such services have been grouped under 
the generic title of 'stroke liaison worker'. There has been one descriptive 
review  of  published  trials  of  'support  workers'  within  the  context  of  a 
broader  review  of  non drug  strategies  aimed  at  reducing  psycho social 
problems after stroke (317). No meta analysis of these studies has yet been 
attempted.  
 
Objectives 
 
To determine the effects of intervention from a stroke liaison worker for 
patients  with  stroke  and  their  carers  in  returning  to  normal  roles,  (as 
measured by improving social activities, participation, and mental health).  
 
 
Methods 
 
Criteria for considering studies for this review 
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Types of studies 
We wanted to review only randomised controlled trials comparing allocation 
to intervention from a stroke liaison worker with no intervention or normal 
care. 
 
Types of participants 
We included trials of survivors of acute stroke with or without their closest 
informal carer. A clinical definition of stroke was used: rapidly developing 
clinical symptoms and/or signs of focal, and at times global loss of cerebral 
function (318). Studies that included TIA patients were not excluded since 
TIA  is  part  of  the  same  disease  spectrum  and  patients  with  TIAs,  while 
seldom having reduced activities, may have reduced participation and a high 
level of anxiety regarding stroke recurrence (138). Participants had to be 
adult (aged 16 or over). Trials that address carer needs alone (and did not 
include patients) were not considered. 
 
Types of interventions 
We considered only trials that evaluated referral to a stroke liaison worker. 
Such  a  worker  would  typically  provide  a  multi faceted  service  including 
more than one of the following: education and information provision; social 
support;  and  liaison  with  other  services  (228).  Often  this  intervention  is 
provided from the point of patient discharge from hospital.  Trials assessing 
workers of any professional background were considered relevant, and might 
include health or social care professionals or volunteers.  Studies where the 
intervention  was  judged  to  be  single  faceted  were  excluded.    This 
distinction is to separate the stroke liaison worker interventions from trials 
of  (for  example)  information  provision  alone  (133).    Similarly,  trials  of 
therapist delivered physical rehabilitation or psychological interventions on 
their own were excluded.  The control group had to receive no intervention 
or usual care. 
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Types of outcome measures 
Outcomes for Patients  
Primary: Subjective Health Status (e.g. GHQ12 (319), SF36 (320), EuroQOL 
(184));  extended  activities  of  daily  living  (including  social  activities  e.g. 
Nottingham EADL (321), Frenchay Activities Index (322)).  
Secondary:  death;  place  of  residence  (institutionalisation);  activities  of 
daily  living  (e.g.  Barthel  (323),  FIM  (324));  dependency  (e.g.  Functional 
Ambulatory  Categories  (325),  Modified  Rankin  (326));  mental  health   
including anxiety and depression (e.g. GDS (327), GHQ (319), HADS (328)); 
knowledge  about  stroke;  use  of  services;  satisfaction  with  services; 
participation (e.g. Reintegration to Normal Living Scale (329)).  
 
Outcomes for Carers  
Primary: Subjective Health Status (including measures of carer strain e.g. 
Carer Strain Index (330), GHQ, SF36).  
Secondary:  Extended  activities  of  daily  living  (e.g.  Frenchay  Activities 
Index,);  mental  health  (e.g.  GHQ,  HADS  etc.);  knowledge  about  stroke, 
satisfaction with services. 
 
Search strategy for identification of studies 
Relevant trials were identified in the Cochrane Stroke Group's trials register. 
The register was searched for trials that relate to psychological therapy, 
counselling, social support, therapists, service provision, support workers, 
carer training, or information giving. 
 
In  addition  we  searched  the  following  bibliographic  databases:  Cochrane 
Central  Register  of  Controlled  Trials  (latest  issue);  MEDLINE  (from  1966); 
EMBASE  (from  1980);  CINAHL  (from  1982);  ASSIA  (Applied  Social  Science 
Index and Abstracts, from 1987); PsychINFO (from 1967); and Social Science 92 
Citation Index (from 1956). The search strategy for MEDLINE is shown below. 
This was adapted for the other databases. 
 
1. stress, psychological/ 
2. psychosocial$.tw. 
3. social adjustment/ 
4. adaptation, psychological/ 
5. activities of daily living/ 
6. exp interpersonal relations/ 
7. morale/ 
8. (cope or coping).tw. 
9. patient satisfaction/ 
10. exp emotions/ 
11. ((psychological or social) and (problem$ or difficult$)).tw. 
12. exp social isolation/ 
13. emotion$.tw. 
14. stress/ 
15. knowledge, attitudes, practice/ 
16. exp motivation/ 
17. quality of life/ 
18. anxiety/ 
19. caregivers/ 
20. life change events/ 
21. depression/ 
22. life style/ 
23. social behavior/ 
24. mental health/ 
25. knowledge/ 
26. psychomotor performance/ 
27. exp family relations/ 
28. or/1 27 
29. patient care management/ 
30. continuity of patient care/ 93 
31. needs assessment/ 
32. rehabilitation nursing/ 
33. home nursing/ 
34. "referral and consultation"/ 
35. social support/ 
36. exp professional patient relations/ 
37. ((patient$ or carer or caregiver$ or famil$) adj10 support$).tw. 
38. patient education/ 
39. exp social work/ 
40. community health services/ 
41. (home or in home or home based).tw. 
42. health services for the aged/ 
43. ((patient$ or carer or caregiver$ or famil$) adj10 information$).tw. 
44. family health/ 
45. family care$.tw. 
46. outreach.tw. 
47. advice.tw. 
48. counseling/ 
49. counsel?ing.tw. 
50. nursing assessment/ 
51. aftercare/ 
52. volunteer$.tw. 
53. exp rehabilitation/ 
54. communit$.tw. 
55. empathy/ 
56. visitor$.tw. 
57. patient centered care/ 
58. health education/ 
59. interview, psychological/ 
60. exp patient care planning/ 
61. domiciliary.tw. 
62. (liaison or link or contact).tw. 
63. Home care services/ 94 
64. ambulatory care/ 
65. or/29 64 
66. exp cerebrovascular disorders/ 
67. (stroke$ or cva$ or cerebrovascular or cerebral vascular or post stroke 
or transient isch$ or TIA).tw. 
68. (cerebral or cerebellar or brain$ or vertebrobasilar).tw. 
69. (infarct$ or isch?emi$ or thrombo$ or emboli$ or apoplexy).tw. 
70. 68 and 69 
71. (cerebral or brain or subarachnoid).tw. 
72. (haemorrhage or hemorrhage or haematoma or hematoma or bleed$ or 
aneurysm).tw. 
73. 71 and 72 
74. hemiplegia/ or exp aphasia/ or hemianopsia/ 
75. (aphasi$ or dysphasi$ or hemianop$ or hemipleg$ or hemipar$).tw. 
76. 66 or 67 or 70 or 73 or 74 or 75 
77. 28 and 65 and 76 
78. limit 77 to human 
 
In order to identify further published and unpublished studies, a citation 
search  was  carried  out  using  the  Web  of  Science  Citation  Indices,  the 
reference lists of identified relevant trials were  checked, and authors of 
relevant  papers  were  contacted.  Relevant  conference  proceedings  were 
reviewed,  trials  registers  were  searched,  and  contact  was  made  with 
investigators  in  this  area  of  stroke  services  trials.    Finally,  a  poster 
presentation  was  made  at  a  major  international  conference  to  invite 
interest from trialists (European Stroke Congress 2005). 
 
Methods of the review: Selection of studies 
Obviously  irrelevant  articles  were  first  excluded  by  me  (GE).    Two 
independent  reviewers  (GE  &  Peter  Langhorne  (PL))  then  reviewed  the 
retrieved abstracts of papers identified.  Papers that clearly did not meet 
the inclusion criteria were excluded at this stage, and the reason recorded. 95 
A  full  text  copy  of  all  possibly  relevant  papers  was  obtained,  and  two 
independent  reviewers  (GE  &  PL)  also  assessed  these  according  to  pre 
defined inclusion criteria. Where there was disagreement, the intention was 
that  Simon  Winner  and  Martin  Dennis  would  moderate.    This  was  not 
required.  
 
Contact with trialists and data collection 
The contact author or lead investigator was contacted and invited to join a 
collaborative review process.  Individual patient data were requested and 
authors were invited to meet in Glasgow to discuss the development of the 
review.  (The members of this collaborative group are listed at the end of 
this chapter.) 
Authors were asked prior to the meeting for additional information including 
information  on  design  characteristics,  the  study  population,  the 
intervention, outcome measures used, and length of follow up, as well as 
additional information regarding the intervention that may not have been 
apparent in the published papers.  Where authors could not be contacted, 
these trial grids were completed by the author and supervising reviewer (PL) 
independently.    Details  on  the  intervention  were  then  used  to  construct 
subgroups according to the apparent emphasis of the intervention (liaison; 
education and information provision; social support). 
The trial grid is attached in Appendix G. 
 
At the trialists meeting (04/03/05), the intentions of the review process and 
methods  were  discussed.    Trialists  were  invited  to  comment  on  the 
classification system developed for grouping trials.  The trialists felt that 
the initial system developed (analysis by primary emphasis, Table 5.2) did 
not adequately describe the similar and differing studies.  This discussion 
led to the development of a subsequent classification (Table 5.1) which was 
used for the primary analysis. 
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Figure 5.1: Definitions of Intervention Subgroups 
 
 
Additional subgroup analyses were suggested by the group and are noted in 
the minutes of the meeting (Appendix H).  These included analysis of the 
intervention by the profession of the individual providing the intervention.  
The  results  were  also  to  be  presented  stratified  by  timing  of  referral  to 
stroke  liaison  worker  (less  than  six  months  after  stroke;  more  than  six 
months after stroke).  
 
Analysis by patient characteristics included subgroups defined by sex, age 
(<65  and  ≥65),  the  presence  or  absence  of  a  main  carer  and  patient 
functional status at baseline.  This last subgroup was considered because 
one trial in particular had suggested that patients with mild to moderate 
functional dependence had the most to gain from the intervention (70).  For 
this reason the same definitions of dependence were used as in the original; 
trial  (Severe  dependence  =  Barthel  <15;  Mild  to  moderate  dependence  = 
Barthel  15 19;  Independent  =  Barthel  20).    All  subgroup  definitions  were 
made prior to data analysis and blind to review data. 
Following  discussion  with  the  trialists,  interventions  were  characterised  in 
three ways: 
 
Proactive and Structured.   
These  interventions  of  a  consistent  intensity  sought  to  contact  all  patients 
proactively, and provided input for a defined period of follow up only.  They 
often covered a range of predefined topics against for example a checklist, 
irrespective of a patients stated needs. 
 
Reactive and Flexible.   
These trials typically provided a flexible intervention that met needs as they 
presented or as requested for a more open-ended time period and variable 
intensity. 
 
Proactive and Focused.   
These  trials  sought  to  contact  all  patients  consistently  and  offer  a  similar 
intensity  of  intervention,  but  often  focussing  on  a  specific  issue  (such  as 
mental health or risk factor control). 
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Assessment of quality 
Eligible trials were not given a quality score (331). Nevertheless, the trials 
were coded with regard to quality of randomisation procedure, method of 
consent,  concealment  of  treatment  allocation,  blinding  of  patients  and 
carers, blinding of outcome assessor, and handling of withdrawals and drop 
outs (313).  
 
Analysis 
Outcome  measures  were  classified  according  to  which  domain  they  were 
assessing  (activities  of  daily  living;  extended  activities  of  daily  living; 
participation;  dependency;  mental  health;  subjective  health  status; 
knowledge about stroke; use of services; satisfaction with services).  Most of 
the  scales  used  were  ordinal.    If  the  same  measure  had  been  used  in 
different studies, then a weighted mean difference was calculated across 
trials using the Cochrane statistical package RevMan 4.2 (Update Software).  
No meta analysis was performed where grossly differing outcome measures 
preclude combination.  Where it was possible to dichotomise the data, then 
odds ratios and 95% confidence intervals were calculated for each study. 
Where it was not possible to dichotomise the data, the effects on outcome 
were summarised in terms of direction of effect (in favour of intervention or 
control),  and  the  size  of  the  effect  (in  terms  of  standardised  mean 
differences).  Results are presented separately for patients and carers for 
each domain of outcome.  
 
Prior to data analysis, an analysis plan was constructed which included the 
apriori  selection  of  outcome  measures  that  would  be  used  in the  review 
process.  This pre planned method was used where trialists had evaluated 
an outcome with more than one outcome measure.  Where one measure 
(e.g.  Frenchay  Activities  Index)  was  used  by  several  trials,  the  most 
commonly used measure was selected.  There was the potential risk of the 98 
reviewer  selecting  an  outcome  measure  that  had  achieved  more  positive 
results, thus influencing the results and it was hoped that the prior planning 
of analysis would reduce that risk.   
In  the  analysis  of  satisfaction,  due  to  differences  between  trials  in  the 
questions  that  were  asked,  it  became  necessary  to  select  questions  for 
comparison.    An  analysis  table  of  satisfaction  questions  was  constructed  
(Table 5.29).  Questions were selected for analysis only if they appeared in 
two or more studies.  All satisfaction questions involved a likert scale with 
four  separate  categories  of  satisfaction  (highly  satisfied,  satisfied, 
dissatisfied  and  highly  dissatisfied).    Results  were  contracted  into  a 
dichotomised outcome (satisfied or dissatisfied) and data were entered into 
analysis to produce an odds ratio for reporting being satisfied. 
 
Individual patient data was cross checked for completeness on receipt.  In 
addition  they  were  cross  checked  with  published  data.    For  subgroup 
analysis, data were split into separate databases and analysed separately.  
Double  data  entry  was  used  for  data  entry  into  RevMan  to  ensure  the 
avoidance  of  simple  errors.    The  direction  of  effect  for  each  outcome 
measure in each trial was checked and all tables were cross checked on 
completion for errors and completeness. 99 
Figure 5.2: Trial Selection
10,848 Titles reviewed 
45 Abstracts or Papers Reviewed 
31 Not suitable 
5 not RCTs  
6 interventions for caregivers only  
5 education interventions alone  
7 rehabilitation interventions  
5 single faceted intervention only  
2 defined sub-population only 
 
16 Included RCTs 
Data 
  12 Individual patient data 
3 Additional data available from authors  
1 Published data only 
 
Contact with trialists 
2 Unpublished studies 
10,803 excluded by title alone 100 
 
Results 
 
Review process results 
The  search  strategy  revealed  10,848  titles  to  be  reviewed  (search  date 
August  2004).    From  these  titles  45  studies  were  selected  as  being  of 
possible  relevance  to  the  review.    Where  possible  the  full  text  of  these 
studies was sought or the abstract where a full paper was not available.  Of 
these  studies,  31  were  considered  unsuitable  for  the  systematic  review.  
Five were not randomised controlled trials, six evaluated interventions for 
caregivers only.  A further five studies evaluated education interventions 
only.  Seven studies evaluated some form of physical rehabilitation and a 
further  five  evaluated  a  single  faceted  intervention  only  such  as  social 
support alone (71).  Two additional studies were identified that evaluated 
only  a  sub population  (such  as  post  surgical  subarachnoid  haemorrhages 
only).  Trial selection is illustrated in Figure 5.2.   
 
Selected Trials 
The  search  strategy  identified  14  published  randomised  trials.    Two 
additional unpublished trials were identified following contact with trialists.  
One (Leeds) evaluated two interventions in separate arms; the input of a 
volunteer or a psychologist for problem solving therapy compared to usual 
care.  One study (Liverpool – the “Life after Stroke” study) evaluated three 
separate interventions, alone or combined.  These included a stroke family 
support  worker  (social),  a  psychology  intervention  (psychology)  and  an 
occupational therapy intervention (physical).  Only the stroke family support 
worker and the psychology arms of the study were considered relevant for 
inclusion  and  where  these  elements  were  combined,  the  data  were  also 
excluded. 101 
Individual  patient  data  were  obtained  for  12  studies,  with  additional 
tabulated data obtained for two additional trials (Philadelphia STAIR study 
and  Adelaide).    Limited  information  from  one  unpublished  trial  was 
available  from  correspondence  with  the  author  (Melbourne  SHIPS  trial).  
Published data only were available for one additional trial (Melbourne). 
The 16 trials came from 4 countries (Australia, Holland, UK and USA).  Most 
were based in city hospitals and evaluated services in urban populations.  13 
studies described adequate allocation concealment. (Tables 5.10–5.25)  11 
studies performed blinding of the final outcome assessor and two studies 
performed additional patient blinding by a means of delayed or modified 
consent (Edinburgh, Utrecht) (159).   
The intervention characteristics are shown in Tables 5.10 5.25.  Subgroup 
allocations  for  the  primary  analysis  are  shown  in  table  5.1.    Four 
interventions  were  classified  as  employing  a  proactive  and  structured 
approach  to  the  intervention.    Eight  interventions  were  reactive  and 
flexible,  whilst  six  interventions  employed  a  proactive  but  focussed 
approach.  Subgroup analysis by intervention emphasis is also illustrated in 
table 5.2.   
Publication bias is recognised as potential risk for meta analysis.  Negative 
studies are less likely to be published or cited and therefore are at risk of 
not being included in a meta analysis (313).  As a result the review is likely 
to  bias  towards  a  more  positive  treatment  result.    Similarly,  studies  of 
poorer methodological quality are more likely to show a positive result and 
give rise to a biased result due to methodological bias.  To evaluate the risk 
of publication bias in this review, we prepared a funnel plot of all included 
studies for the primary outcome (subjective health status) shown in Figure 
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Figure 5.3:  Funnel Plot of Included Trials 103 
The analysis plan for each trial and outcome measure is shown in Tables 
5.26 28.  The satisfaction questions selected for comparison are shown in 
Table 5.29. 
 
Available data for some outcomes was very limited and not combinable.  For 
instance  knowledge  was  only  apparently  evaluated  in  two  studies 
(Oxford/Mansfield).    Neither  study  used  validated  methods  to  test  that 
knowledge and data were only available for one study (Oxford).  For this 
reason, no attempt has been made to perform a meta analysis of knowledge 
as an outcome.  Similarly, data on caregiver knowledge were only available 
for one study (Oxford).  Resource or service usage was reported in several 
studies  (Edinburgh,  Liverpool,  Melbourne  SHIPS,  Oxford,  Philadelphia  and 
Utrecht).    Data  were  only  available  for  two  of  these  studies  (Oxford, 
Utrecht).    Due  to  variations  in  service  provision,  and  differences  in  the 
available data it was felt to be too difficult to combine and dichotomise 
these data.  For this reason, no meta analysis of service usage has been 
performed.   
 
After  receipt  of  data  it  became  apparent  that  analysis  of  mental  health 
under  one  single  heading  was  potentially  inaccurate  where  some  general 
measures of mental health (such as GHQ28) were being combined with more 
specific  measures  of  depression  (such  as  the  HADS Depression  scale)  or 
anxiety (HADS Anxiety scale).  In addition, since it was apparent that some 
studies had used the Anxiety scale of the HADS, it was felt to be of potential 
additional value to split mental health outcomes into depression and anxiety 
in  addition  to  analysis  under  a  generic  mental  health  domain.    It  was 
considered  plausible  that  the  intervention  might  reduce  anxiety  without 
necessarily  reducing  depression.    This  decision  was  made  post hoc,  and 
therefore  the  results  are  presented  with  that  caution  alongside  generic 
mental health results as originally planned. 
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Review results 
These data are presented in two stages for simplicity.  Overall data have 
been  presented  here  with  subgroups  as  pre planned  by  the  collaborative 
group according to intervention characteristic (Table 5.1, Figures 5.4 5.50).   
Primary Patient outcomes 
 
1.  Subjective health status: Analysis of data for 3349 participants (13 
interventions) did not show a significant overall difference between 
the intervention and control groups for this outcome, although the 
direction of effect was in favour of the intervention (SMD  0.05, 95% 
CI  0.11 to 0.02, p=0.18).  Tests for heterogeneity were borderline 
(Chi
2  heterogeneity  p=0.08),  however  no  single  subgroup  showed  a 
significant effect.   Considerable heterogeneity (Chi
2 heterogeneity 
p=0.007)  was  present  in  the  Proactive  and  Structured  subgroup, 
largely due to the positive results of one study (Preston). 
 
2.  Extended activities of daily living: Analysis of data for 3258 patients 
(15 interventions) did not show any benefit of Stroke Liaison Workers 
over control group for an improvement in extended activities of daily 
living (SMD 0.04, 95% CI  0.03 to 0.11, p=0.22).  In addition there 
were no positive subgroups.  No significant subgroup interaction was 
present (Chi
2 heterogeneity p>0.05). 
 
Secondary Patient Outcomes 
 
1.  Death:  There was no significant effect of the Stroke Liaison Worker 
intervention  on  the  outcome  of  death.    (4181  participants,  16 
interventions, OR 0.87, 95% CI 0.72 to 1.06, p=0.17).  There was no 
single subgroup effect and no subgroup interaction (Chi
2 p>0.05). 
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2.  Place of residence (Institutionalisation):  Data was more limited for 
analysis  of  institutionalisation  (1146  participants,  6  interventions), 
however there was no overall effect (OR 0.83, 95% CI 0.51 to 1.36, 
p=0.46) and no significant subgroup effect (Chi
2 p>0.05). 
 
3.  Activities of daily living:  No significant benefit was seen on activities 
of  daily  living  for  the  intervention  group  compared  to  the  control 
group (3457 participants, 15 interventions, SMD  0.02, 95% CI  0.09 to 
0.05, p=0.55).  No subgroup interaction existed (Chi
2 p>0.05). 
 
4.   Dependency:    Data  on  dependency  was  more  limited  (1494 
participants,  4  trials)  and  were  not  available  for  one  subgroup 
(Proactive and Focused).  No overall benefit was seen for the Stroke 
Liaison Worker intervention, with the direction of benefit favouring 
the control group (SMD 0.03, 95% CI  0.07 to 0.14, p=0.53).  There 
was  no  significant  heterogeneity  seen  between  the  two  remaining 
subgroups  (Chi
2  p  >0.05).    Few  outcome  measures  for  dependency 
were used, providing only limited outcome data for dependency (four 
trials, 1,494 participants).  In contrast a larger number of studies (12 
interventions,  2,906  participants),  used  the  Barthel  measure.    We 
therefore decided to dichotomise the Barthel measure as an outcome 
for  dependency.    The  potential  “cut point”  for  dependency  was 
discussed with trialists and set at 19/20 (i.e. dependent in one or 
more  activities  of  daily  living).    This  decision  was  made  prior  to 
analysis of the data without prior knowledge of the results.  Analysis 
using  this  outcome  for  dependency  yielded  greater  participant 
involvement across a greater range of studies.  In addition it allowed 
the  use  of  odds  ratios  for  an  identical  outcome  measure  allowing 
more accurate combination of results.  For this reason, subsequent 
analyses for the outcome of dependency were conducted using this 
definition  of  dependency.    Overall,  there  was  no  significant 
difference between the treatment and control groups for a reduction 
in dependence (OR 0.90, 95% CI 0.76 to 1.06, p=0.20).  There was a 106 
trend to a reduction in dependence in the Proactive and Structured 
group (OR 0.72, 95% CI 0.52 to 1.01, p=0.06), although this was not 
statistically significant and there was no subgroup interaction (Chi
2 
p>0.05). 
 
5.  Mental Health (Generic): Data were available for 3314 participants 
from 15 interventions.  Overall results did not suggest any beneficial 
effect  of  Stroke  Liaison  Workers  compared  to  control  for  an 
improvement in mental health score (SMD  0.02, 95% CI  0.09 to 0.05, 
p=0.56).  One subgroup (the Proactive and Focused subgroup) showed 
a trend toward benefit from the Stroke Liaison Workers versus control 
(p=0.09).    This  might  not  be  surprising  given  that  many  of  the 
interventions in this group had a psychological focus, however there 
was no subgroup interaction (Chi
2 p>0.05) to support this effect. 
 
6.  Mental  Health  (Depression):  Analysis  of  data  from  15  interventions 
(2949 participants) did not show any evidence of a beneficial effect 
from  the  input  of  a  Stroke  Liaison  Worker  when  compared  to  the 
control group, despite the direction of effect favouring the treatment 
group (SMD  0.05, 95% CI  0.12 to 0.02, p=0.17).  Again one group 
(Proactive and Structured) demonstrated a trend towards a benefit 
from the Stroke Liaison Workers  (p=0.08), however again there was 
no subgroup interaction to support this effect (Chi
2 p>0.05). 
 
7.  Mental  Health  (Anxiety):    Data  were  available  for  two  subgroups 
(Proactive  and  Structured,  Reactive  and  Flexible)  involving  5 
interventions (1222 participants).  No significant benefit was seen for 
the  intervention  group  (WMD   0.20,  95%  CI   0.66  to  0.26,  p=0.39).  
Tests  for  heterogeneity  were  borderline  overall  (p>0.05), 
predominantly because of one study (Adelaide) that showed a positive 
treatment  effect  ( 1.7,  95%  CI   2.89  to   0.51),  however  this  study 
reported  differences  in  the  groups  at  baseline  that  may  have 
accounted for the effect. 107 
 
8.  Participation:  Results  for  participation  were  more  limited  in  the 
number of participants (n=886) and only available for one subgroup 
(Reactive and Flexible).  Overall there were no significant differences 
between the groups (SMD  0.04, 95% CI  0.17 to 0.10, p=0.59) and 
there was no heterogeneity within the available subgroup (p>0.05). 
 
Primary Caregiver Outcome: 
 
1.  Caregiver  Subjective  Health  Status:  Data  for  1921  caregivers  was 
available from 15 interventions.  The predominant measure used was 
the Carer strain index (9/13 trials).  For this reason, this measure was 
used  in  the  Oxford  study,  rather  than  the  more positive published 
Carer  SF36.  Although  the  direction  of  effect  was  in  favour  of  the 
control group, there was no overall significant effect (SMD 0.04, 95% 
CI   0.05  to  0.13,  p=0.33)  and  no  significant  subgroup  or  subgroup 
interaction (Chi
2 p>0.05). 
 
Secondary Caregiver Outcomes: 
 
1.  Caregiver  extended  activities  of  daily  living:  Only  two  subgroups 
(Proactive and Structured, Reactive and Flexible) had adequate data 
from  5  trials  (776  participants).    There  was  a  trend  to  an 
improvement in extended activities of living in the control group (SMD 
 0.13,  95%  CI   0.28  to  0.01,  p=0.07).    No  significant  subgroup 
interaction existed (Chi
2 p>0.05). 
 
2.  Caregiver  mental  health:  Data  for  1777  caregivers  was  analysed 
across 13 intervention arms.  No significant overall effect or subgroup 
effect  existed.  (SMD   0.02,  95%  CI   0.12  to  0.07,  p=0.62,  
heterogeneity p>0.05). 108 
 
Patient Satisfaction Data 
Satisfaction data are presented in Figures 5.18 5.34 
 
In summary, only one domain of patient satisfaction reached a statistically 
significant result with data from three trials (915 participants).  Patients in 
the intervention group were significantly more satisfied that “Someone has 
really listened” (OR 1.58, 95% CI 1.14 to 2.19, p=0.006).  Subgroup results 
suggested  borderline  heterogeneity  (Chi
2  p=0.07),  with  one  subgroup 
(Reactive and Flexible) strongly positive (two trials, n=439, p=0.0005) and 
one (Proactive and Structured) being neutral (one trial, n=470, p=0.61). 
 
Carer Satisfaction Data 
Carer Satisfaction data are presented in Figures 5.35 5.50 
 
 
Four questions for carers yielded statistically significant results. 
1.  “I received all the information I needed about the nature and causes 
of the patient’s illness” was included in three trials (459 caregivers) 
from one subgroup (Reactive and Flexible).  The question was positive 
in favour of the Stroke Liaison Worker arm of the trial (OR 1.72, 95% 
CI 1.04 to 2.85, p=0.03). 
 
2.  “I  have  received  enough  information  about  recovery  and 
rehabilitation” was answered favourably by the treatment group in 
three trials (457 caregivers, OR 1.98, 95% CI 1.25 to 3.14, p=0.004). 
 
3.  “Someone has really listened” was answered in two trials (Edinburgh 
and London), both in the same subgroup, with a smaller number of 
caregivers (n=300, OR 2.56, 95% CI 1.52 to 4.31, p=0.0004). 
 109 
4.  Caregivers in the Stroke Liaison Workers group were more likely to 
report that they felt that they were not neglected (OR 2.62, 95% CI 
1.44 to 4.77, p= 0.002) than in the control group. 110 
Table 5.1: Subgroup Analysis: Intervention Characteristics 
  N in 
analysis 
Analysis  Total [95% CI]  Subgroup 
Heterogeneity 
(Chi
2) 
Subgroup Results 
          Proactive and 
Structured 
Reactive and Flexible  Proactive and Focused 
Primary Outcomes for Patients               
Subjective Health Status  3349  SMD  -0.05 (-0.11, 0.02), p=0.18  >0.05  -0.05 (-0.17, 0.07), 
p=0.43 
0.01 (-0.10, 0.13), 
p=0.83† 
-0.10 (-0.22, 0.01), 
p=0.08 
Extended Activities of Daily Living  3260  SMD   0.04 (-0.03, 0.11), p=0.23  >0.05   0.09 (-0.03, 0.21), 
p=0.15 
0.07 (-0.04, 0.18), 
p=0.22 
-0.05 (-0.18, 0.08), 
p=0.49† 
               
Secondary Outcomes for Patients               
Death  4183  OR   0.87 (0.72, 1.06),  p=0.17  >0.05  1.14 (0.66, 1.95), 
p=0.64† 
0.83 (0.65, 1.06), p=0.14  0.86 (0.59, 1.27), p=0.46 
Place of Residence (Institutionalisation)  1146  OR   0.83 (0.51, 1.36),  p=0.46  >0.05  1.00 (0.34, 2.94), p=1.00  1.00 (0.42, 2.38), p=1.00  0.67 (0.32, 1.39), p=0.28 
Activities of Daily Living  3463  SMD  -0.02 (-0.09, 0.05), p=0.55  >0.05  0.07 (-0.06, 0.20), 
p=0.32 
-0.03 [-0.14, 0.07], 
p=0.51† 
-0.08 [-0.20, 0.05], 
p=0.22† 
Dependence*  2908  OR   0.90 (0.76, 1.06),  p=0.20  >0.05  0.72 (0.52, 1.01), p=0.06  0.95 (0.74, 1.21), p=0.67  0.99 (0.73, 1.33), p=0.94 
Depression  2949  SMD  -0.05 (-0.12, 0.02), p=0.17  >0.05  -0.13 (-0.28, 0.02), 
p=0.08 
0.03 (-0.08, 0.15), 
p=0.56† 
-0.09 (-0.21, 0.03), 
p=0.14 
Anxiety  1222  SMD  -0.20 (-0.66, 0.26), p=0.39  >0.05  -0.38 (-0.18, 0.42), 
p=0.35 
-0.11 (-0.67, 0.45), 
p=0.70 
NA 
Participation  886  SMD  -0.04 (-0.17, 0.10), p=0.59  NA  NA  -0.04 (-0.17, 0.10), 
p=0.59 
NA 
               
Primary Outcome for Carers               
Subjective Health Status  1915  SMD   0.04 (-0.05, 0.13), p=0.33†  >0.05  0.06 (-0.10, 0.21), 
p=0.46† 
0.02 (-0.12, 0.16), 
p=0.76† 
0.06 (-0.12, 0.25), 
p=0.49† 
               
Secondary Outcome for Carers               
Extended Activities of Daily Living  752  SMD  -0.13 (-0.28, 0.01), p=0.07†  >0.05  -0.10 (-0.35, 0.15), 
p=0.42† 
-0.15 (-0.32, 0.03), 
p=0.10† 
NA 
Caregiver Mental Health  1777  SMD  -0.02 (-0.12, 0.07), p=0.62  >0.05  0.02 (-0.15, 0.20), 
p=0.80† 
-0.08 (-0.22, 0.06), 
p=0.27 
0.02 (-0.16, 0.21), 
p=0.81† 
               
Subgroup analysis was stratified by intervention characteristic 
*Defined as Barthel score ≤19 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) 
SMD = Standardised Mean Difference, OR = Odds Ratio 111 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 01 Subjective Health Status                                                                                   
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                120    123.25(115.02)       120    108.80(95.14)       7.23      0.14 [-0.12, 0.39]       
Preston                  87    158.36(113.82)        89    218.94(127.37)      5.15     -0.50 [-0.80, -0.20]      
Utrecht                 227    -60.28(20.88)        246    -59.39(20.99)      14.25     -0.04 [-0.22, 0.14]       
Rhode Island             62    -54.33(23.28)         82    -57.97(22.71)       4.25      0.16 [-0.17, 0.49]       
Subtotal (95% CI)    496                         537  30.88     -0.05 [-0.17, 0.07]
Test for heterogeneity: Chi² = 12.20, df = 3 (P = 0.007), I² = 75.4%
Test for overall effect: Z = 0.79 (P = 0.43)
02 Reactive and Flexible
Liverpool                85      3.66(4.10)          77      4.74(4.13)        4.84     -0.26 [-0.57, 0.05]       
Edinburgh               156      8.22(7.05)         154      7.57(7.13)        9.35      0.09 [-0.13, 0.31]       
Oxford                  156      4.39(0.91)         167      4.36(1.00)        9.74      0.03 [-0.19, 0.25]       
Adelaide                 39    -39.70(6.40)          40    -40.90(7.60)        2.38      0.17 [-0.27, 0.61]       
Mansfield               126     16.55(7.62)         124     16.41(7.39)        7.55      0.02 [-0.23, 0.27]       
Subtotal (95% CI)    562                         562  33.84      0.01 [-0.10, 0.13]
Test for heterogeneity: Chi² = 4.00, df = 4 (P = 0.41), I² = 0%
Test for overall effect: Z = 0.22 (P = 0.83)
03 Proactive and Focused
Leeds (Psychology)      151      4.50(5.26)         150      5.77(5.31)        9.02     -0.24 [-0.47, -0.01]      
Leeds (Volunteers)      149      5.52(5.40)         150      5.77(5.31)        9.02     -0.05 [-0.27, 0.18]       
Liverpool (Psych)        39      3.90(4.33)          77      4.74(4.13)        3.11     -0.20 [-0.58, 0.19]       
Boston (FIRST)          129      2.77(1.05)         134      2.80(1.05)        7.94     -0.03 [-0.27, 0.21]       
Glasgow                 100    -63.06(21.41)        105    -62.58(22.82)       6.18     -0.02 [-0.30, 0.25]       
Subtotal (95% CI)    568                         616  35.28     -0.10 [-0.22, 0.01]
Test for heterogeneity: Chi² = 2.57, df = 4 (P = 0.63), I² = 0%
Test for overall effect: Z = 1.73 (P = 0.08)
Total (95% CI)   1626                        1715 100.00     -0.05 [-0.11, 0.02]
Test for heterogeneity: Chi² = 20.63, df = 13 (P = 0.08), I² = 37.0%
Test for overall effect: Z = 1.34 (P = 0.18)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 02 Extended Activities of Daily Living                                                                        
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                120     13.37(8.73)         120     12.19(9.39)        7.42      0.13 [-0.12, 0.38]       
Preston                  87     16.02(10.25)         89     14.81(10.64)       5.44      0.12 [-0.18, 0.41]       
Utrecht                 236     19.34(2.20)         252     19.31(1.75)       15.10      0.02 [-0.16, 0.19]       
Rhode Island             63     23.51(10.27)         81     20.75(12.26)       4.36      0.24 [-0.09, 0.57]       
Subtotal (95% CI)    506                         542  32.32      0.09 [-0.03, 0.21]
Test for heterogeneity: Chi² = 1.60, df = 3 (P = 0.66), I² = 0%
Test for overall effect: Z = 1.43 (P = 0.15)
02 Reactive and Flexible
Liverpool                84     12.70(7.49)          77     12.03(7.45)        4.97      0.09 [-0.22, 0.40]       
Edinburgh               164     21.66(9.66)         164     21.24(11.55)      10.16      0.04 [-0.18, 0.26]       
Oxford                  156     16.23(11.48)        167     15.98(10.56)       9.99      0.02 [-0.20, 0.24]       
Adelaide                 32     21.60(5.50)          30     18.30(5.10)        1.83      0.61 [0.10, 1.12]        
Mansfield               126     23.64(16.48)        124     25.73(16.26)       7.73     -0.13 [-0.38, 0.12]       
London                   83    -15.06(3.05)          86    -16.00(3.22)        5.18      0.30 [-0.01, 0.60]       
Subtotal (95% CI)    645                         648  39.86      0.07 [-0.04, 0.18]
Test for heterogeneity: Chi² = 9.23, df = 5 (P = 0.10), I² = 45.8%
Test for overall effect: Z = 1.24 (P = 0.22)
03 Proactive and Focused
Leeds (Psychology)      116     12.74(10.79)        124     15.37(11.97)       7.38     -0.23 [-0.48, 0.02]       
Leeds (Volunteers)      124     14.37(11.23)        124     15.37(11.97)       7.68     -0.09 [-0.33, 0.16]       
Liverpool (Psych)        39     13.64(7.84)          77     12.03(7.45)        3.19      0.21 [-0.18, 0.60]       
Philadelphia (STAIR)     21     31.00(8.30)          21     31.10(10.70)       1.30     -0.01 [-0.62, 0.59]       
Boston (FIRST)          133     10.83(3.15)         134     10.68(2.98)        8.27      0.05 [-0.19, 0.29]       
Subtotal (95% CI)    433                         480  27.82     -0.05 [-0.18, 0.08]
Test for heterogeneity: Chi² = 4.42, df = 4 (P = 0.35), I² = 9.5%
Test for overall effect: Z = 0.70 (P = 0.49)
Total (95% CI)   1584                        1670 100.00      0.04 [-0.03, 0.11]
Test for heterogeneity: Chi² = 17.81, df = 14 (P = 0.22), I² = 21.4%
Test for overall effect: Z = 1.23 (P = 0.22)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 03 Death                                                                                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Bradford                   17/120             15/120          5.86      1.16 [0.55, 2.44]        
 Preston                     7/87               8/89           3.31      0.89 [0.31, 2.56]        
 Utrecht                     7/263              5/273          2.17      1.47 [0.46, 4.68]        
Subtotal (95% CI) 470                482  11.33      1.14 [0.66, 1.95]
Total events: 31 (Treatment), 28 (Control)
Test for heterogeneity: Chi² = 0.40, df = 2 (P = 0.82), I² = 0%
Test for overall effect: Z = 0.47 (P = 0.64)
02 Reactive and Flexible
 Liverpool                  12/137             20/139          8.24      0.57 [0.27, 1.22]        
 Melbourne                  11/110             20/103          8.46      0.46 [0.21, 1.02]        
 Edinburgh                  19/210             22/207          9.17      0.84 [0.44, 1.60]        
 Oxford                     65/156             67/167         17.17      1.07 [0.68, 1.66]        
 Adelaide                    1/35               1/33           0.45      0.94 [0.06, 15.69]       
 Mansfield                  17/126             24/126          9.44      0.66 [0.34, 1.31]        
 London                     30/170             28/170         10.49      1.09 [0.62, 1.91]        
Subtotal (95% CI) 944                945  63.41      0.83 [0.65, 1.06]
Total events: 155 (Treatment), 182 (Control)
Test for heterogeneity: Chi² = 5.58, df = 6 (P = 0.47), I² = 0%
Test for overall effect: Z = 1.48 (P = 0.14)
03 Proactive and Focused
 Leeds (Psychology)         21/150             22/149          8.63      0.94 [0.49, 1.79]        
 Leeds (Volunteers)         22/147             22/149          8.45      1.02 [0.54, 1.93]        
 Liverpool (Psych)           4/67              20/139          5.56      0.38 [0.12, 1.15]        
 Philadelphia (STAIR)        0/21               0/20                 Not estimable         
 Boston (FIRST)              7/146              6/145          2.61      1.17 [0.38, 3.56]        
 Glasgow                     0/100              0/105                Not estimable         
Subtotal (95% CI) 631                707  25.25      0.86 [0.59, 1.27]
Total events: 54 (Treatment), 70 (Control)
Test for heterogeneity: Chi² = 2.70, df = 3 (P = 0.44), I² = 0%
Test for overall effect: Z = 0.74 (P = 0.46)
Total (95% CI) 2045               2134 100.00      0.87 [0.72, 1.06]
Total events: 240 (Treatment), 280 (Control)
Test for heterogeneity: Chi² = 9.71, df = 13 (P = 0.72), I² = 0%
Test for overall effect: Z = 1.37 (P = 0.17)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 04 Place of Residence                                                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Bradford                    7/120              7/120         18.92      1.00 [0.34, 2.94]        
Subtotal (95% CI) 120                120  18.92      1.00 [0.34, 2.94]
Total events: 7 (Treatment), 7 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.00 (P = 1.00)
02 Reactive and Flexible
 Liverpool                   9/137              9/139         23.96      1.02 [0.39, 2.64]        
 Adelaide                    2/35               2/33           5.57      0.94 [0.12, 7.08]        
Subtotal (95% CI) 172                172  29.54      1.00 [0.42, 2.38]
Total events: 11 (Treatment), 11 (Control)
Test for heterogeneity: Chi² = 0.00, df = 1 (P = 0.95), I² = 0%
Test for overall effect: Z = 0.00 (P = 1.00)
03 Proactive and Focused
 Liverpool (Psych)           3/67               9/139         16.05      0.68 [0.18, 2.59]        
 Philadelphia (STAIR)        2/21               2/20           5.32      0.95 [0.12, 7.46]        
 Boston (FIRST)              7/146             11/145         30.17      0.61 [0.23, 1.63]        
Subtotal (95% CI) 234                304  51.54      0.67 [0.32, 1.39]
Total events: 12 (Treatment), 22 (Control)
Test for heterogeneity: Chi² = 0.14, df = 2 (P = 0.93), I² = 0%
Test for overall effect: Z = 1.08 (P = 0.28)
Total (95% CI) 526                596 100.00      0.83 [0.51, 1.36]
Total events: 30 (Treatment), 40 (Control)
Test for heterogeneity: Chi² = 0.77, df = 5 (P = 0.98), I² = 0%
Test for overall effect: Z = 0.74 (P = 0.46)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 05 Activities of Daily Living                                                                                 
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                120     15.94(4.67)         120     15.57(4.86)        7.17      0.08 [-0.18, 0.33]       
Preston                  87     14.44(5.66)          89     13.44(4.79)        5.24      0.19 [-0.11, 0.49]       
Utrecht                 236     19.34(2.20)         252     19.31(1.75)       14.57      0.02 [-0.16, 0.19]       
Subtotal (95% CI)    443                         461  26.98      0.07 [-0.06, 0.20]
Test for heterogeneity: Chi² = 1.00, df = 2 (P = 0.61), I² = 0%
Test for overall effect: Z = 0.99 (P = 0.32)
02 Reactive and Flexible
Liverpool                92     15.27(5.75)          86     14.34(6.41)        5.30      0.15 [-0.14, 0.45]       
Melbourne (SHIPS)        42     20.00(0.00)          45     20.00(0.70)              Not estimable         
Edinburgh               210     16.76(11.91)        207     16.81(12.24)      12.46      0.00 [-0.20, 0.19]       
Oxford                  156     15.09(5.36)         167     16.07(4.98)        9.60     -0.19 [-0.41, 0.03]       
Adelaide                 39     18.70(2.00)          40     17.40(3.90)        2.31      0.41 [-0.03, 0.86]       
Mansfield               126     13.74(4.95)         124     14.63(4.23)        7.44     -0.19 [-0.44, 0.06]       
London                   94     14.13(5.83)          89     14.06(5.84)        5.47      0.01 [-0.28, 0.30]       
Subtotal (95% CI)    759                         758  42.58     -0.03 [-0.14, 0.07]
Test for heterogeneity: Chi² = 9.10, df = 5 (P = 0.11), I² = 45.1%
Test for overall effect: Z = 0.65 (P = 0.51)
03 Proactive and Focused
Leeds (Psychology)      151     15.40(4.78)         150     16.52(4.29)        8.93     -0.25 [-0.47, -0.02]      
Leeds (Volunteers)      149     15.76(4.84)         150     16.52(4.29)        8.91     -0.17 [-0.39, 0.06]       
Liverpool (Psych)        45     14.02(7.05)          86     14.34(6.41)        3.53     -0.05 [-0.41, 0.31]       
Philadelphia (STAIR)     20    103.60(25.10)         20    102.50(27.10)       1.20      0.04 [-0.58, 0.66]       
Boston (FIRST)          131     89.50(14.10)        134     86.50(18.20)       7.89      0.18 [-0.06, 0.42]       
Subtotal (95% CI)    496                         540  30.45     -0.08 [-0.20, 0.05]
Test for heterogeneity: Chi² = 7.36, df = 4 (P = 0.12), I² = 45.6%
Test for overall effect: Z = 1.23 (P = 0.22)
Total (95% CI)   1698                        1759 100.00     -0.02 [-0.09, 0.05]
Test for heterogeneity: Chi² = 20.02, df = 13 (P = 0.09), I² = 35.1%
Test for overall effect: Z = 0.59 (P = 0.55)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 06 Dependency                                                                                                 
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                120     -3.80(1.63)         120     -3.84(1.58)       16.37      0.02 [-0.23, 0.28]       
Utrecht                 237      1.43(0.99)         251      1.45(1.04)       33.25     -0.02 [-0.20, 0.16]       
Subtotal (95% CI)    357                         371  49.61      0.00 [-0.15, 0.14]
Test for heterogeneity: Chi² = 0.08, df = 1 (P = 0.78), I² = 0%
Test for overall effect: Z = 0.07 (P = 0.95)
02 Reactive and Flexible
Edinburgh               210      4.60(13.28)        207      3.34(6.87)       28.38      0.12 [-0.07, 0.31]       
Oxford                  156    -15.41(5.42)         167    -15.45(5.04)       22.00      0.01 [-0.21, 0.23]       
Subtotal (95% CI)    366                         374  50.39      0.07 [-0.07, 0.21]
Test for heterogeneity: Chi² = 0.56, df = 1 (P = 0.45), I² = 0%
Test for overall effect: Z = 0.95 (P = 0.34)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    723                         745 100.00      0.03 [-0.07, 0.14]
Test for heterogeneity: Chi² = 1.16, df = 3 (P = 0.76), I² = 0%
Test for overall effect: Z = 0.63 (P = 0.53)
 -1  -0.5  0  0.5  1
 Favours treatment  Favours control  
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 10 Dependence (Defined as a Barthel </= 19)                                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Bradford                   81/102             82/105          5.56      1.08 [0.56, 2.11]        
 Preston                    45/63              54/62           5.20      0.37 [0.15, 0.93]        
 Utrecht                    47/236             65/252         16.84      0.72 [0.47, 1.10]        
Subtotal (95% CI) 401                419  27.60      0.72 [0.52, 1.01]
Total events: 173 (Treatment), 201 (Control)
Test for heterogeneity: Chi² = 3.43, df = 2 (P = 0.18), I² = 41.7%
Test for overall effect: Z = 1.91 (P = 0.06)
02 Reactive and Flexible
 Liverpool                  65/92              67/86           6.80      0.68 [0.35, 1.35]        
 Edinburgh                 116/210            118/207         17.79      0.93 [0.63, 1.37]        
 Oxford                    110/146            105/148          8.60      1.25 [0.75, 2.10]        
 Adelaide                   19/32              18/30           2.52      0.97 [0.35, 2.69]        
 Mansfield                  84/95              86/92           3.38      0.53 [0.19, 1.51]        
 London                     78/94              72/89           4.21      1.15 [0.54, 2.45]        
Subtotal (95% CI) 669                652  43.31      0.95 [0.74, 1.21]
Total events: 472 (Treatment), 466 (Control)
Test for heterogeneity: Chi² = 3.45, df = 5 (P = 0.63), I² = 0%
Test for overall effect: Z = 0.42 (P = 0.67)
03 Proactive and Focused
 Leeds (Psychology)         83/116             81/124          7.45      1.34 [0.77, 2.31]        
 Leeds (Volunteers)         82/124             81/124          9.17      1.04 [0.61, 1.75]        
 Boston (FIRST)             75/134             85/135         12.47      0.75 [0.46, 1.22]        
Subtotal (95% CI) 374                383  29.09      0.99 [0.73, 1.33]
Total events: 240 (Treatment), 247 (Control)
Test for heterogeneity: Chi² = 2.45, df = 2 (P = 0.29), I² = 18.2%
Test for overall effect: Z = 0.07 (P = 0.94)
Total (95% CI) 1444               1454 100.00      0.90 [0.76, 1.06]
Total events: 885 (Treatment), 914 (Control)
Test for heterogeneity: Chi² = 11.43, df = 11 (P = 0.41), I² = 3.8%
Test for overall effect: Z = 1.28 (P = 0.20)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 07 Mental Health - Generic                                                                                    
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Preston                  87      9.26(6.04)          89     10.41(6.30)        5.34     -0.19 [-0.48, 0.11]       
Utrecht                 263     35.33(2.90)         273     35.13(3.21)       16.32      0.07 [-0.10, 0.23]       
Rhode Island             62      4.21(4.12)          82      3.90(3.86)        4.30      0.08 [-0.25, 0.41]       
Subtotal (95% CI)    412                         444  25.96      0.02 [-0.12, 0.15]
Test for heterogeneity: Chi² = 2.24, df = 2 (P = 0.33), I² = 10.6%
Test for overall effect: Z = 0.23 (P = 0.82)
02 Reactive and Flexible
Liverpool                85      3.66(4.10)          77      4.74(4.13)        4.88     -0.26 [-0.57, 0.05]       
Edinburgh               128     11.10(8.03)         124      9.82(7.57)        7.65      0.16 [-0.08, 0.41]       
Oxford                  156     45.53(170.15)       167     34.16(107.41)      9.82      0.08 [-0.14, 0.30]       
Adelaide                 39      4.50(2.10)          40      4.80(1.00)        2.40     -0.18 [-0.62, 0.26]       
Mansfield               126     16.55(7.62)         124     16.41(7.39)        7.62      0.02 [-0.23, 0.27]       
London                   88     15.58(9.11)          85     14.46(8.63)        5.26      0.13 [-0.17, 0.42]       
Subtotal (95% CI)    622                         617  37.63      0.03 [-0.08, 0.14]
Test for heterogeneity: Chi² = 6.00, df = 5 (P = 0.31), I² = 16.7%
Test for overall effect: Z = 0.53 (P = 0.60)
03 Proactive and Focused
Leeds (Psychology)      151      4.50(5.26)         150      5.77(5.31)        9.10     -0.24 [-0.47, -0.01]      
Leeds (Volunteers)      149      5.52(5.40)         150      5.77(5.31)        9.11     -0.05 [-0.27, 0.18]       
Liverpool (Psych)        39      3.90(4.33)          77      4.74(4.13)        3.14     -0.20 [-0.58, 0.19]       
Philadelphia (STAIR)     19     18.90(8.60)          19     20.20(9.80)        1.15     -0.14 [-0.77, 0.50]       
Boston (FIRST)          126     11.68(9.97)         128     10.20(7.70)        7.71      0.17 [-0.08, 0.41]       
Glasgow                 100      4.26(3.17)         105      5.06(3.61)        6.20     -0.23 [-0.51, 0.04]       
Subtotal (95% CI)    584                         629  36.42     -0.10 [-0.21, 0.02]
Test for heterogeneity: Chi² = 7.32, df = 5 (P = 0.20), I² = 31.7%
Test for overall effect: Z = 1.69 (P = 0.09)
Total (95% CI)   1618                        1690 100.00     -0.02 [-0.09, 0.05]
Test for heterogeneity: Chi² = 18.42, df = 14 (P = 0.19), I² = 24.0%
Test for overall effect: Z = 0.58 (P = 0.56)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 51 Mental Health: Depression                                                                                  
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Preston                  61      9.26(6.04)          56     10.41(6.30)        3.99     -0.19 [-0.55, 0.18]       
Utrecht                 215      4.59(4.45)         240      5.43(4.73)       15.50     -0.18 [-0.37, 0.00]       
Rhode Island             62      4.21(4.12)          82      3.90(3.86)        4.84      0.08 [-0.25, 0.41]       
Subtotal (95% CI)    338                         378  24.33     -0.13 [-0.28, 0.02]
Test for heterogeneity: Chi² = 1.92, df = 2 (P = 0.38), I² = 0%
Test for overall effect: Z = 1.75 (P = 0.08)
02 Reactive and Flexible
Liverpool                85      3.66(4.10)          77      4.74(4.13)        5.50     -0.26 [-0.57, 0.05]       
Edinburgh               128      5.40(4.12)         124      4.60(3.97)        8.60      0.20 [-0.05, 0.44]       
Oxford                  115      5.57(3.20)         109      5.41(3.51)        7.68      0.05 [-0.21, 0.31]       
Adelaide                 39      4.50(2.10)          40      4.80(1.00)        2.70     -0.18 [-0.62, 0.26]       
Mansfield               126     16.55(7.62)         124     16.41(7.39)        8.58      0.02 [-0.23, 0.27]       
London                   89      8.17(4.93)          86      7.29(4.93)        5.98      0.18 [-0.12, 0.47]       
Subtotal (95% CI)    582                         560  39.03      0.03 [-0.08, 0.15]
Test for heterogeneity: Chi² = 7.00, df = 5 (P = 0.22), I² = 28.5%
Test for overall effect: Z = 0.59 (P = 0.56)
03 Proactive and Focused
Leeds (Psychology)      116      4.50(5.26)         123      5.77(5.31)        8.13     -0.24 [-0.49, 0.02]       
Leeds (Volunteers)      124      5.52(5.40)         123      5.77(5.31)        8.47     -0.05 [-0.30, 0.20]       
Liverpool (Psych)        39      3.90(4.33)          77      4.74(4.13)        3.54     -0.20 [-0.58, 0.19]       
Philadelphia (STAIR)     19     18.90(8.60)          19     20.20(9.80)        1.30     -0.14 [-0.77, 0.50]       
Boston (FIRST)          126     11.68(9.97)         128     10.20(7.70)        8.68      0.17 [-0.08, 0.41]       
Glasgow                  93      4.26(3.17)          98      5.06(3.61)        6.50     -0.23 [-0.52, 0.05]       
Subtotal (95% CI)    517                         568  36.63     -0.09 [-0.21, 0.03]
Test for heterogeneity: Chi² = 6.89, df = 5 (P = 0.23), I² = 27.5%
Test for overall effect: Z = 1.48 (P = 0.14)
Total (95% CI)   1437                        1506 100.00     -0.05 [-0.12, 0.02]
Test for heterogeneity: Chi² = 19.45, df = 14 (P = 0.15), I² = 28.0%
Test for overall effect: Z = 1.39 (P = 0.17)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 52 Mental Health: Anxiety                                                                                     
Study  Treatment  Control  WMD (fixed)  Weight  WMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Utrecht                 215      5.17(4.51)         244      5.55(4.22)       32.97     -0.38 [-1.18, 0.42]       
Subtotal (95% CI)    215                         244  32.97     -0.38 [-1.18, 0.42]
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
02 Reactive and Flexible
Edinburgh               128      5.70(4.58)         124      5.22(4.30)       17.65      0.48 [-0.62, 1.58]       
Oxford                  119      4.85(3.88)         118      4.53(3.56)       23.62      0.32 [-0.63, 1.27]       
Adelaide                 39      4.50(2.70)          40      6.20(2.70)       14.97     -1.70 [-2.89, -0.51]      
London                   88      7.40(5.21)          85      7.22(4.16)       10.79      0.18 [-1.22, 1.58]       
Subtotal (95% CI)    374                         367  67.03     -0.11 [-0.67, 0.45]
Test for heterogeneity: Chi² = 8.91, df = 3 (P = 0.03), I² = 66.3%
Test for overall effect: Z = 0.39 (P = 0.70)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    589                         611 100.00     -0.20 [-0.66, 0.26]
Test for heterogeneity: Chi² = 9.20, df = 4 (P = 0.06), I² = 56.5%
Test for overall effect: Z = 0.85 (P = 0.39)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 11 Participation                                                                                              
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
Edinburgh               156     34.40(3.57)         150     34.20(3.18)       35.63     0.06 [-0.17, 0.28]       
Oxford                  156     15.41(5.42)         167     15.45(5.04)       37.60    -0.01 [-0.23, 0.21]       
Adelaide                 32     22.10(4.40)          30     22.90(3.40)        7.18    -0.20 [-0.70, 0.30]       
London                   83      6.51(3.45)          86      7.19(3.16)       19.59    -0.20 [-0.51, 0.10]       
Subtotal (95% CI)    427                         433 100.00    -0.04 [-0.17, 0.10]
Test for heterogeneity: Chi² = 2.37, df = 3 (P = 0.50), I² = 0%
Test for overall effect: Z = 0.53 (P = 0.59)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    427                         433 100.00    -0.04 [-0.17, 0.10]
Test for heterogeneity: Chi² = 2.37, df = 3 (P = 0.50), I² = 0%
Test for overall effect: Z = 0.53 (P = 0.59)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 12 Caregiver Subjective Health Status                                                                         
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                 56      4.04(5.07)          55      4.24(5.62)        5.88     -0.04 [-0.41, 0.33]       
Preston                  37      4.08(2.63)          36      5.11(2.28)        3.78     -0.41 [-0.88, 0.05]       
Utrecht                 145     22.99(3.14)         179     22.43(3.35)       16.91      0.17 [-0.05, 0.39]       
Rhode Island             58      4.00(3.49)          79      3.57(3.63)        7.07      0.12 [-0.22, 0.46]       
Subtotal (95% CI)    296                         349  33.65      0.06 [-0.10, 0.21]
Test for heterogeneity: Chi² = 5.38, df = 3 (P = 0.15), I² = 44.2%
Test for overall effect: Z = 0.74 (P = 0.46)
02 Reactive and Flexible
Liverpool                61      3.93(4.02)          52      4.23(3.43)        5.94     -0.08 [-0.45, 0.29]       
Melbourne (SHIPS)        20      3.50(2.80)          28      3.00(4.20)        2.47      0.13 [-0.44, 0.71]       
Edinburgh                68     10.44(17.18)         69     13.38(15.93)       7.23     -0.18 [-0.51, 0.16]       
Oxford                  107      3.86(2.98)         100      3.51(3.01)       10.93      0.12 [-0.16, 0.39]       
Adelaide                 32    -48.20(12.10)         30    -49.40(13.70)       3.28      0.09 [-0.41, 0.59]       
Mansfield                74      5.55(3.64)          69      5.25(3.41)        7.56      0.08 [-0.24, 0.41]       
London                   43     21.58(3.93)          49     21.49(3.58)        4.85      0.02 [-0.39, 0.43]       
Subtotal (95% CI)    405                         397  42.26      0.02 [-0.12, 0.16]
Test for heterogeneity: Chi² = 2.45, df = 6 (P = 0.87), I² = 0%
Test for overall effect: Z = 0.30 (P = 0.76)
03 Proactive and Focused
Leeds (Psychology)       87      4.52(3.16)          88      4.43(3.59)        9.27      0.03 [-0.27, 0.32]       
Leeds (Volunteers)       90      5.08(3.72)          88      4.43(3.59)        9.39      0.18 [-0.12, 0.47]       
Liverpool (Psych)        22      4.41(3.39)          52      4.23(3.43)        3.27      0.05 [-0.45, 0.55]       
Philadelphia (STAIR)     21     42.70(8.00)          20     44.70(8.40)        2.15     -0.24 [-0.85, 0.38]       
Subtotal (95% CI)    220                         248  24.09      0.06 [-0.12, 0.25]
Test for heterogeneity: Chi² = 1.56, df = 3 (P = 0.67), I² = 0%
Test for overall effect: Z = 0.69 (P = 0.49)
Total (95% CI)    921                         994 100.00      0.04 [-0.05, 0.13]
Test for heterogeneity: Chi² = 9.57, df = 14 (P = 0.79), I² = 0%
Test for overall effect: Z = 0.96 (P = 0.33)
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Figure 5.15: Carer Subjective Health 123 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 13 Caregiver Extended Activities of Daily Living                                                              
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                 56     27.39(7.39)          61     27.64(5.57)       15.68     -0.04 [-0.40, 0.32]       
Rhode Island             56     29.63(7.96)          78     30.92(7.92)       17.45     -0.16 [-0.51, 0.18]       
Subtotal (95% CI)    112                         139  33.13     -0.10 [-0.35, 0.15]
Test for heterogeneity: Chi² = 0.23, df = 1 (P = 0.63), I² = 0%
Test for overall effect: Z = 0.81 (P = 0.42)
02 Reactive and Flexible
Edinburgh                87     47.00(3.57)          84     48.00(2.14)       22.63     -0.34 [-0.64, -0.03]      
Oxford                  103     31.03(6.69)          96     31.07(7.12)       26.69     -0.01 [-0.28, 0.27]       
Mansfield                67     51.42(18.96)         64     53.34(14.72)      17.55     -0.11 [-0.45, 0.23]       
Subtotal (95% CI)    257                         244  66.87     -0.15 [-0.32, 0.03]
Test for heterogeneity: Chi² = 2.55, df = 2 (P = 0.28), I² = 21.5%
Test for overall effect: Z = 1.63 (P = 0.10)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    369                         383 100.00     -0.13 [-0.28, 0.01]
Test for heterogeneity: Chi² = 2.86, df = 4 (P = 0.58), I² = 0%
Test for overall effect: Z = 1.80 (P = 0.07)
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Figure 5.16: Carers’ Extended Activities of Daily Living 124 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 14 Caregiver Mental Health                                                                                    
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                 56     19.80(11.34)         55     20.64(12.84)       6.39     -0.07 [-0.44, 0.30]       
Utrecht                 126     84.48(9.85)         163     84.22(8.72)       16.36      0.03 [-0.20, 0.26]       
Rhode Island             47      9.28(6.70)          74      8.68(5.62)        6.61      0.10 [-0.27, 0.46]       
Subtotal (95% CI)    229                         292  29.36      0.02 [-0.15, 0.20]
Test for heterogeneity: Chi² = 0.40, df = 2 (P = 0.82), I² = 0%
Test for overall effect: Z = 0.26 (P = 0.80)
02 Reactive and Flexible
Liverpool                64      2.69(3.78)          53      3.11(3.03)        6.66     -0.12 [-0.48, 0.24]       
Edinburgh                94      7.22(8.32)          92      8.36(7.62)       10.68     -0.14 [-0.43, 0.15]       
Oxford                   93      3.66(4.29)          90      4.00(4.68)       10.52     -0.08 [-0.37, 0.21]       
Adelaide                 32    -46.40(6.80)          30    -48.40(6.20)        3.52      0.30 [-0.20, 0.80]       
Mansfield                75     14.08(5.70)          70     14.77(7.47)        8.33     -0.10 [-0.43, 0.22]       
London                   45     12.67(8.77)          55     13.71(8.35)        5.69     -0.12 [-0.52, 0.27]       
Subtotal (95% CI)    403                         390  45.40     -0.08 [-0.22, 0.06]
Test for heterogeneity: Chi² = 2.53, df = 5 (P = 0.77), I² = 0%
Test for overall effect: Z = 1.11 (P = 0.27)
03 Proactive and Focused
Leeds (Psychology)       82      5.02(5.25)          85      5.33(6.18)        9.61     -0.05 [-0.36, 0.25]       
Leeds (Volunteers)       88      5.58(6.55)          85      5.33(6.18)        9.95      0.04 [-0.26, 0.34]       
Liverpool (Psych)        22      2.73(3.10)          53      3.11(3.03)        3.57     -0.12 [-0.62, 0.37]       
Philadelphia (STAIR)     19     21.40(10.40)         19     16.60(6.60)        2.10      0.54 [-0.11, 1.19]       
Subtotal (95% CI)    211                         242  25.24      0.02 [-0.16, 0.21]
Test for heterogeneity: Chi² = 3.02, df = 3 (P = 0.39), I² = 0.8%
Test for overall effect: Z = 0.23 (P = 0.81)
Total (95% CI)    843                         924 100.00     -0.02 [-0.12, 0.07]
Test for heterogeneity: Chi² = 7.08, df = 12 (P = 0.85), I² = 0%
Test for overall effect: Z = 0.49 (P = 0.62)
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Figure 5.17: Carers’ Mental Health 125 
 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 34 "I have been treated with kindness and respect" - patient                                                  
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   221/230            250/253         31.86      0.29 [0.08, 1.10]        
Subtotal (95% CI) 230                253  31.86      0.29 [0.08, 1.10]
Total events: 221 (Treatment), 250 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.07)
02 Reactive and Flexible
 Edinburgh                 135/136            139/142          3.42      2.91 [0.30, 28.36]       
 Oxford                    114/128            123/130         45.65      0.46 [0.18, 1.19]        
Subtotal (95% CI) 264                272  49.07      0.63 [0.28, 1.45]
Total events: 249 (Treatment), 262 (Control)
Test for heterogeneity: Chi² = 2.15, df = 1 (P = 0.14), I² = 53.5%
Test for overall effect: Z = 1.08 (P = 0.28)
03 Proactive and Focused
 Leeds (Psychology)        110/111            119/121          3.51      1.85 [0.17, 20.67]       
 Leeds (Volunteers)        112/115            119/121         10.35      0.63 [0.10, 3.83]        
 Glasgow                    93/94              98/98           5.21      0.32 [0.01, 7.86]        
Subtotal (95% CI) 320                340  19.06      0.77 [0.22, 2.70]
Total events: 315 (Treatment), 336 (Control)
Test for heterogeneity: Chi² = 0.85, df = 2 (P = 0.65), I² = 0%
Test for overall effect: Z = 0.41 (P = 0.68)
Total (95% CI) 814                865 100.00      0.55 [0.30, 1.01]
Total events: 785 (Treatment), 848 (Control)
Test for heterogeneity: Chi² = 4.15, df = 5 (P = 0.53), I² = 0%
Test for overall effect: Z = 1.93 (P = 0.05)
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Figure 5.18: Patient Satisfaction; “I have been treated with kindness and respect” 126 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 35 "The staff attended well to my personal needs" - patient                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   219/230            249/253         28.26      0.32 [0.10, 1.02]        
Subtotal (95% CI) 230                253  28.26      0.32 [0.10, 1.02]
Total events: 219 (Treatment), 249 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.93 (P = 0.05)
02 Reactive and Flexible
 Edinburgh                 134/136            135/140          4.88      2.48 [0.47, 13.01]       
 Oxford                    112/128            117/129         36.30      0.72 [0.33, 1.59]        
Subtotal (95% CI) 264                269  41.18      0.93 [0.46, 1.86]
Total events: 246 (Treatment), 252 (Control)
Test for heterogeneity: Chi² = 1.76, df = 1 (P = 0.19), I² = 43.1%
Test for overall effect: Z = 0.21 (P = 0.83)
03 Proactive and Focused
 Leeds (Psychology)        107/111            114/121          9.80      1.64 [0.47, 5.77]        
 Leeds (Volunteers)        109/115            114/121         14.44      1.12 [0.36, 3.42]        
 Glasgow                    92/94              98/98           6.33      0.19 [0.01, 3.96]        
Subtotal (95% CI) 320                340  30.56      1.09 [0.50, 2.37]
Total events: 308 (Treatment), 326 (Control)
Test for heterogeneity: Chi² = 1.69, df = 2 (P = 0.43), I² = 0%
Test for overall effect: Z = 0.22 (P = 0.82)
Total (95% CI) 814                862 100.00      0.81 [0.51, 1.28]
Total events: 773 (Treatment), 827 (Control)
Test for heterogeneity: Chi² = 6.73, df = 5 (P = 0.24), I² = 25.7%
Test for overall effect: Z = 0.92 (P = 0.36)
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Figure 5.19: Patient Satisfaction; “The staff have attended well to my personal needs” 127 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 36 "I was able to talk to the staff about any problems" - patient                                             
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   199/228            230/250         33.17      0.60 [0.33, 1.09]        
Subtotal (95% CI) 228                250  33.17      0.60 [0.33, 1.09]
Total events: 199 (Treatment), 230 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.69 (P = 0.09)
02 Reactive and Flexible
 Edinburgh                 124/136            132/142         13.55      0.78 [0.33, 1.88]        
 Oxford                    102/125            111/127         24.08      0.64 [0.32, 1.28]        
Subtotal (95% CI) 261                269  37.63      0.69 [0.40, 1.19]
Total events: 226 (Treatment), 243 (Control)
Test for heterogeneity: Chi² = 0.13, df = 1 (P = 0.72), I² = 0%
Test for overall effect: Z = 1.34 (P = 0.18)
03 Proactive and Focused
 Leeds (Psychology)        102/111            110/121         10.14      1.13 [0.45, 2.85]        
 Leeds (Volunteers)        103/115            110/121         13.30      0.86 [0.36, 2.03]        
 Glasgow                    89/94              93/98           5.76      0.96 [0.27, 3.42]        
Subtotal (95% CI) 320                340  29.20      0.97 [0.55, 1.71]
Total events: 294 (Treatment), 313 (Control)
Test for heterogeneity: Chi² = 0.19, df = 2 (P = 0.91), I² = 0%
Test for overall effect: Z = 0.09 (P = 0.93)
Total (95% CI) 809                859 100.00      0.74 [0.54, 1.03]
Total events: 719 (Treatment), 786 (Control)
Test for heterogeneity: Chi² = 1.77, df = 5 (P = 0.88), I² = 0%
Test for overall effect: Z = 1.79 (P = 0.07)
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Figure 5.20: Patient Satisfaction; “I was able to talk to the staff about any problems” 128 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 37 "I received all the information I want about the causes and nature of my disease" - patient                
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   184/230            213/252         28.08      0.73 [0.46, 1.17]        
Subtotal (95% CI) 230                252  28.08      0.73 [0.46, 1.17]
Total events: 184 (Treatment), 213 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.30 (P = 0.19)
02 Reactive and Flexible
 Edinburgh                 114/137            115/140         13.19      1.08 [0.58, 2.01]        
 Oxford                     96/124            101/128         15.50      0.92 [0.50, 1.67]        
 Mansfield                  83/95              70/90           6.27      1.98 [0.90, 4.32]        
 London                     70/92              61/87          10.36      1.36 [0.70, 2.63]        
Subtotal (95% CI) 448                445  45.33      1.21 [0.87, 1.68]
Total events: 363 (Treatment), 347 (Control)
Test for heterogeneity: Chi² = 2.58, df = 3 (P = 0.46), I² = 0%
Test for overall effect: Z = 1.15 (P = 0.25)
03 Proactive and Focused
 Leeds (Psychology)         98/111            101/121          7.82      1.49 [0.70, 3.17]        
 Leeds (Volunteers)         91/115            101/121         14.19      0.75 [0.39, 1.45]        
 Glasgow                    87/94              91/98           4.58      0.96 [0.32, 2.84]        
Subtotal (95% CI) 320                340  26.59      1.00 [0.64, 1.57]
Total events: 276 (Treatment), 293 (Control)
Test for heterogeneity: Chi² = 1.83, df = 2 (P = 0.40), I² = 0%
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 998                1037 100.00      1.02 [0.81, 1.28]
Total events: 823 (Treatment), 853 (Control)
Test for heterogeneity: Chi² = 7.34, df = 7 (P = 0.39), I² = 4.7%
Test for overall effect: Z = 0.18 (P = 0.86)
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Figure 5.21: Patient Satisfaction; “I received all the information about the causes and nature of my disease” 129 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 38 "The staff have done everything to make me well" - patient                                                 
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   217/229            246/254         32.58      0.59 [0.24, 1.47]        
Subtotal (95% CI) 229                254  32.58      0.59 [0.24, 1.47]
Total events: 217 (Treatment), 246 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.25)
02 Reactive and Flexible
 Edinburgh                 134/137            137/141          7.88      1.30 [0.29, 5.94]        
 Oxford                    112/122            122/131         25.71      0.83 [0.32, 2.11]        
Subtotal (95% CI) 259                272  33.59      0.94 [0.42, 2.07]
Total events: 246 (Treatment), 259 (Control)
Test for heterogeneity: Chi² = 0.25, df = 1 (P = 0.62), I² = 0%
Test for overall effect: Z = 0.16 (P = 0.88)
03 Proactive and Focused
 Leeds (Psychology)        107/111            114/121         10.48      1.64 [0.47, 5.77]        
 Leeds (Volunteers)        106/114            114/121         20.69      0.81 [0.29, 2.32]        
 Glasgow                    93/94              96/98           2.67      1.94 [0.17, 21.73]       
Subtotal (95% CI) 319                340  33.83      1.16 [0.55, 2.46]
Total events: 306 (Treatment), 324 (Control)
Test for heterogeneity: Chi² = 0.91, df = 2 (P = 0.64), I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)
Total (95% CI) 807                866 100.00      0.90 [0.56, 1.43]
Total events: 769 (Treatment), 829 (Control)
Test for heterogeneity: Chi² = 2.40, df = 5 (P = 0.79), I² = 0%
Test for overall effect: Z = 0.45 (P = 0.65)
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Figure 5.22: Patient Satisfaction; “The staff have done everything to make me well” 130 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 39 "I am happy with my recovery" - patient                                                                    
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   206/229            228/254         18.68      1.02 [0.57, 1.85]        
Subtotal (95% CI) 229                254  18.68      1.02 [0.57, 1.85]
Total events: 206 (Treatment), 228 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.94)
02 Reactive and Flexible
 Edinburgh                 114/137            127/144         17.89      0.66 [0.34, 1.30]        
 Oxford                     92/125            107/130         23.83      0.60 [0.33, 1.09]        
Subtotal (95% CI) 262                274  41.72      0.63 [0.40, 0.98]
Total events: 206 (Treatment), 234 (Control)
Test for heterogeneity: Chi² = 0.05, df = 1 (P = 0.83), I² = 0%
Test for overall effect: Z = 2.04 (P = 0.04)
03 Proactive and Focused
 Leeds (Psychology)         91/111             92/120         13.71      1.38 [0.73, 2.63]        
 Leeds (Volunteers)         89/115             92/120         17.52      1.04 [0.57, 1.91]        
 Glasgow                    83/94              85/98           8.38      1.15 [0.49, 2.72]        
Subtotal (95% CI) 320                338  39.60      1.18 [0.80, 1.75]
Total events: 263 (Treatment), 269 (Control)
Test for heterogeneity: Chi² = 0.40, df = 2 (P = 0.82), I² = 0%
Test for overall effect: Z = 0.85 (P = 0.40)
Total (95% CI) 811                866 100.00      0.92 [0.71, 1.20]
Total events: 675 (Treatment), 731 (Control)
Test for heterogeneity: Chi² = 4.96, df = 5 (P = 0.42), I² = 0%
Test for overall effect: Z = 0.61 (P = 0.54)
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Figure 5.23: Patient Satisfaction; “I am happy with my recovery” 131 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 40 "I am satisfied with the type of treatment I have received" - patient                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   164/187            195/221         35.59      0.95 [0.52, 1.73]        
Subtotal (95% CI) 187                221  35.59      0.95 [0.52, 1.73]
Total events: 164 (Treatment), 195 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
02 Reactive and Flexible
 Edinburgh                 118/128            119/133         14.76      1.39 [0.59, 3.25]        
 Oxford                     92/103            100/108         16.88      0.67 [0.26, 1.74]        
Subtotal (95% CI) 231                241  31.64      1.00 [0.54, 1.88]
Total events: 210 (Treatment), 219 (Control)
Test for heterogeneity: Chi² = 1.25, df = 1 (P = 0.26), I² = 20.2%
Test for overall effect: Z = 0.01 (P = 0.99)
03 Proactive and Focused
 Leeds (Psychology)         98/111            107/120         19.50      0.92 [0.40, 2.07]        
 Leeds (Volunteers)        106/115            107/120         13.27      1.43 [0.59, 3.49]        
Subtotal (95% CI) 226                240  32.77      1.12 [0.62, 2.05]
Total events: 204 (Treatment), 214 (Control)
Test for heterogeneity: Chi² = 0.52, df = 1 (P = 0.47), I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)
Total (95% CI) 644                702 100.00      1.02 [0.72, 1.46]
Total events: 578 (Treatment), 628 (Control)
Test for heterogeneity: Chi² = 1.93, df = 4 (P = 0.75), I² = 0%
Test for overall effect: Z = 0.14 (P = 0.89)
 0.1  0.2  0.5  1  2  5  10
 Favours control  Favours treatment  
 
 
Figure 5.24: Patient Satisfaction; “I am satisfied with the type of treatment I have received” 132 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 41 "I was given all the information I needed about allowances" - patient                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   130/210            139/225         34.42      1.01 [0.68, 1.48]        
Subtotal (95% CI) 210                225  34.42      1.01 [0.68, 1.48]
Total events: 130 (Treatment), 139 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
02 Reactive and Flexible
 Edinburgh                 104/125            106/133         11.62      1.26 [0.67, 2.37]        
 Oxford                     96/120             98/127         12.82      1.18 [0.64, 2.18]        
 Mansfield                  64/68              47/52           2.11      1.70 [0.43, 6.68]        
 London                     50/74              48/67          11.00      0.82 [0.40, 1.70]        
Subtotal (95% CI) 387                379  37.55      1.13 [0.79, 1.62]
Total events: 314 (Treatment), 299 (Control)
Test for heterogeneity: Chi² = 1.22, df = 3 (P = 0.75), I² = 0%
Test for overall effect: Z = 0.67 (P = 0.50)
03 Proactive and Focused
 Leeds (Psychology)         95/107            102/119          7.29      1.32 [0.60, 2.91]        
 Leeds (Volunteers)         91/112            102/119         12.49      0.72 [0.36, 1.45]        
 Glasgow                    77/91              81/94           8.25      0.88 [0.39, 2.00]        
Subtotal (95% CI) 310                332  28.03      0.92 [0.60, 1.43]
Total events: 263 (Treatment), 285 (Control)
Test for heterogeneity: Chi² = 1.27, df = 2 (P = 0.53), I² = 0%
Test for overall effect: Z = 0.35 (P = 0.73)
Total (95% CI) 907                936 100.00      1.03 [0.82, 1.29]
Total events: 707 (Treatment), 723 (Control)
Test for heterogeneity: Chi² = 3.00, df = 7 (P = 0.89), I² = 0%
Test for overall effect: Z = 0.26 (P = 0.80)
 0.1  0.2  0.5  1  2  5  10
 Favours control  Favours treatment  
 
Figure 5.25: Patient Satisfaction; “I was given all the information I needed about allowances” 133 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 42 "Things were well prepared for my return home" - patient                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   125/183            145/204         46.03      0.88 [0.57, 1.35]        
Subtotal (95% CI) 183                204  46.03      0.88 [0.57, 1.35]
Total events: 125 (Treatment), 145 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.55)
02 Reactive and Flexible
 Edinburgh                 102/120            106/128         16.30      1.18 [0.60, 2.32]        
 Oxford                    111/123            122/129         12.30      0.53 [0.20, 1.40]        
Subtotal (95% CI) 243                257  28.60      0.90 [0.52, 1.55]
Total events: 213 (Treatment), 228 (Control)
Test for heterogeneity: Chi² = 1.74, df = 1 (P = 0.19), I² = 42.6%
Test for overall effect: Z = 0.38 (P = 0.70)
03 Proactive and Focused
 Leeds (Psychology)         98/107            101/118          8.56      1.83 [0.78, 4.31]        
 Leeds (Volunteers)         93/111            101/118         16.81      0.87 [0.42, 1.79]        
Subtotal (95% CI) 218                236  25.37      1.19 [0.69, 2.06]
Total events: 191 (Treatment), 202 (Control)
Test for heterogeneity: Chi² = 1.71, df = 1 (P = 0.19), I² = 41.5%
Test for overall effect: Z = 0.64 (P = 0.52)
Total (95% CI) 644                697 100.00      0.96 [0.72, 1.29]
Total events: 529 (Treatment), 575 (Control)
Test for heterogeneity: Chi² = 4.23, df = 4 (P = 0.38), I² = 5.3%
Test for overall effect: Z = 0.25 (P = 0.80)
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Figure 5.26: Patient Satisfaction; “Things were well prepared for my return home” 134 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 43 "I get all the services I need" - patient                                                                  
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                    92/157            111/177         45.97      0.84 [0.54, 1.31]        
Subtotal (95% CI) 157                177  45.97      0.84 [0.54, 1.31]
Total events: 92 (Treatment), 111 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
02 Reactive and Flexible
 Edinburgh                 104/120            100/120         14.19      1.30 [0.64, 2.65]        
 Oxford                    115/122            118/130          6.98      1.67 [0.64, 4.39]        
 London                     39/52              35/47           9.78      1.03 [0.41, 2.55]        
Subtotal (95% CI) 294                297  30.94      1.30 [0.80, 2.10]
Total events: 258 (Treatment), 253 (Control)
Test for heterogeneity: Chi² = 0.51, df = 2 (P = 0.77), I² = 0%
Test for overall effect: Z = 1.06 (P = 0.29)
03 Proactive and Focused
 Leeds (Psychology)        100/106            106/118          6.04      1.89 [0.68, 5.22]        
 Leeds (Volunteers)         90/107            106/118         17.04      0.60 [0.27, 1.32]        
Subtotal (95% CI) 213                236  23.09      0.94 [0.51, 1.71]
Total events: 190 (Treatment), 212 (Control)
Test for heterogeneity: Chi² = 3.05, df = 1 (P = 0.08), I² = 67.2%
Test for overall effect: Z = 0.21 (P = 0.83)
Total (95% CI) 664                710 100.00      1.00 [0.76, 1.34]
Total events: 540 (Treatment), 576 (Control)
Test for heterogeneity: Chi² = 5.30, df = 5 (P = 0.38), I² = 5.7%
Test for overall effect: Z = 0.03 (P = 0.97)
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Figure 5.27: Patient Satisfaction; “I get all the services I need” 135 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 44 "I am satisfied with outpatient services" - patient                                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   185/220            217/243         46.00      0.63 [0.37, 1.09]        
Subtotal (95% CI) 220                243  46.00      0.63 [0.37, 1.09]
Total events: 185 (Treatment), 217 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.65 (P = 0.10)
02 Reactive and Flexible
 Edinburgh                 119/127            116/127         10.25      1.41 [0.55, 3.63]        
Subtotal (95% CI) 127                127  10.25      1.41 [0.55, 3.63]
Total events: 119 (Treatment), 116 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
03 Proactive and Focused
 Leeds (Psychology)         98/107            106/118         11.89      1.23 [0.50, 3.05]        
 Leeds (Volunteers)         91/110            106/118         24.77      0.54 [0.25, 1.18]        
 Glasgow                    89/94              97/98           7.08      0.18 [0.02, 1.60]        
Subtotal (95% CI) 311                334  43.75      0.67 [0.39, 1.16]
Total events: 278 (Treatment), 309 (Control)
Test for heterogeneity: Chi² = 3.39, df = 2 (P = 0.18), I² = 41.1%
Test for overall effect: Z = 1.42 (P = 0.16)
Total (95% CI) 658                704 100.00      0.73 [0.51, 1.04]
Total events: 582 (Treatment), 642 (Control)
Test for heterogeneity: Chi² = 5.53, df = 4 (P = 0.24), I² = 27.7%
Test for overall effect: Z = 1.74 (P = 0.08)
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Figure 5.28: Patient Satisfaction; “I am satisfied with the outpatient services” 136 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 45 "I am satisfied with the practical help I have received" - patient                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   133/190            162/213         84.00      0.73 [0.47, 1.14]        
Subtotal (95% CI) 190                213  84.00      0.73 [0.47, 1.14]
Total events: 133 (Treatment), 162 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.37 (P = 0.17)
02 Reactive and Flexible
 Edinburgh                 114/124            110/128         16.00      1.87 [0.82, 4.22]        
Subtotal (95% CI) 124                128  16.00      1.87 [0.82, 4.22]
Total events: 114 (Treatment), 110 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 314                341 100.00      0.92 [0.62, 1.34]
Total events: 247 (Treatment), 272 (Control)
Test for heterogeneity: Chi² = 3.88, df = 1 (P = 0.05), I² = 74.2%
Test for overall effect: Z = 0.45 (P = 0.65)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 46 "I have had enough information about recovery" - patient                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   161/226            180/250         51.24      0.96 [0.65, 1.44]        
Subtotal (95% CI) 226                250  51.24      0.96 [0.65, 1.44]
Total events: 161 (Treatment), 180 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.85)
02 Reactive and Flexible
 Edinburgh                 112/128            101/125         13.31      1.66 [0.84, 3.31]        
 Mansfield                  67/94              62/90          18.96      1.12 [0.60, 2.11]        
 London                     62/91              48/85          16.49      1.65 [0.89, 3.05]        
Subtotal (95% CI) 313                300  48.76      1.45 [1.00, 2.09]
Total events: 241 (Treatment), 211 (Control)
Test for heterogeneity: Chi² = 0.96, df = 2 (P = 0.62), I² = 0%
Test for overall effect: Z = 1.96 (P = 0.05)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 539                550 100.00      1.20 [0.91, 1.57]
Total events: 402 (Treatment), 391 (Control)
Test for heterogeneity: Chi² = 3.10, df = 3 (P = 0.38), I² = 3.2%
Test for overall effect: Z = 1.32 (P = 0.19)
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Figure 5.30: Patient Satisfaction; “I have had enough information about recovery and rehabilitation” 138 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 47 "Someone has really listened" - patient                                                                    
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   177/222            193/248         62.77      1.12 [0.72, 1.75]        
Subtotal (95% CI) 222                248  62.77      1.12 [0.72, 1.75]
Total events: 177 (Treatment), 193 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.61)
02 Reactive and Flexible
 Edinburgh                 114/125            103/132         14.98      2.92 [1.39, 6.14]        
 London                     70/92              53/86          22.25      1.98 [1.04, 3.78]        
Subtotal (95% CI) 217                218  37.23      2.36 [1.45, 3.83]
Total events: 184 (Treatment), 156 (Control)
Test for heterogeneity: Chi² = 0.59, df = 1 (P = 0.44), I² = 0%
Test for overall effect: Z = 3.46 (P = 0.0005)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 439                466 100.00      1.58 [1.14, 2.19]
Total events: 361 (Treatment), 349 (Control)
Test for heterogeneity: Chi² = 5.39, df = 2 (P = 0.07), I² = 62.9%
Test for overall effect: Z = 2.77 (P = 0.006)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 50 "I have not felt neglected" - patient                                                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   177/223            205/250         59.79      0.84 [0.53, 1.33]        
Subtotal (95% CI) 223                250  59.79      0.84 [0.53, 1.33]
Total events: 177 (Treatment), 205 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
02 Reactive and Flexible
 Edinburgh                 130/136            123/136          8.14      2.29 [0.84, 6.21]        
 London                     64/92              68/86          32.08      0.61 [0.31, 1.20]        
Subtotal (95% CI) 228                222  40.21      0.95 [0.55, 1.63]
Total events: 194 (Treatment), 191 (Control)
Test for heterogeneity: Chi² = 4.66, df = 1 (P = 0.03), I² = 78.5%
Test for overall effect: Z = 0.20 (P = 0.84)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 451                472 100.00      0.89 [0.62, 1.26]
Total events: 371 (Treatment), 396 (Control)
Test for heterogeneity: Chi² = 4.71, df = 2 (P = 0.09), I² = 57.6%
Test for overall effect: Z = 0.68 (P = 0.50)
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Figure 5.32: Patient Satisfaction; “I have not felt neglected” 140 
 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 48 "I have had enough emotional support" - patient                                                            
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   167/224            194/247         53.69      0.80 [0.52, 1.23]        
Subtotal (95% CI) 224                247  53.69      0.80 [0.52, 1.23]
Total events: 167 (Treatment), 194 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
02 Reactive and Flexible
 Edinburgh                 127/136            118/134          9.00      1.91 [0.81, 4.50]        
 Mansfield                  55/58              31/35           2.29      2.37 [0.50, 11.26]       
Subtotal (95% CI) 194                169  11.28      2.01 [0.95, 4.25]
Total events: 182 (Treatment), 149 (Control)
Test for heterogeneity: Chi² = 0.05, df = 1 (P = 0.82), I² = 0%
Test for overall effect: Z = 1.82 (P = 0.07)
03 Proactive and Focused
 Leeds (Psychology)         94/108             99/118         14.03      1.29 [0.61, 2.72]        
 Leeds (Volunteers)         94/111             99/118         16.81      1.06 [0.52, 2.16]        
 Glasgow                    90/94              88/98           4.19      2.56 [0.77, 8.46]        
Subtotal (95% CI) 313                334  35.03      1.33 [0.83, 2.13]
Total events: 278 (Treatment), 286 (Control)
Test for heterogeneity: Chi² = 1.54, df = 2 (P = 0.46), I² = 0%
Test for overall effect: Z = 1.20 (P = 0.23)
Total (95% CI) 731                750 100.00      1.12 [0.84, 1.50]
Total events: 627 (Treatment), 629 (Control)
Test for heterogeneity: Chi² = 6.75, df = 5 (P = 0.24), I² = 26.0%
Test for overall effect: Z = 0.78 (P = 0.43)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 49 "I know who to contact" - patient                                                                          
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   167/222            198/247         67.71      0.75 [0.49, 1.16]        
Subtotal (95% CI) 222                247  67.71      0.75 [0.49, 1.16]
Total events: 167 (Treatment), 198 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.28 (P = 0.20)
02 Reactive and Flexible
 Edinburgh                 129/135            122/138          7.82      2.82 [1.07, 7.44]        
 London                     71/92              63/86          21.67      1.23 [0.62, 2.44]        
Subtotal (95% CI) 227                224  29.49      1.65 [0.96, 2.86]
Total events: 200 (Treatment), 185 (Control)
Test for heterogeneity: Chi² = 1.87, df = 1 (P = 0.17), I² = 46.5%
Test for overall effect: Z = 1.80 (P = 0.07)
03 Proactive and Focused
 Glasgow                    92/94              92/98           2.79      3.00 [0.59, 15.25]       
Subtotal (95% CI) 94                 98   2.79      3.00 [0.59, 15.25]
Total events: 92 (Treatment), 92 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
Total (95% CI) 543                569 100.00      1.08 [0.78, 1.50]
Total events: 459 (Treatment), 475 (Control)
Test for heterogeneity: Chi² = 8.07, df = 3 (P = 0.04), I² = 62.8%
Test for overall effect: Z = 0.46 (P = 0.64)
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 53 "The patient has been treated with kindness and respect" - carer                                           
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 100/100            104/106          2.48      4.81 [0.23, 101.40]      
 Oxford                    109/123            117/131         63.61      0.93 [0.42, 2.04]        
Subtotal (95% CI) 223                237  66.09      1.08 [0.51, 2.27]
Total events: 209 (Treatment), 221 (Control)
Test for heterogeneity: Chi² = 1.06, df = 1 (P = 0.30), I² = 5.3%
Test for overall effect: Z = 0.20 (P = 0.85)
03 Proactive and Focused
 Leeds (Psychology)         85/87              87/88           9.81      0.49 [0.04, 5.49]        
 Leeds (Volunteers)         85/90              87/88          24.11      0.20 [0.02, 1.71]        
Subtotal (95% CI) 177                176  33.91      0.28 [0.06, 1.37]
Total events: 170 (Treatment), 174 (Control)
Test for heterogeneity: Chi² = 0.31, df = 1 (P = 0.58), I² = 0%
Test for overall effect: Z = 1.57 (P = 0.12)
Total (95% CI) 400                413 100.00      0.81 [0.42, 1.55]
Total events: 379 (Treatment), 395 (Control)
Test for heterogeneity: Chi² = 3.25, df = 3 (P = 0.35), I² = 7.8%
Test for overall effect: Z = 0.65 (P = 0.52)
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Figure 5.35: Carer Satisfaction; “The patient has been treated with kindness and respect” 143 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 54 "The staff have attended to my needs" - carer                                                              
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  94/99              92/106         11.12      2.86 [0.99, 8.26]        
 Oxford                    105/123            111/131         39.00      1.05 [0.53, 2.10]        
Subtotal (95% CI) 222                237  50.12      1.45 [0.82, 2.56]
Total events: 199 (Treatment), 203 (Control)
Test for heterogeneity: Chi² = 2.41, df = 1 (P = 0.12), I² = 58.5%
Test for overall effect: Z = 1.29 (P = 0.20)
03 Proactive and Focused
 Leeds (Psychology)         78/87              79/84          20.61      0.55 [0.18, 1.71]        
 Leeds (Volunteers)         77/90              79/84          29.26      0.37 [0.13, 1.10]        
Subtotal (95% CI) 177                168  49.88      0.45 [0.20, 0.97]
Total events: 155 (Treatment), 158 (Control)
Test for heterogeneity: Chi² = 0.23, df = 1 (P = 0.63), I² = 0%
Test for overall effect: Z = 2.03 (P = 0.04)
Total (95% CI) 399                405 100.00      0.95 [0.61, 1.48]
Total events: 354 (Treatment), 361 (Control)
Test for heterogeneity: Chi² = 7.99, df = 3 (P = 0.05), I² = 62.4%
Test for overall effect: Z = 0.22 (P = 0.82)
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Figure 5.36: Carer Satisfaction; “The staff have attended to my needs” 144 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 55 "I received all the information I needed about the nature and causes of the patients illness" - carer      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  84/99              81/107         50.11      1.80 [0.89, 3.64]        
 Mansfield                  73/76              62/70          10.82      3.14 [0.80, 12.35]       
 London                     38/50              41/57          39.07      1.24 [0.52, 2.95]        
Subtotal (95% CI) 225                234 100.00      1.72 [1.04, 2.85]
Total events: 195 (Treatment), 184 (Control)
Test for heterogeneity: Chi² = 1.31, df = 2 (P = 0.52), I² = 0%
Test for overall effect: Z = 2.12 (P = 0.03)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 225                234 100.00      1.72 [1.04, 2.85]
Total events: 195 (Treatment), 184 (Control)
Test for heterogeneity: Chi² = 1.31, df = 2 (P = 0.52), I² = 0%
Test for overall effect: Z = 2.12 (P = 0.03)
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Figure 5.37: Carer Satisfaction; “I received all the information I needed about the nature and causes of the patient’s illness” 145 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 56 "The staff have done everything to make the patient well" - carer                                          
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  94/99             100/106         19.90      1.13 [0.33, 3.82]        
 Oxford                    112/122            115/128         37.54      1.27 [0.53, 3.01]        
Subtotal (95% CI) 221                234  57.44      1.22 [0.60, 2.47]
Total events: 206 (Treatment), 215 (Control)
Test for heterogeneity: Chi² = 0.02, df = 1 (P = 0.88), I² = 0%
Test for overall effect: Z = 0.55 (P = 0.58)
03 Proactive and Focused
 Leeds (Psychology)         84/87              84/88          11.75      1.33 [0.29, 6.14]        
 Leeds (Volunteers)         82/90              84/88          30.81      0.49 [0.14, 1.68]        
Subtotal (95% CI) 177                176  42.56      0.72 [0.28, 1.84]
Total events: 166 (Treatment), 168 (Control)
Test for heterogeneity: Chi² = 1.00, df = 1 (P = 0.32), I² = 0.4%
Test for overall effect: Z = 0.68 (P = 0.49)
Total (95% CI) 398                410 100.00      1.01 [0.58, 1.76]
Total events: 372 (Treatment), 383 (Control)
Test for heterogeneity: Chi² = 1.75, df = 3 (P = 0.63), I² = 0%
Test for overall effect: Z = 0.02 (P = 0.98)
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Figure 5.38: Carer Satisfaction; “The staff have done everything to make the patient well” 146 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 57 "I am satisfied with the type of treatment the patient received" - carer                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  82/94              88/105         40.34      1.32 [0.59, 2.93]        
 Oxford                     93/112             95/118         59.66      1.19 [0.61, 2.32]        
Subtotal (95% CI) 206                223 100.00      1.24 [0.74, 2.07]
Total events: 175 (Treatment), 183 (Control)
Test for heterogeneity: Chi² = 0.04, df = 1 (P = 0.84), I² = 0%
Test for overall effect: Z = 0.82 (P = 0.41)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 206                223 100.00      1.24 [0.74, 2.07]
Total events: 175 (Treatment), 183 (Control)
Test for heterogeneity: Chi² = 0.04, df = 1 (P = 0.84), I² = 0%
Test for overall effect: Z = 0.82 (P = 0.41)
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Figure 5.39: Carer Satisfaction; “I am satisfied with the type of treatment the patient received” 147 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 58 "They have had enough therapy" - carer                                                                     
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  66/94              60/104         38.06      1.73 [0.96, 3.11]        
 Oxford                     71/115             75/124         61.94      1.05 [0.63, 1.77]        
Subtotal (95% CI) 209                228 100.00      1.31 [0.89, 1.93]
Total events: 137 (Treatment), 135 (Control)
Test for heterogeneity: Chi² = 1.52, df = 1 (P = 0.22), I² = 34.2%
Test for overall effect: Z = 1.37 (P = 0.17)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 209                228 100.00      1.31 [0.89, 1.93]
Total events: 137 (Treatment), 135 (Control)
Test for heterogeneity: Chi² = 1.52, df = 1 (P = 0.22), I² = 34.2%
Test for overall effect: Z = 1.37 (P = 0.17)
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Figure 5.40: Carer Satisfaction; “The patient has had enough therapy” 148 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 59 "I was given enough information about allowances available" - carer                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  75/97              69/100         18.04      1.53 [0.81, 2.90]        
 Oxford                     90/115             85/126         20.64      1.74 [0.97, 3.10]        
 Mansfield                  53/54              42/50           0.95     10.10 [1.21, 83.93]       
 London                     23/40              34/46          15.74      0.48 [0.19, 1.18]        
Subtotal (95% CI) 306                322  55.37      1.45 [1.01, 2.10]
Total events: 241 (Treatment), 230 (Control)
Test for heterogeneity: Chi² = 9.37, df = 3 (P = 0.02), I² = 68.0%
Test for overall effect: Z = 1.99 (P = 0.05)
03 Proactive and Focused
 Leeds (Psychology)         65/87              63/87          18.65      1.13 [0.57, 2.21]        
 Leeds (Volunteers)         58/89              63/87          25.98      0.71 [0.38, 1.35]        
Subtotal (95% CI) 176                174  44.63      0.89 [0.56, 1.41]
Total events: 123 (Treatment), 126 (Control)
Test for heterogeneity: Chi² = 0.93, df = 1 (P = 0.34), I² = 0%
Test for overall effect: Z = 0.52 (P = 0.61)
Total (95% CI) 482                496 100.00      1.20 [0.90, 1.60]
Total events: 364 (Treatment), 356 (Control)
Test for heterogeneity: Chi² = 12.53, df = 5 (P = 0.03), I² = 60.1%
Test for overall effect: Z = 1.25 (P = 0.21)
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Figure 5.41: Carer Satisfaction; “I was given enough information about allowances available” 149 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 60 "Things were well prepared for their return home" - carer                                                  
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  74/93              72/96          22.49      1.30 [0.66, 2.57]        
 Oxford                     91/113             99/122         28.80      0.96 [0.50, 1.84]        
Subtotal (95% CI) 206                218  51.30      1.11 [0.69, 1.77]
Total events: 165 (Treatment), 171 (Control)
Test for heterogeneity: Chi² = 0.39, df = 1 (P = 0.53), I² = 0%
Test for overall effect: Z = 0.43 (P = 0.67)
03 Proactive and Focused
 Leeds (Psychology)         69/87              67/84          21.92      0.97 [0.46, 2.05]        
 Leeds (Volunteers)         65/87              67/84          26.79      0.75 [0.37, 1.54]        
Subtotal (95% CI) 174                168  48.70      0.85 [0.51, 1.42]
Total events: 134 (Treatment), 134 (Control)
Test for heterogeneity: Chi² = 0.24, df = 1 (P = 0.62), I² = 0%
Test for overall effect: Z = 0.62 (P = 0.54)
Total (95% CI) 380                386 100.00      0.98 [0.69, 1.39]
Total events: 299 (Treatment), 305 (Control)
Test for heterogeneity: Chi² = 1.19, df = 3 (P = 0.76), I² = 0%
Test for overall effect: Z = 0.10 (P = 0.92)
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Figure 5.42: Carer Satisfaction; “Things were well prepared for their return home” 150 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 61 "I get all the support I need from services" - carer                                                       
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  69/89              66/94          19.85      1.46 [0.75, 2.85]        
 Oxford                     90/111             97/121         24.16      1.06 [0.55, 2.04]        
 London                     14/22              23/29           9.93      0.46 [0.13, 1.59]        
Subtotal (95% CI) 222                244  53.94      1.10 [0.71, 1.69]
Total events: 173 (Treatment), 186 (Control)
Test for heterogeneity: Chi² = 2.62, df = 2 (P = 0.27), I² = 23.7%
Test for overall effect: Z = 0.42 (P = 0.67)
03 Proactive and Focused
 Leeds (Psychology)         68/84              65/83          17.14      1.18 [0.55, 2.50]        
 Leeds (Volunteers)         57/84              65/83          28.92      0.58 [0.29, 1.17]        
Subtotal (95% CI) 168                166  46.06      0.81 [0.49, 1.34]
Total events: 125 (Treatment), 130 (Control)
Test for heterogeneity: Chi² = 1.79, df = 1 (P = 0.18), I² = 44.1%
Test for overall effect: Z = 0.84 (P = 0.40)
Total (95% CI) 390                410 100.00      0.96 [0.69, 1.34]
Total events: 298 (Treatment), 316 (Control)
Test for heterogeneity: Chi² = 5.23, df = 4 (P = 0.26), I² = 23.5%
Test for overall effect: Z = 0.23 (P = 0.82)
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Figure 5.43: Carer Satisfaction; “I get all the support I need from services” 151 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 62 "I have received enough practical help" - carer                                                            
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  85/98              79/98          69.39      1.57 [0.73, 3.39]        
 Mansfield                  55/61              42/48          30.61      1.31 [0.39, 4.35]        
Subtotal (95% CI) 159                146 100.00      1.49 [0.78, 2.85]
Total events: 140 (Treatment), 121 (Control)
Test for heterogeneity: Chi² = 0.06, df = 1 (P = 0.80), I² = 0%
Test for overall effect: Z = 1.21 (P = 0.23)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 159                146 100.00      1.49 [0.78, 2.85]
Total events: 140 (Treatment), 121 (Control)
Test for heterogeneity: Chi² = 0.06, df = 1 (P = 0.80), I² = 0%
Test for overall effect: Z = 1.21 (P = 0.23)
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Figure 5.44: Carer Satisfaction; “I have received enough practical help” 152 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 63 "I have received enough information about recovery and rehabilitation" - carer                             
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  84/99              72/105         40.47      2.57 [1.29, 5.10]        
 Mansfield                  67/76              59/70          27.80      1.39 [0.54, 3.58]        
 London                     37/49              37/58          31.72      1.75 [0.75, 4.07]        
Subtotal (95% CI) 224                233 100.00      1.98 [1.25, 3.14]
Total events: 188 (Treatment), 168 (Control)
Test for heterogeneity: Chi² = 1.17, df = 2 (P = 0.56), I² = 0%
Test for overall effect: Z = 2.90 (P = 0.004)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 224                233 100.00      1.98 [1.25, 3.14]
Total events: 188 (Treatment), 168 (Control)
Test for heterogeneity: Chi² = 1.17, df = 2 (P = 0.56), I² = 0%
Test for overall effect: Z = 2.90 (P = 0.004)
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Figure 5.45: Carer Satisfaction; “I have received enough information about recovery and rehabilitation” 153 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 64 "Someone has really listened" - carer                                                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  82/97              64/99          53.94      2.99 [1.50, 5.95]        
 London                     32/47              29/57          46.06      2.06 [0.92, 4.60]        
Subtotal (95% CI) 144                156 100.00      2.56 [1.52, 4.31]
Total events: 114 (Treatment), 93 (Control)
Test for heterogeneity: Chi² = 0.48, df = 1 (P = 0.49), I² = 0%
Test for overall effect: Z = 3.54 (P = 0.0004)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 144                156 100.00      2.56 [1.52, 4.31]
Total events: 114 (Treatment), 93 (Control)
Test for heterogeneity: Chi² = 0.48, df = 1 (P = 0.49), I² = 0%
Test for overall effect: Z = 3.54 (P = 0.0004)
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Figure 5.46: Carer Satisfaction; “Someone has really listened” 154 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 65 "I have not felt neglected" - carer                                                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  91/99              78/103         44.11      3.65 [1.56, 8.54]        
 London                     35/46              37/58          55.89      1.81 [0.76, 4.28]        
Subtotal (95% CI) 145                161 100.00      2.62 [1.44, 4.77]
Total events: 126 (Treatment), 115 (Control)
Test for heterogeneity: Chi² = 1.29, df = 1 (P = 0.26), I² = 22.6%
Test for overall effect: Z = 3.14 (P = 0.002)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 145                161 100.00      2.62 [1.44, 4.77]
Total events: 126 (Treatment), 115 (Control)
Test for heterogeneity: Chi² = 1.29, df = 1 (P = 0.26), I² = 22.6%
Test for overall effect: Z = 3.14 (P = 0.002)
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Figure 5.47: Carer Satisfaction; “I have not felt neglected” 155 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 66 "I have received enough emotional support" - carer                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  81/97              72/98          21.95      1.83 [0.91, 3.68]        
 Mansfield                  45/46              16/18           0.93      5.63 [0.48, 66.32]       
Subtotal (95% CI) 143                116  22.88      1.98 [1.01, 3.88]
Total events: 126 (Treatment), 88 (Control)
Test for heterogeneity: Chi² = 0.74, df = 1 (P = 0.39), I² = 0%
Test for overall effect: Z = 2.00 (P = 0.05)
03 Proactive and Focused
 Leeds (Psychology)         60/87              57/86          33.05      1.13 [0.60, 2.14]        
 Leeds (Volunteers)         51/87              57/86          44.07      0.72 [0.39, 1.34]        
Subtotal (95% CI) 174                172  77.12      0.90 [0.58, 1.39]
Total events: 111 (Treatment), 114 (Control)
Test for heterogeneity: Chi² = 0.99, df = 1 (P = 0.32), I² = 0%
Test for overall effect: Z = 0.48 (P = 0.63)
Total (95% CI) 317                288 100.00      1.14 [0.79, 1.65]
Total events: 237 (Treatment), 202 (Control)
Test for heterogeneity: Chi² = 5.48, df = 3 (P = 0.14), I² = 45.2%
Test for overall effect: Z = 0.73 (P = 0.47)
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Figure 5.48: Carer Satisfaction; “I have received enough emotional support” 156 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 67 "I have received enough special equipment" - carer                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  76/88              69/89          77.00      1.84 [0.84, 4.03]        
 London                     30/33              34/40          23.00      1.76 [0.41, 7.68]        
Subtotal (95% CI) 121                129 100.00      1.82 [0.91, 3.64]
Total events: 106 (Treatment), 103 (Control)
Test for heterogeneity: Chi² = 0.00, df = 1 (P = 0.96), I² = 0%
Test for overall effect: Z = 1.69 (P = 0.09)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 121                129 100.00      1.82 [0.91, 3.64]
Total events: 106 (Treatment), 103 (Control)
Test for heterogeneity: Chi² = 0.00, df = 1 (P = 0.96), I² = 0%
Test for overall effect: Z = 1.69 (P = 0.09)
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Figure 5.49: Carer Satisfaction; “I have received enough special equipment” 157 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 68 "I know who to contact" - carer                                                                            
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                  91/100             80/100         34.43      2.53 [1.09, 5.87]        
 London                     31/47              45/58          65.57      0.56 [0.24, 1.33]        
Subtotal (95% CI) 147                158 100.00      1.24 [0.69, 2.20]
Total events: 122 (Treatment), 125 (Control)
Test for heterogeneity: Chi² = 6.01, df = 1 (P = 0.01), I² = 83.4%
Test for overall effect: Z = 0.72 (P = 0.47)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 147                158 100.00      1.24 [0.69, 2.20]
Total events: 122 (Treatment), 125 (Control)
Test for heterogeneity: Chi² = 6.01, df = 1 (P = 0.01), I² = 83.4%
Test for overall effect: Z = 0.72 (P = 0.47)
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Figure 5.50: Carer Satisfaction; “I know who to contact” 158 
 
Subgroup analyses 
 
Within a systematic review, sub grouping of trials offers a potentially useful 
method  of  trying  to  establish  which  aspects  of  an  intervention  are  most 
effective  or  which  patient  group  are  likely  to  benefit  most.    This  last 
grouping according to patient characteristics is only largely possible with 
individual patient data. 
 
In order to find out which aspects of the Stroke Liaison Worker intervention 
might be effective, and which might not, an attempt was made to form 
meaningful  intervention  subgroups.    This  sub grouping  was  based  on 
external or pragmatic factors rather than on a known mechanism of effect 
for the intervention.  Because individual trials were conflicting, it could not 
be clearly established which aspects of the intervention might be resulting 
in  a  positive  benefit  (170)  and  which  might  result  in  harm  (76).    These 
subgroups were agreed by the trialists at the meeting.  They are presented 
here with their rationale and results.  Satisfaction data are presented for 
sub grouping  according  to  intervention  type  rather  than  for  patient 
characteristics. 
 
Prior  to  the  meeting  of  trialists,  an  attempt  was  made  to  form  a 
classification based on the dominant emphasis of an intervention (education 
and information provision; social support; liaison).  In order to acquire more 
detailed information about the types of intervention, trialists were asked to 
complete a “grid” detailing different aspects of the Stroke Liaison Workers 
role and function (Appendix G).  Trials were then allocated to a subgroup 
(education and information provision; social support; liaison) according to 
the dominant emphasis of a particular trial.  Where trialists could not be 
contacted, PL and GE completed trial grids independently. 
 
The results of the trial grids is illustrated in Table 5.2 159 
Results are presented in Table 5.3.  Results are discussed here where there 
was a significant subgroup or subgroup interaction. 
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Table 5.2:  Subgrouping of Trials by Primary Intervention Emphasis 
 *Both intervention arms reported by the trialist as the same 
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Leeds (Psychiatry Nurse)      ●              ●    ●    ●      ●         
Melbourne(SHIPS)      ●                            ●  ●  ●     161 
 
Primary Patient outcomes 
1.  Subjective health status: Analysis of data for 3341 participants (14 
interventions) did not suggest an overall benefit from Stroke Liaison 
Worker  (as  before).    The  subgroup  providing  education  and 
information provision (two interventions) as the dominant emphasis 
of the service showed a positive subgroup result (SMD  0.24, 95% CI  
0.44 to  0.04, p=0.02).  Similarly the group providing liaison as the 
dominant  emphasis  (one  intervention)  suggested  a  benefit  in  the 
treatment group (SMD  0.24, 95% CI  0.47 to  0.01, p=0.04).  There 
was no benefit seen for the larger subgroup (11 interventions) whose 
dominant emphasis was on social support (SMD 0.00, 95% CI  0.07 to 
0.08, p=0.94).  Overall there was significant subgroup heterogeneity 
(p<0.05) suggesting that the contrast between social support and the 
other aspects of the Stroke Liaison role reflected a real difference in 
the intervention.   
 
Patient Satisfaction Data 
1.  “Someone  has  really  listened”:  Data  were  available  for  915 
participants from three interventions, but only one subgroup (social 
support).  Results suggest a benefit from the Stroke Liaison Worker 
intervention (OR 1.58 in favour of treatment, 95% CI 1.14 to 2.19, 
p=0.006). 
 
Carer Satisfaction Data 
1.  “I received all the information I needed about the nature and causes 
of the patient’s illness”: Results for this question were available from 
459  carers  in  three  interventions  but  only  one  subgroup  (social 
support).  Results favoured the treatment group (OR 1.72, 95% CI 1.04 
to 2.85, p=0.03). 
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2.  “Someone has really listened”: Data were available from 300 carers 
in two interventions, but again only one subgroup (social support). 
Results favoured the intervention group (OR 2.56, 95% CI 1.52 to 4.31, 
p=0.0004). 
 
3.  “I  have  not  felt  neglected”:  Results  were  available  from  two 
interventions (306 carers) in one subgroup (social  support).  These 
suggested a significant benefit in favour of the intervention group (OR 
2.62, 95% CI 1.44 to 4.77, p=0.002). 
 
4.  “I  have  received  enough  information  about  recovery  and 
rehabilitation”: Results were only available for one subgroup (social 
support),  three  trials  with  457  carers.  Results  demonstrate 
significantly improved satisfaction in favour of the treatment group 
(OR 1.98, 95% CI 1.25 to 3.14, p=0.004). 163 
Table 5.3: Subgroup Analysis : Emphasis of Stroke Liaison Worker Intervention 
  N in 
analysis 
Analysis  Total [95% CI]  Subgroup 
Heterogeneity 
(Chi
2) 
Subgroup Results     
          Education and 
Information Provision 
Social Support  Liaison 
Primary Outcomes for Patients               
Subjective Health Status  3345  SMD  -0.05 (-0.11, 0.02), p=0.18  <0.05  -0.24 (-0.44, -0.04), p=0.02#  0.00 (-0.07, 0.08), 
p=0.94† 
-0.24 (-0.47, -0.01), 
p=0.04 
Extended Activities of Daily Living  3254  SMD   0.04 (-0.03, 0.11), p=0.22  >0.05   0.12 (-0.18, 0.41), p=0.44  0.06 (-0.01, 0.14), 
p=0.10 
-0.23 (-0.48, 0.02), 
p=0.08† 
               
Secondary Outcomes for Patients               
Death  4183  OR   0.87 (0.72, 1.06),  p=0.17  >0.05  0.89 (0.31, 2.56), p=0.82  0.91 (0.73, 1.13), p=0.39  0.70 (0.43, 1.15), p=0.16 
Place of Residence 
(Institutionalisation) 
1146  OR   0.83 (0.51, 1.36),  p=0.46  >0.05  NA  0.80 (0.51, 1.36), p=0.46  NA 
Activities of Daily Living  3457  SMD  -0.02 (-0.09, 0.05), p=0.55  >0.05  0.19 (-0.11, 0.49), p=0.21  -0.01 (-0.08, 0.06), 
p=0.79 
-0.25 (-0.47, -0.02), 
p=0.03† 
Dependence (Barthel score ≤19)  2898  OR   0.90 (0.76, 1.06),  p=0.20  >0.05  0.37 (0.15, 0.93), p=0.03  0.89 (0.75, 1.06), p=0.21  1.34 (0.77, 2.31), p=0.30† 
Depression  2945  SMD  -0.05 (-0.12, 0.02), p=0.17  >0.05  -0.22 (-0.44, 0.01), p=0.06  -0.01 (-0.09, 0.07), 
p=0.78 
-0.24 (-0.49, 0.02), 
p=0.07 
Anxiety  1200  SMD  -0.20 (-0.66, 0.26), p=0.39  NA  NA  -0.20 (-0.66, 0.26), 
p=0.39 
NA 
Participation  860  SMD  -0.04 (-0.17, 0.10), p=0.59  NA  NA  -0.04 (-0.17, 0.10), 
p=0.59 
NA 
               
Primary Outcome for Carers               
Subjective Health Status  1915  SMD   0.04 (-0.05, 0.13), p=0.33†  >0.05  -0.41 (-0.88, 0.05), p=0.08  0.06 (-0.03, 0.16), 
p=0.20† 
0.05 (-0.21, 0.31), 
p=0.72† 
               
Secondary Outcome for Carers               
Extended Activities of Daily Living  752  SMD  -0.13 (-0.28, 0.01), p=0.07†  NA  NA  -0.13 (-0.28, 0.01), 
p=0.07† 
NA 
Caregiver Mental Health  1767  SMD  -0.02 (-0.12, 0.07), p=0.62  >0.05  NA  -0.02 (-0.12, 0.08), 
p=0.69 
-0.05 (-0.36, 0.25), 
p=0.73 
Subgroup analysis stratified by the emphasis of the Stroke Liaison Worker intervention  
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi
2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group. (†Direction of effect favours control group.) 
#Intra-group heterogeneity present, SMD = Standardised Mean Difference, OR = Odds Ratio 164 
 
Profession of Stroke Liaison Worker 
 
The  term  “Stroke  Liaison  Worker”  describes  a  role  that  spans  different 
professions including Nursing, Psychology, Social Work, other Allied health 
professions or the voluntary sector.  It could be argued that differing levels 
of knowledge and skill rather than attitude alone may differentiate between 
otherwise,  externally  comparable  roles.    This  knowledge  or  skills  may 
influence  patient  education  and  information  provision,  or  provide  more 
focused patient and carer counselling.  For this reason dividing the results 
by professional grouping seems a legitimate method of analysing the overall 
results. 
 
Trialists were asked to provide information on the professional background 
of the Stroke Liaison Worker evaluated in each trial where this was not clear 
from  published  data.    The  professions  were  grouped  into  four  distinct 
subgroups:  Nurse,  Psychologist,  Social  Worker  and  a  final  grouping  of 
Generic Health Care Worker or Volunteer.  This last subgroup included trials 
where the SLW was from an Allied Health Profession, the voluntary sector or 
(in  the  case  of  some  trials  with  more  than  one  worker)  no  specific 
background but had been trained in the SLW role. 
 
Results are presented in Table 5.4.  Results are discussed here where there 
was a significant subgroup or subgroup interaction. 
 
Secondary Patient Outcomes 
1.  Mental  Health  (Depression):  Overall  analysis  from  15  interventions 
(2949 participants) as we have seen suggests a non significant trend 
towards the Stroke Liaison Worker intervention being beneficial.  In 
one subgroup (nurse) this effect becomes significant (SMD  0.20, 95% 165 
CI  0.34 to  0.05, p=0.007).  Subgroup heterogeneity was present with 
the Chi
2 heterogeneity p<0.05 suggesting a real subgroup interaction.  
 
Patient Satisfaction Data 
The most relevant satisfaction results are listed here. 
 
1.  “The staff attended well to my personal needs”: Data were available 
for  1668  participants  across  6  interventions  in  all  four  subgroups.  
Overall,  the  results  for  this  question  did  not  show  any  significant 
results,  however  the  nurse  subgroup  showed  a  significant  effect 
suggesting  less  satisfaction  in  the  Stroke  Liaison  Worker  group (OR 
controls 0.30, 95% CI 0.10 to 0.87, p=0.03).  There was significant 
subgroup  heterogeneity  (p<0.05)  suggesting  a  significant  subgroup 
interaction. 
 
Carer Satisfaction Data 
1.  “I know who to contact”: 305 Carers in two subgroups (Social Worker 
and Generic Health Care Worker or Volunteer) did not demonstrate 
any overall significant improvement in satisfaction for this question 
(OR 1.24, 95% CI 0.69 to 2.20, p=0.01) however one subgroup (Social 
Worker) did report a significant improvement in satisfaction (OR 2.53, 
95% CI 1.09 to 5.87, p=0.03) in the intervention group.  The other 
subgroup  (Generic  Health  Care  Worker  or  Volunteer)  suggested  a 
trend in favour of an improvement in control group satisfaction (OR 
0.56, 95% CI 0.69 to 2.20, p=0.19).  As a result there was a significant 
subgroup effect (test for heterogeneity p<0.05). 
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Table 5.4: Subgroup Analysis: Profession of Stroke Liaison Worker 
  N in 
analysis 
Analysis  Total [95% CI]  Subgroup 
Heterogeneity 
(Chi
2) 
Subgroup Results       
          Nurse  Psychologist  Social Worker  Generic Health Care 
Worker or Volunteer 
Primary Outcomes for 
Patients 
               
Subjective Health Status  3343  SMD  -0.05 (-0.11, 0.02), p=0.18  >0.05  -0.07 (-0.19, 0.05), p=0.24  -0.10 (-0.23, 0.03), p=0.12   0.11 (-0.09, 0.31), 
p=0.29† 
-0.03 (-0.15, 0.10), p=0.70 
Extended Activities of 
Daily Living 
3254  SMD   0.04 (-0.03, 0.11), p=0.22  >0.05   0.07 (-0.07, 0.20), p=0.33  -0.06 (-0.19, 0.07), 
p=0.38† 
 0.13 (-0.07, 0.33), p=0.21   0.08 (-0.04, 0.20), p=0.20 
                 
Secondary Outcomes 
for Patients 
               
Death  4179  OR   0.87 (0.72, 1.06),  p=0.17  >0.05   1.14 (0.66, 1.95), p=0.64†   0.74 (0.50, 1.10), p=0.14   0.66 (0.41, 1.08), p=0.10   0.97 (0.73, 1.29), p=0.83† 
Place of Residence 
(Institutionalisation) 
1122  OR   0.83 (0.51, 1.36),  p=0.46  >0.05   1.00 (0.34, 2.94), p=1.00   0.64 (0.29, 1.40), p=0.26   0.94 (0.12, 7.08), p=0.95   1.00 (0.42, 2.39), p=0.99 
Activities of Daily Living  3457  SMD  -0.02 (-0.09, 0.05), p=0.55  >0.05   0.07 (-0.06, 0.20), p=0.32  -0.08 (-0.21, 0.04), 
p=0.20† 
 0.06 (-0.12, 0.24), p=0.50  -0.08 (-0.20, 0.04), 
p=0.21† 
Dependence (Barthel ≤19)  2898  OR   0.90 (0.76, 1.06),  p=0.20  >0.05   0.72 (0.52, 1.01), p=0.06   0.90 (0.64, 1.27), p=0.56   0.94 (0.65, 1.34), p=0.72   1.03 (0.77, 1.39), p=0.83† 
Depression  2943  SMD  -0.05 (-0.12, 0.02), p=0.17  >0.05  -0.20 (-0.34, -0.05), 
p=0.007 
-0.04 (-0.17, 0.10), p=0.60   0.11 (-0.11, 0.32), 
p=0.33† 
-0.01 (-0.13, 0.12), p=0.92 
Anxiety  1200  SMD  -0.20 (-0.66, 0.26), p=0.39  >0.05  -0.38 (-1.18, 0.42), p=0.35  NA  -0.52 (-1.33, 0.29), p=0.21   0.28 (-0.51, 1.06), 
p=0.49† 
Participation  860  SMD  -0.04 (-0.17, 0.10), p=0.59  >0.05  NA  NA   0.02 (-0.19, 0.22), p=0.88  -0.08 (-0.25, 0.10), 
p=0.41† 
                 
Primary Outcome for 
Carers 
               
Subjective Health Status  1915  SMD   0.04 (-0.05, 0.13), p=0.33†  >0.05   0.05 (-0.12, .22), p=0.56†   0.05 (-0.15, 0.25), 
p=0.61† 
-0.09 (-0.37, 0.19), p=0.51   0.07 (-0.07, 0.21), 
p=0.32† 
                 
Secondary Outcome for 
Carers 
               
Extended Activities of 
Daily Living 
752  SMD  -0.13 (-0.28, 0.01), p=0.07†  >0.05  -0.04 (-0.40, 0.32), 
p=0.84† 
-0.11 (-0.45, 0.23), p=0.52  -0.34 (-0.64, -0.03), 
p=0.03† 
-0.07 (-0.28, 0.15), p=0.54 
Caregiver Mental Health  1767  SMD  -0.02 (-0.12, 0.07), p=0.62  >0.05   0.00 (-0.20, 0.20), p=0.99  -0.08 (-0.29, 0.12), p=0.41  -0.03 (-0.28, 0.22), p=0.80   0.00 (-0.15, 0.14), p=0.97 
Subgroup analysis stratified by the profession of the Stroke Liaison Worker  
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi
2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) SMD = Standardised Mean Difference, OR = Odds Ratio 167 
Patient Characteristics - Subgroup analysis 
 
Patient Age 
 
Patient data were dichotomised where possible into two subgroups - under 
65s  and  65  or  older.    It  was  postulated  that  younger  patients  may  have 
differing or greater psychosocial problems to older patients, and may respond 
differently to the intervention.  The results are shown in Table 5.5.  Results are 
described here where a significant subgroup exists along with a significant 
subgroup interaction.  Results for the outcome of depression are significant 
overall,  however  as  with  other  subgroups,  the  data  analysed  here  is  only 
available from datasets that have adequate individual patient data and does 
not  represent  the  overall  dataset.    For  this  reason,  these  results  are  not 
discussed here. 
 
Secondary Patient Outcomes 
1.  Activities of Daily Living (ADL): Results for ADL were available for 2424 
participants  dichotomised  by  age  from  11  interventions  (9  trials).  
Analysis by patient age (<65 or >65) revealed one positive subgroup 
for  the  outcome  of  activities  of  daily  living  in  favour  of  the  younger 
treatment group (n=706, SMD 0.15, 95% CI 0.00 to 0.30, p=0.05).  The 
older  age  group  had a  non-significant  result  in favour  of  the  control 
group  (SMD  -0.04,  95%  CI  -0.14  to  0.05,  p=0.38).    Chi
2  Tests  for 
heterogeneity  were  significant  (<0.05)  suggesting  a  significant 
subgroup interaction. 
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Table 5.5: Subgroup Analysis; Patient Age 
 
  N in 
analysis‡ 
Analysis  Total [95% CI]  Subgroup 
heterogeneity 
(Chi
2) 
Subgroup Results   
      Overall    Under 65  Over 65 
Primary Outcomes for Patients             
Subjective Health Status  2503  SMD  -0.06 (-0.14, 0.01), p=0.11  >0.05  -0.09 (-0.23, 0.05), p=0.20  -0.05 (-0.15, 0.04), p=0.29 
Extended Activities of Daily Living  2122  SMD  0.08 (0.00, 0.17), p=0.06  >0.05  0.15 (-0.03, 0.32), p=0.10  0.06 (-0.04, 0.16), p=0.21 
             
Secondary Outcomes for Patients             
Death  2856  OR  0.88 (0.69, 1.12), p=0.29  >0.05  0.60 (0.26, 1.39), p=0.23  0.91 (0.70, 1.18), p=0.47 
Place of Residence 
(Institutionalisation) 
1227  OR  1.12 (0.76, 1.65), p=0.56†  >0.05  0.75 (0.23, 2.43), p=0.63  1.18 (0.78, 1.78), p=0.43† 
Activities of Daily Living  2424  SMD  0.01 (-0.07, 0.09), p=0.76  <0.05  0.15 (0.00, 0.30), p=0.05  -0.04 (-0.14, 0.05), p=0.38† 
Dependence (Barthel ≤19)  2150  OR  0.91 (0.75, 1.11), p=0.36  >0.05  0.80 (0.56, 1.14), p=0.21  0.97 (0.77, 1.22), p=0.78 
Depression  2384  SMD  -0.08 (-0.16, 0.00), p=0.05  >0.05  -0.12 (-0.26, 0.03), p=0.11  -0.06 (-0.16, 0.04), p=0.21 
Anxiety  868  SMD  0.09 (-0.84, 1.02), p=0.85†  >0.05  0.09 (-0.84, 1.02), p=0.85†  0.03 (-0.67, 0.74), p=0.92† 
             
Primary Outcome for Carers             
Subjective Health Status  1483  SMD  -0.01 (-0.11, 0.09), p=0.87  >0.05  0.06 (-0.12, 0.24), p=0.53†  -0.04 (-0.16, 0.08), p=0.53) 
             
Secondary Outcome for Carers             
Extended Activities of Daily Living  316  SMD  0.00 (-0.22, 0.22), p=0.99  >0.05  0.20 (-0.33, 0.73), p=0.47  -0.04 (-0.29, 0.20), p=0.72† 
Caregiver Mental Health  1051  SMD  -0.03 (-0.15, 0.09), p=0.65  >0.05  0.10 (-0.15, 0.34), p=0.43†  -0.07 (-0.21, 0.07), p=0.33 
Subgroup analysis stratified by patient age (Under 65, 65 or older). 
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi
2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) 
#Intra-group heterogeneity present 
SMD = Standardised Mean Difference, OR = Odds Ratio 169 
Patient Sex 
Data were dichotomised on the basis of sex.  It seemed reasonable to explore 
this  sub  grouping  as  men  and  women  may  respond  to  differently  to  an 
intervention with a significant psychological and social component.  It should 
be noted that for analysis of carer data, these are analysed according to the 
sex of the patient and may not reflect the sex of the carer.  For instance a 
carer may well be a daughter looking after a mother or a wife looking after a 
husband.    Data  on  carer  sex  was  inadequate  across  the  trials  to  analyse 
according to carer sex.  Results are presented in Table 5.6.  No significant 
subgroups  or  significant  subgroup  interaction  was  observed.    As  before 
results for the outcome of depression are positive, but do not represent the 
totality of data and should be treated with caution. 
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Table 5.6: Subgroup Analysis: Patient Sex 
 
  N in 
analysis‡ 
Analysis  Total [95% CI]  Subgroup 
Heterogeneity 
(Chi
2) 
Subgroup Results   
      Overall    Male  Female 
Primary Outcomes for Patients             
Subjective Health Status  2491  SMD  -0.05 (-0.13, 0.03), p=0.20  >0.05  0.00 (-0.11, 0.10), p=0.93  -0.11 (-0.22, 0.01), p=0.08 
Extended Activities of Daily Living  2118  SMD  0.03 (-0.06, 0.11), p=0.52  >0.05  0.05 (-0.6, 0.17), p=0.36  0.00 (-0.13, 0.12), p=0.96 
             
Secondary Outcomes for Patients             
Death  2658  OR  0.88 (0.69, 1.13), p=0.32  >0.05  1.06 (0.75, 1.52), p=0.73†  0.75 (0.54, 1.05), p=0.09 
Place of Residence 
(Institutionalisation) 
1055  OR  1.05 (0.68, 1.61), p=0.82†  >0.05  1.41 (0.68, 2.90), p=0.36†  0.90 (0.53, 1.53), p=0.69 
Activities of Daily Living  2425  SMD  0.00 (-0.08, 0.08), p=0.91  >0.05  0.04 (-0.07, 0.15), p=0.51  -0.05 (-0.17, 0.07), p=0.38† 
Dependence (Barthel ≤19)  2363  OR  0.88 (0.73, 1.06), p=0.17  >0.05  0.94 (0.74, 1.21), p=0.64  0.80 (0.60, 1.06), p=0.13 
Depression  2325  SMD  -0.08 (-0.17, 0.00), p=0.05  >0.05  -0.07 (-0.18, 0.04), p=0.23  -0.10 (-0.23, 0.02), p=0.10 
Anxiety  869  SMD  -0.01 (-0.56, 0.55), p=0.99  >0.05  0.02 (-0.75, 0.80), p=0.96†  -0.03 (-0.84, 0.77), p=0.93 
             
Primary Outcome for Carers             
Subjective Health Status  1483  SMD  -0.01 (-0.11, 0.10), p=0.89  >0.05  0.06 (-0.08, 0.20), p=0.39†  -0.10 (-0.25, 0.06), p=0.23 
             
Secondary Outcome for Carers             
Extended Activities of Daily Living  316  SMD  0.02 (-0.20, 0.24), p=0.86  >0.05  0.07 (-0.22, 0.37), p=0.62  -0.05 (-0.39, 0.29), p=0.76† 
Caregiver Mental Health  1051  SMD  -0.04 (-0.17, 0.08), p=0.49  >0.05  0.03 (-0.13, 0.19), p=0.73†  -0.15 (-0.34, 0.05), p=0.13 
Subgroup analysis stratified by patient sex. 
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi
2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group. (†Direction of effect favours control group) 
#Intra-group heterogeneity present 
SMD = Standardised Mean Difference, OR = Odds Ratio 171 
Presence of a Carer 
 
It is theoretically possible that patients without identified carer support might 
be  at  higher  risk  of  (as  we  have  discussed  in  Chapter  One).    It  therefore 
follows that this subgroup might benefit the most from social support aspects 
of the intervention.  Within the trials there was varied involvement of carers.  
(See Table 5.7).  Some trials (Rhode Island, Adelaide) specifically recruited 
only patients who had an identified primary caregiver.  Other studies did not 
include or record caregiver involvement at all (Glasgow).  Clearly these trials 
do not allow us to test the hypothesis that the presence or absence of an 
identified primary caregiver results in different responses to the Stroke Liaison 
Worker intervention.  For this reason, these trials have been excluded from 
this subgroup analysis.   
The quality of recording of caregiver presence and proximity of involvement 
with the patient was variable.  Two trials reported carer relationship (Oxford, 
Utrecht).  Other trials did not collect this data.  To adequately analyse these 
trials,  I  hypothesised  that  the  presence  of  carer  data  recorded  by  trialists 
formed a proxy for the clear identification of a caregiver.  This proxy has its 
limitations,  as the  proximity  and  level  of  involvement of a  caregiver  with  a 
patient  may  vary  considerably  and  not  be  sensitively  measured  by  this 
dichotomisation.  Nevertheless it could be postulated that a closely involved 
carer is more likely to be contactable and therefore available for simple data 
collection.  Data were therefore dichotomised according to whether a carer 
was identified (Oxford, Utrecht) or whether carer outcome data was collected.  
Results are presented here for these two subgroups.  Clearly there can be no 
comparison  of  carer  outcomes  for  this  subgroup  analysis.    Results  are 
presented in Table 5.8.  No significant subgroup or subgroup interaction was 
observed. 
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Table 5.7: Trial Involvement of Carers 
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London    ●   
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Boston      ● 
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Classification of trials by their involvement of carers.173 
Table 5.8: Subgroup Analysis: Presence or Absence of Main Carer 
  N in 
analysis‡ 
Analysis  Total [95% CI]  Subgroup 
Heterogeneity 
(Chi
2)
 
Subgroup Results   
      Overall    Carer present  Carer absent 
Primary Outcomes for Patients             
Subjective Health Status  2296  SMD  -0.05 (-0.13, 0.03), p=0.26  >0.05  -0.08 (-0.18, 0.02), p=0.14  0.01 (-0.13, 0.16), p=0.88† 
Extended Activities of Daily Living  2145  SMD   0.04 (-0.04, 0.13), p=0.34  >0.05   0.06 (-0.05, 0.17), p=0.32  0.02 (-0.11, 0.15), p=0.77 
             
Secondary Outcomes for Patients             
Death  1965  OR   0.99 (0.75, 1.31), p=0.95  >0.05   1.05 (0.56, 1.98), p=0.88†   0.98 (0.71, 1.34), p=0.88 
Place of Residence 
(Institutionalisation) 
637  OR   1.45 (0.91, 2.32), p=0.12†  >0.05   1.36 (0.68, 2.69), p=0.39†   1.55 (0.82, 2.92), p=0.18† 
Activities of Daily Living  2673  SMD  -0.05 (-0.13, 0.03), p=0.21  >0.05  -0.04 (-0.13, 0.06), p=0.43  -0.07 (-0.20, 0.06), p=0.29 
Dependence (Barthel ≤19) 
 
2889  OR   0.89 (0.75, 1.05), p=0.18  >0.05   0.86 (0.68, 1.08), p=0.19   0.93 (0.72, 1.19), p=0.57 
Depression  2223  SMD  -0.08 (-0.16, 0.01), p=0.08  >0.05  -0.10 (-0.20, 0.00), p=0.06  -0.03 (-0.17, 0.11), p=0.69 
Anxiety  1127  SMD   0.08 (-0.43, 0.58), p=0.76†  >0.05   0.06 (-0.57, 0.68), p=0.86†   0.12 (-0.74, 0.98), p=0.78† 
             
Subgroup analysis by presence of a carer. 
Unless otherwise stated the direction of effect favours the treatment group. (†Direction of effect favours control group.) 
SMD = Standardised Mean Difference, OR = Odds Ratio 
.   
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Patient Functional Status 
 
It has been assumed in most trials that the intervention of a Stroke Liaison 
Worker should be applied to all patients regardless of their level of disability or 
functional  dependence.    Data  from  one  trial  (Bradford)  has  previously 
suggested that patients with mild to moderate disability (as measured by - 
Barthel Index 15 - 19) make the most gains from Stroke Liaison Worker input.  
It  was  decided  therefore  to  evaluate  this  question  by  functional  status 
according to Barthel measurement.  Patients were divided according to their 
Barthel  index  at  recruitment  (which  usually  equated  to  their  Barthel  at 
discharge from hospital).  They were divided into three subgroups: Barthel 20 
(independent), Barthel 15-19 (Mild to moderately dependent) and Barthel <15 
(dependent). 
Barthel indices at recruitment varied across the trials as might be expected 
and are illustrated in Figure 5.51.  Recruitment appeared highest in the more 
independent groups as might be expected for a trial evaluating psychosocial 
interventions  in  a  population  returning  to  the  community.    Interestingly  the 
patient population appears to trichotomise relatively equally.  (Figures 5.52, 
5.53) 
Results are shown in Table 5.9.  Where a significant subgroup effect was 
seen  in  conjunction  with  a  significant  subgroup  interaction,  the  results  are 
discussed here. 
 
Patient Secondary Outcomes 
 
1.  Dependence (Barthel £19): Data were analysed for 2494 participants in 
12  interventions  of  10  trials.    The  subgroup  Barthel  15-19  had  a 
significant reduction in dependence (OR 0.60, 95% CI 0.44 to 0.83, 
p=0.002).  This effect size would equate to 10 less dependent patients 
(95% CI 17 less to 4 less) for every 100 patients with mild to moderate 
disability  that  were  seen  by  the  Stroke  Liaison  Worker.    Significant 
subgroup  heterogeneity  existed  suggesting  that  this  subgroup  was 
responding differently to the intervention than the others (Chi
2 <0.05).  175 
The  other  subgroups  did  not  show  a  significant  effect  of  the  Stroke 
Liaison Worker  intervention  however  (Barthel  <15  OR  1.21,  95%  CI 
0.87  to  1.68,  p=0.26;  Barthel  20  OR  1.01,  95%  CI  0.71  to  1.44, 
p=0.94).  (Figure 5.52). 
 
2.  Death or Dependence:  It was decided after analysis of dependence 
data to look at this combined outcome.  The concern was that there 
might  appear  to  be  a  reduction  in  dependence  at  the  expense  of 
increased mortality.  Data were combined using the same dependence 
data.    Overall  data  for  this  new  outcome  did  not  show  a  significant 
benefit  from  the  Stroke  Liaison  Worker  for  a  reduction  in  Death  or 
Dependence (OR 0.87, 95% CI 0.73 to 1.04, p=0.12).  A significant 
subgroup effect was again seen (Barthel 15-19) as well as subgroup 
heterogeneity suggesting that this group responded differently to the 
Stroke Liaison Worker input. (OR 0.62, 95% CI 0.47 0.83, p=0.001).  
This  risk  difference  equates  to  11  less  dead  or  dependent  patients 
(95% CI 17 less to 4 less) as a result of Stroke Liaison Worker input for 
the  group  with  mild  to  moderate  disability.    Results  for  the  other 
subgroups were not significant (Barthel <15 OR 1.06, 95% CI 0.79 to 
1.40, p=0.71; Barthel 20 OR 1.10, 95% CI 0.75 to 1.59, p=0.63; Chi
2 
<0.05).  (Figure 5.53). 
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Table 5.9: Subgroup Analysis; Patient Dependency 
  N in 
analysis‡ 
Analysis  Total [95% CI]  Subgroup 
Heterogeneity 
(Chi
2) 
Subgroup Results     
      Overall    Barthel <15  Barthel 15-19  Barthel 20 
Primary Outcomes for Patients               
Subjective Health Status  2268  SMD  -0.03 (-0.11, 0.05), p=0.46  >0.05  -0.06 (-0.19, 0.07), 
p=0.35# 
-0.11 (-0.27, 0.04), 
p=0.16 
 0.09 (-0.06, 0.24), 
p=0.26† 
Extended Activities of Daily Living  2138  SMD  -0.02 (-0.10, 0.07), p=0.69†  >0.05  -0.01 (-0.13, 0.11), 
p=0.83† 
 0.02 (-0.13, 0.18), 
p=0.78 
-0.09 (-0.28, 0.10), 
p=0.38† 
               
Secondary Outcomes for Patients               
Death  2801  OR   0.85 (0.66, 1.09), p=0.20  >0.05   0.82 (0.61, 1.10), 
p=0.18 
 0.68 (0.39, 1.18), 
p=0.17 
2.26 (0.88, 5.81), 
p=0.09† 
Place of Residence 
(Institutionalisation) 
1198  OR   1.17 (0.79, 1.74), p=0.44†  >0.05   1.27 (0.80, 2.00), 
p=0.31† 
 1.04 (0.45, 2.43), 
p=0.93† 
0.16 (0.00, 4.87), 
p=0.29 
Activities of Daily Living  2540  SMD   0.00 (-0.08, 0.08), p=1.00  >0.05  -0.07 (-0.19, 0.05), 
p=0.27† 
 0.09 (-0.06, 0.23), 
p=0.25 
0.01 (-0.14, 0.16), 
p=0.88 
Dependence (Barthel ≤19)  2494  OR   0.89 (0.74, 1.08), p=0.25  <0.05   1.21 (0.87, 1.68), 
p=0.26† 
 0.60 (0.44, 0.83), 
p=0.002 
1.01 (0.71, 1.44), 
p=0.94 
Death or Dependence  2225  OR   0.91 (0.74, 1.12), p=0.37  <0.05   1.45 (0.99, 2.11), 
p=0.06† 
 0.55 (0.39, 0.78), 
p=0.0008 
1.02 (0.71, 1.45), 
p=0.93 
Depression  2205  SMD  -0.07 (-0.15, 0.02), p=0.11  >0.05  -0.10 (-0.23, 0.02), 
p=0.11 
-0.03 (-0.18, 0.13), 
p=0.73 
-0.06 (-0.23, 0.11), 
p=0.48 
Anxiety  826  SMD   0.07 (-0.53, 0.66), p=0.83†  >0.05   0.59 (-0.50, 1.69), 
p=0.29† 
 0.37 (-0.79, 1.52), 
p=0.53† 
-0.47 (-1.36, 0.42], 
p=0.30 
               
Primary Outcome for Carers               
Subjective Health Status  1509  SMD  0.01 (-0.10, 0.11), p=0.90  >0.05  0.10 (-0.06, 0.26), 
p=0.24† 
-0.07 (-0.26, 0.12), 
p=0.47 
-0.04 (-0.23, 0.15), 
p=0.67 
               
Secondary Outcome for Carers               
Extended Activities of Daily Living  495  SMD  -0.01 (-0.19, 0.16), p=0.89  >0.05  -0.02 (-0.25, 0.21), 
p=0.87 
 0.03 (-0.37, 0.43), 
p=0.87† 
-0.04 (-0.42, 0.34), 
p=0.85 
Caregiver Mental Health  1387  SMD  -0.02 (-0.13, 0.09), p=0.71  >0.05   0.00 (-0.17, 0.17), 
p=0.97 
-0.13 (-0.33, 0.07), 
p=0.20 
0.05 (-0.14, 0.24), 
p=0.62† 
Subgroup analysis stratified by baseline Barthel index (Barthel <15, Barthel 15-19, or 20). 
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi
2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) 
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Review: Stroke liaison workers for stroke patients and carers
Comparison:05 Stroke Liaison Workers Versus Usual Care - Patient Functional Status                                       
Outcome: 17 Barthel Dependency                                                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Barthel <15
 Leeds (Psychology)         53/60              42/54           2.33      2.16 [0.78, 5.98]        
 Leeds (Volunteers)         52/57              42/54           1.71      2.97 [0.97, 9.10]        
 Liverpool                  20/20              27/28           0.25      2.24 [0.09, 57.75]       
 Liverpool (Psych)           8/9               27/28           0.66      0.30 [0.02, 5.29]        
 Bradford                    1/1                1/1                  Not estimable         
 Oxford                     70/79              59/73           3.16      1.85 [0.75, 4.57]        
 Mansfield                  66/95              65/90           9.21      0.88 [0.46, 1.65]        
 Boston (FIRST)             56/79              68/86           8.57      0.64 [0.32, 1.31]        
 Preston                    32/35              34/37           1.28      0.94 [0.18, 5.01]        
 Utrecht                     7/14               2/10           0.53      4.00 [0.62, 25.96]       
 London                     47/50              42/45           1.20      1.12 [0.21, 5.85]        
Subtotal (95% CI) 499                506  28.89      1.21 [0.87, 1.68]
Total events: 412 (Treatment), 409 (Control)
Test for heterogeneity: Chi² = 11.29, df = 9 (P = 0.26), I² = 20.3%
Test for overall effect: Z = 1.13 (P = 0.26)
02 Barthel 15-19
 Leeds (Psychology)         27/42              31/42           5.00      0.64 [0.25, 1.62]        
 Leeds (Volunteers)         23/40              31/42           5.81      0.48 [0.19, 1.22]        
 Liverpool                  19/27              27/31           3.37      0.35 [0.09, 1.34]        
 Liverpool (Psych)          13/16              27/31           1.56      0.64 [0.12, 3.30]        
 Bradford                   21/22              19/19           0.61      0.37 [0.01, 9.56]        
 Oxford                      6/13              10/17           2.11      0.60 [0.14, 2.58]        
 Mansfield                  16/25              19/30           2.81      1.03 [0.34, 3.10]        
 Boston (FIRST)             17/46              16/45           4.61      1.06 [0.45, 2.50]        
 Preston                    12/20              18/22           3.10      0.33 [0.08, 1.36]        
 Utrecht                    21/73              38/78          11.83      0.43 [0.22, 0.83]        
 London                     24/30              25/32           2.19      1.12 [0.33, 3.82]        
Subtotal (95% CI) 354                389  42.99      0.60 [0.44, 0.83]
Total events: 199 (Treatment), 261 (Control)
Test for heterogeneity: Chi² = 6.25, df = 10 (P = 0.79), I² = 0%
Test for overall effect: Z = 3.06 (P = 0.002)
03 Barthel 20
 Leeds (Psychology)          3/14               8/28           1.89      0.68 [0.15, 3.11]        
 Leeds (Volunteers)          7/27               8/28           2.63      0.88 [0.27, 2.87]        
 Liverpool                  19/38              10/25           2.73      1.50 [0.54, 4.17]        
 Liverpool (Psych)          11/18              10/25           1.47      2.36 [0.68, 8.15]        
 Bradford                   59/79              62/85           6.83      1.09 [0.54, 2.20]        
 Oxford                      0/3                0/1                  Not estimable         
 Mansfield                   2/6                2/4            0.72      0.50 [0.04, 6.68]        
 Boston (FIRST)              2/9                1/4            0.49      0.86 [0.05, 13.48]       
 Preston                     1/8                2/3            1.15      0.07 [0.00, 1.73]        
 Utrecht                    18/146             24/163          8.99      0.81 [0.42, 1.57]        
 London                      7/14               5/12           1.22      1.40 [0.30, 6.62]        
Subtotal (95% CI) 362                378  28.12      1.01 [0.71, 1.44]
Total events: 129 (Treatment), 132 (Control)
Test for heterogeneity: Chi² = 6.27, df = 9 (P = 0.71), I² = 0%
Test for overall effect: Z = 0.08 (P = 0.94)
Total (95% CI) 1215               1273 100.00      0.89 [0.74, 1.08]
Total events: 740 (Treatment), 802 (Control)
Test for heterogeneity: Chi² = 32.53, df = 30 (P = 0.34), I² = 7.8%
Test for overall effect: Z = 1.14 (P = 0.25)
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Review: Stroke liaison workers for stroke patients and carers
Comparison:05 Stroke Liaison Workers Versus Usual Care - Patient Functional Status                                       
Outcome: 07 Death or Dependence                                                                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Barthel <15
 Leeds (Psychology)         53/60              42/54           2.70      2.16 [0.78, 5.98]        
 Leeds (Volunteers)         52/57              42/54           1.98      2.97 [0.97, 9.10]        
 Liverpool                  20/20              27/28           0.29      2.24 [0.09, 57.75]       
 Liverpool (Psych)           8/9               27/28           0.76      0.30 [0.02, 5.29]        
 Bradford                    1/1                1/1                  Not estimable         
 Oxford                     70/79              59/73           3.66      1.85 [0.75, 4.57]        
 Mansfield                  66/95              65/90          10.67      0.88 [0.46, 1.65]        
 Preston                    32/35              34/37           1.48      0.94 [0.18, 5.01]        
 Utrecht                     7/14               2/10           0.61      4.00 [0.62, 25.96]       
 London                     47/50              42/45           1.39      1.12 [0.21, 5.85]        
Subtotal (95% CI) 420                420  23.54      1.45 [0.99, 2.11]
Total events: 356 (Treatment), 341 (Control)
Test for heterogeneity: Chi² = 7.59, df = 8 (P = 0.47), I² = 0%
Test for overall effect: Z = 1.92 (P = 0.06)
02 Barthel 15-19
 Leeds (Psychology)         27/42              31/42           5.80      0.64 [0.25, 1.62]        
 Leeds (Volunteers)         23/40              31/42           6.73      0.48 [0.19, 1.22]        
 Liverpool                  19/27              27/31           3.90      0.35 [0.09, 1.34]        
 Liverpool (Psych)          13/16              27/31           1.80      0.64 [0.12, 3.30]        
 Bradford                   21/22              19/19           0.71      0.37 [0.01, 9.56]        
 Oxford                      6/13              10/17           2.44      0.60 [0.14, 2.58]        
 Mansfield                  16/25              19/30           3.25      1.03 [0.34, 3.10]        
 Preston                    12/20              18/22           3.59      0.33 [0.08, 1.36]        
 Utrecht                    21/73              38/78          13.70      0.43 [0.22, 0.83]        
 London                     24/30              25/32           2.53      1.12 [0.33, 3.82]        
Subtotal (95% CI) 308                344  44.46      0.55 [0.39, 0.78]
Total events: 182 (Treatment), 245 (Control)
Test for heterogeneity: Chi² = 4.30, df = 9 (P = 0.89), I² = 0%
Test for overall effect: Z = 3.36 (P = 0.0008)
03 Barthel 20
 Leeds (Psychology)          3/14               8/28           2.19      0.68 [0.15, 3.11]        
 Leeds (Volunteers)          7/27               8/28           3.05      0.88 [0.27, 2.87]        
 Liverpool                  19/38              10/25           3.16      1.50 [0.54, 4.17]        
 Liverpool (Psych)          11/18              10/25           1.70      2.36 [0.68, 8.15]        
 Bradford                   59/79              62/85           7.92      1.09 [0.54, 2.20]        
 Oxford                      0/3                0/1                  Not estimable         
 Mansfield                   2/6                2/4            0.84      0.50 [0.04, 6.68]        
 Preston                     1/8                2/3            1.33      0.07 [0.00, 1.73]        
 Utrecht                    18/146             24/163         10.41      0.81 [0.42, 1.57]        
 London                      7/14               5/12           1.41      1.40 [0.30, 6.62]        
Subtotal (95% CI) 353                374  32.00      1.02 [0.71, 1.45]
Total events: 127 (Treatment), 131 (Control)
Test for heterogeneity: Chi² = 6.25, df = 8 (P = 0.62), I² = 0%
Test for overall effect: Z = 0.09 (P = 0.93)
Total (95% CI) 1081               1138 100.00      0.91 [0.74, 1.12]
Total events: 665 (Treatment), 717 (Control)
Test for heterogeneity: Chi² = 31.55, df = 27 (P = 0.25), I² = 14.4%
Test for overall effect: Z = 0.90 (P = 0.37)
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Discussion 
 
Individual data meta analysis confers considerable advantage in unpacking 
the potential benefits or harms of an intervention.  At a statistical level, it 
is less likely to overestimate the effect of an intervention, but also gives 
narrower confidence intervals, reducing the chance of missing a real benefit 
or harm (313).  They permit a greater understanding of the studies involved, 
which is vital where the interventions and trials are complex, as in this case.  
Additionally they allow greater flexibility in exploring subgroups (313).  This 
is  important  in  this  case  as  little  is  understood  regarding  the  underlying 
mechanism of potential benefit for Stroke Liaison Workers and therefore it 
is hard to identify which intervention characteristics are most important and 
additionally  which  patient  subgroup  if  any  are  most  likely  to  benefit.  
However  individual  patient  data  meta analysis  is  considerably  more 
complex.   
Meta analysis is secondary analysis of research where ethics approval has 
already been obtained.  Despite that however, some trialists did run into 
difficulties in sharing their data.  Two studies (Boston, Adelaide) described 
having to have permission to share their data with a third party.  In one case 
(Adelaide),  the  ethics  committee  would  not  give  permission  to  share 
anonymised individual patient data with the collaborative group.  Instead, 
data for subgroup analysis were provided in aggregate form on request from 
the  lead  author.    In  one  case  (Boston)  awaiting  approval  from  the  data 
review  board  took  approximately  one  year  and  represented  considerable 
delay for the review process. 
 
It is important to state that in the planning of this analysis, the lack of a 
theoretical  or  pathophysiological  rationale  for  Stroke  Liaison  Workers 
affected  the  selection  of  appropriate  primary  outcome  measures.    Given 
that  this  is  a  broad  or  comprehensive  intervention  for  a  wide  range  of 
problems, it was unclear from the published trials (76;167;170;297) which 
outcome might be expected to be impacted most.  As a result, the published 
trials evaluated different primary outcome measures from activities of daily 181 
living (101), satisfaction (296;297),  subjective health status (170;295) and 
extended activities of daily living (70) or none at all (76).  For this reason, 
two primary outcome measures were chosen, as it was argued that if the 
Stroke Liaison Workers aim was to return patients to normal roles that this 
might be measured in activities and perceived health.  It remains a relevant 
potential criticism that we chose the wrong outcome measure to evaluate 
effectiveness and that Stroke Liaison Workers might have an unanticipated 
impact in an entirely different domain. 
The  intervention  of  a  Stroke  Liaison  Worker  did  not  affect  the  primary 
outcomes of subjective health status or extended activities of daily living.  
The implication is that patients who were seen by the Stroke Liaison Worker 
did not feel their health or quality of life to be better than controls, and 
they were not more independent.  There are two potential explanations for 
failing to demonstrate an impact.  The first concerns the intervention itself.  
The second concerns matters of methodology. 
The criticism of the intervention might appropriately be that it is poorly 
focused  and  too  broad  or  diffuse  to  impact  a  single,  specific  outcome.  
Because  these  interventions  were  developed  on  a  practical  and  intuitive 
basis, as has already been said, they lack a clear underlying mechanism of 
action.  This development of services to meet a wide range of problems post 
stroke may have been too ambitious and as a consequence poorly focused.  
The  provision  of  information  and  education  is  a  real  need  with  a  wider 
evidence base than in this review alone (133).  The impact of information 
might reasonably be expected to be measured in satisfaction first, rather 
than in behaviour change (as we have seen from Chapters One and Two).  
Liaison as a service offered for patients may be difficult to measure and is 
perhaps poorly addressed in the Stroke Liaison Worker trials.  It might be 
reasonable  to  expect  that  liaison  between  the  patient  and  community 
services  or  health  services  might  be  measured  in  resource  use.  
Unfortunately we were unable to assess resource use in this review due to a 
lack  of  standardised  measures.    In  addition  the  meaning  of  increased 
resource use must be evaluated.  It is unclear whether increased uptake of 182 
community  services  for  instance  means  increased  access  and  enhanced 
resources, or conversely an increasing dependence.  Similarly in a health 
care context, it would be difficult to tell from crude data whether increased 
use of medical and therapy resources meant an attitude of active and self 
motivated health care or simply increasing ill health.  Social support, whilst 
being potentially hardest to define, may in fact be the one outcome that 
has  the  most  measures  of  effectiveness.    Many  of  these  outcomes  are 
surrogates  (e.g.  measures  of  mental  health,  self  efficacy,  satisfaction, 
participation)  and  poorly  correlated  with  what  is  a  diffuse  and  poorly 
defined  entity.    Some  trials  have  tried  to  be  more  specific  about  social 
support and have included counselling as part of the intervention (101;257).  
Whilst  it  might  be  expected  that  this  would  more  directly  impact  some 
measures (e.g. depression, anxiety etc.) it has not been so clear in either 
the trials or the review process. 
It  has  been  assumed  that  all  patients  have  information  needs  and  share 
many of the psychological and social problems post stroke.  Similarly it has 
been  assumed  that  the  intervention  should  be  targeted  at  all  patients 
regardless  of  age,  sex  or  stroke  severity.    This  assumption  does  not 
adequately take into consideration differences in risk between patients in 
terms of (for example) the onset of post stroke depression, social isolation, 
anxiety  etc.    Patient  subgroup  analysis  was  only  possible  for  those 
identifiers that allow division of patients into groups (e.g. age, sex, Barthel 
at  recruitment  etc.).    These  patient  descriptors  may  not  adequately 
correlate with the risks of a poor outcome (e.g. age and depression) and 
therefore  may  not  subdivide  patient  subgroups  according  to  meaningful 
groups.    Despite  these  shortfalls,  and  because  of  the  existing  limitations 
with the data the subgroup analysis by age, sex, Barthel and the presence of 
a carer seems a robust and plausible exploration of the data.   
Only one study (Melbourne) recruited patients more than six months after 
stroke.    Data  for  this  study  were  only  obtained  from  published  data  for 
limited  numbers of  outcomes.    For  this  reason  subgroup analysis  for  this 
description was felt to be unhelpful. 183 
Subgroup  analysis  within  the  review  process  highlights  some  interesting 
areas  of  differences  that  may  be  important  and  may  identify  important 
aspects of either the intervention or the target population.  It is recognised 
in observational studies and trials that multiple analyses carry the risk of 
false  positive  results.    This  risk  should  be  lessened  in  meta analysis, 
nevertheless it still remains a risk with multiple subgroup analyses.  For this 
reason  we  have  only  considered  subgroup  results  where  there  is  both  a 
significant subgroup effect and a significant subgroup interaction. 
Analysis of the intervention effect by emphasis of the intervention highlights 
some differences between the intervention types that may be important.  In 
the  analysis  of  subjective  health  status  for  instance,  two  subgroups 
(education and information provision as well as liaison) were significant in 
favour  of  the  intervention,  whilst  one  subgroup  (social  support)  was  non 
significant.  Importantly, the subgroups varied in size, with the education 
and information provision subgroup containing two studies, and the Liaison 
group  containing  only  one.    The  social  support  group  contained  10 
interventions from eight trials.  The differences between the groups could 
be potentially accounted for by “regression to the mean” where the larger 
subgroup  has  more  neutral  results.    Heterogeneity  tests  were  positive, 
suggesting  that  a  subgroup  interaction  exists  and  that  the  subgroups  are 
behaving differently for this outcome.  There is a risk of over interpreting 
subgroup data and given the overall non significant result for Stroke Liaison 
Workers we cannot necessarily conclude that any one subgroup is effective.  
Despite  this  it  is  possible  to  conclude  that  interventions  with  a  strong 
emphasis on social support are less effective at impacting subjective health 
status.   
Analysis of the same data by the profession of the Stroke Liaison Worker 
reveals a few interesting findings.  Patients whose Stroke Liaison Worker 
was  a  nurse  by  professional  background  appear  to  have  a  significant 
reduction in depression score when compared to controls.  This effect also 
differed  significantly  from  the  other  subgroups  suggesting  that  the 184 
intervention,  when  delivered  by  a  nurse,  differed  in  nature  from 
interventions delivered by other professions.    
If the intervention itself is does not appear to be effective for all patients, 
it is reasonable to explore patient subgroups to establish which groups of 
patients  (if  any)  benefit,  and  which  do  not.    Analysis  by  age  suggested 
differences between the two subgroups in how they responded to the Stroke 
Liaison Worker in the area of ADL.  Younger patients appeared to benefit in 
improvement  in  ADL  score  in  the  group  reviewed  by  the  Stroke  Liaison 
Worker.  In addition, heterogeneity tests were positive suggesting that the 
younger  (<65)  and  older  (³65)  patients  respond  differently  to  the 
intervention of a Stroke Liaison Worker.  It is not possible to say whether 
these differences relate to differences in the way the Stroke Liaison Workers 
treated patients who were younger, or more probably because there are 
important differences in the patient group examined. 
Analysis of data by the presence or absence of a carer could be criticized for 
our choice of a surrogate for carer involvement.  The absence of data for a 
primary carer does  not  mean the  absence  of  a  good caregiving  network.  
This may be a reason that no significant differences were found between 
the two subgroups.  Equally, the impact of a Stroke Liaison Worker’s social 
support on the effects of social isolation may be small.  Arguably, several 
short visits from a Stroke Liaison Worker may not be enough to mitigate 
against the risks of social isolation, depression and mortality that appear to 
be  associated  with  reduced  social  support.    In  an  exploration  of  the 
difference  between  those  who  have  a  carer  and  those  who  do  not,  we 
compared the mortality of patients who had a carer with those who did not.  
Treatment and control groups were combined for each subgroup.  Results 
were  striking,  with  patients  who  had  an  identified  carer  having  a  90% 
reduction in mortality compared with those who did not have an identified 
carer (OR 0.10, 95% CI 0.07 to 0.15, p<0.00001).  These results must be 
treated  with  caution  for  a  number  of  reasons.    Firstly,  because 
heterogeneity tests were strongly positive (p<0.00001), largely due to one 185 
trial (Oxford) that had a disproportionate difference in mortality in favour 
of those with carers.  Removal of this study from the analysis still results in 
an overall positive effect, but without the heterogeneity (OR 0.21, 95% CI 
0.14 to 0.31, p<0.00001, Chi
2 heterogeneity p>0.05).  Secondly, and most 
importantly, this research methodology is not appropriate for exploring the 
relationship between risk and outcome in cohorts of patients.  Thirdly, the 
effect size is greater than that previously identified in the literature (37 
39;52).    Fourthly,  patients  enrolled  in  this  study  are  not  necessarily 
representative  of  the  wider  stroke  population.    Patients  may  have  been 
randomised who were considered isolated or at high risk.  Additionally, as 
we  have  already  said  the  absence  of  data  for  a  carer  does  not  directly 
equate with reduced or absent social support.  We have assumed it to be 
suggestive, but cannot infer more than this.  Patients without carer data 
may have been more dependent and therefore not directly comparable to 
patients who had carer data.  It may be that this relationship between the 
presence  of a  strong  carer  relationship  and  mortality  should  be  explored 
further  in carefully  designed  cohort  studies.    Key  to  the design  of  these 
studies must be some robust description or measure of the degree of social 
support. 
The  final  patient  subgrouping  is  the  functional  status  of  the  patient  at 
recruitment.  This subgrouping was suggested by one of the trials (Bradford 
(167))  as  identifying  patients  who  would  benefit  most.    This  trial  had 
suggested  that  patients  with  mild moderate  dependence  (Barthel  15 19) 
benefited  most.    For  this  reason,  we  have  used  the  same  definitions  of 
dependence.  It is plausible that patients with severe dependence may make 
minimal  gains  with  information  provision.    Similarly  patients  who  are 
dependent may already have established connections with services (such as 
carers,  social  work,  primary care  etc.) and  may  have  little  to gain  from 
liaison input.  Alternatively, you might expect that caregivers of patients 
who are dependent would need the most support and might be the most 
satisfied.  By contrast, independent patients might be expected to have the 
least  risk  of  depression  or  morbidity,  and  the  least  to  gain  from  social 186 
support or liaison.  The finding of a reduction in dependence (or an increase 
in  the  number  who  were  independent  in  ADL)  was  in  some  respects 
surprising.  The intervention was primarily a psycho social one and was not 
expected to impact physical outcomes.  As has already been said, there was 
concern that the reduction in dependence could be at the expense of an 
increase in mortality.  For this reason a post hoc analysis of a combined 
outcome of death or dependency was considered necessary in order to rule 
out this concern.  This result was also considered surprising.   The effect 
size of this reduction in death or dependence is considerable equating to 11 
fewer  dead  or  dependent  patients  for  every  100  patients  treated.    The 
mechanism of this effect is not clear.  It is interesting to note that the 
review of Early Supported Discharge after stroke also found that patients 
with mild to moderate disability (Barthel 10 20) made the most gains with 
Early  Supported  Discharge  resulting  in  reductions  in  death  or  disability 
(223).  It is interesting to postulate whether the improvement seen in this 
group reflects the impact of the Stroke Liaison Worker per se (as opposed to 
any  other  form  of  rehabilitation  intervention)  or  whether  it  reflects  the 
sensitivity of this particular patient group to rehabilitation and to potential 
gains in independence.  None of the studies in the Stroke Liaison Worker 
review  appears  to  have  had  input  from  an  Early  Supported  Discharge 
service.  There may be potential benefit from further research exploring the 
rehabilitation potential of this patient subgroup and the most appropriate 
design of rehabilitation interventions. 
Data  for  the  outcome  of  satisfaction  appear  to  provide  the  only  overall 
statistically  significant  results  for  the  intervention.    Patients  responded 
significantly  to  only  one  question:  “Someone  has  really  listened”.    This 
response would potentially fit well with the social support intentions of the 
intervention.  It is interesting to note however that there are a number of 
patient responses that show a trend towards significance in favour of the 
control group (“I have been treated with kindness and respect”, “I was able 
to  talk  to  the  staff  about  any  problems  I  had”  and  “I  am  satisfied  with 
outpatient services”).  There may be more than one explanation for these 187 
findings  (although  in  the  absence  of  statistical  significance  we  must  be 
cautious about drawing conclusions).  One possible explanation is that in 
simple terms patients were as satisfied with the intervention as those who 
did  not  receive  it.    One  additional  potential  explanation  reflects  the 
complexity of using satisfaction as an outcome measure.  Satisfaction, it 
might  be  argued,  is  based  in  part  on  a  participant’s  expectations.    If 
expectations are low, participants may express high satisfaction with what 
is  delivered.    If  expectations  are  raised  for  example  by  a  Stroke  Liaison 
Worker  educating  patients  on  the  importance  of  treatment  and 
investigation, it might be expected that patients become less satisfied with 
service provision (e.g. outpatient services).  In addition, it is recognised that 
satisfaction questionnaires have a ceiling effect and that they may not be 
sensitive to discriminate between groups if overall satisfaction is high. 
Interestingly,  carers  appear  to  express  satisfaction  more  frequently  than 
patients.  The responses that reach significance appear to be related to the 
nature of the intervention and are therefore plausible.  For example the 
response     “I  have  received  enough  information  about  recovery  and 
rehabilitation”  and  the  response  “I  have  received  all  the  information  I 
needed about the causes of the patient’s illness” would plausibly fit with 
the  education  and  information  provision  aspects  of  the  intervention.  
Similarly,  the  response  “Someone  has  really  listened”  would  fit  with  the 
social support aspects of the intervention and the response “I have not felt 
neglected” would fit with the liaison aspects of the service.  In some cases 
however  the  positive  results  are  drawn  from  only  two  studies  studying 
approximately 300 carers.  The results, although statistically significant are 
not robust, and the addition of as few as 10 positive responses to the control 
group could result in a change to a non significant result (“Someone has 
really listened”). 
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Group details 
The Stroke Liaison Workers Collaboration are (in study alphabetical order): 
Michael Clark (Adelaide), Martha Fay, Thomas Glass (Boston   FIRST), Anne 
Forster (Bradford), Martin Dennis, Suzanne O’Rourke (Edinburgh), Graham 
Ellis,  Peter  Langhorne  (Glasgow),  Allan  House  (Leeds),  Michael  Leathley, 
Anil.Sharma, Caroline Watkins (Liverpool), Kate Tilling, Catherine Coshall, 
Charles  Wolfe  (London),  Nadina  Lincoln  (Mansfield),  Judith  Frayne 
(Melbourne – SHIPS), Jonathan Mant (Oxford), Arthur Gershkoff (Philadelphia 
  STAIR), Chris Burton (Preston), Ivan Miller, Duane Bishop (Rhode Island), 
Han Boter, Thora Hafsteinsdottir (Utrecht). 189 
 
Table 5.10: Study Characteristics   Adelaide 
Trial Location  Adelaide      
Study 
methodology 
Randomised controlled trial. 
Randomisation  Centralised randomisation procedure. 
Recruitment   Stroke  patients  and  carers  recruited  from  a  stroke 
rehabilitation  unit  in  Adelaide  within  two  weeks  of 
stroke onset (n=62 patients and 62 carers). 
Exclusion criteria  Exclusion criteria: severe communication problems, poor 
English language, cognitive impairment and ongoing care 
or rehabilitation needs. 
Inclusion criteria  Inclusion  criteria:  Confirmed  stroke,  co resident  with 
spouse and returning to the community. 
Patient 
characteristics 
Mean  age  71  (SD  9)  controls,  73  (SD  9)  experiment, 
approximately 60% male. 
Intervention  The intervention comprised an information package and 
three  visits  from  a  Social  Worker  trained  in  family 
counselling  techniques.    Visits  lasted  on  average  one 
hour.  Final visits were conducted at five months. 
Comparison  Control group patients and their spouses did not receive 
the  information  pack  or  the  visits  from  the  Social 
Worker.     
Outcome 
assessment 
Follow up was at six months, conducted by a research 
nurse independent of the interventions.  No blinding is 
described.  Patient outcomes assessed were: Subjective 
health status (SF 36); extended activities of daily living 
(Adelaide  activities  profile);  Activities  of  daily  living 
(Barthel);  Mood  (Geriatric  Depression  Score,  Hospital 
Anxiety  and  Depression  Scale     Anxiety  component); 
McMaster  Family  Assessment  Device  Global  Function 
Scale  Mastery Scale). 
Carers  Involvement of a spouse was compulsory for entry into 
the  study.    Carer  outcomes  were:  Subjective  health 
status (SF36; McMaster Family Assessment Device Global 
Functioning Scale).   
Allocation 
concealment 
A=adequate* 
Data  Aggregated data was available on request. 
Publication 
status 
Published 
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Table 5.11: Study Characteristics   Boston 
Trial Location  Boston (FIRST) 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Centralised  randomisation  by  computer  generated 
random numbers and remote, telephone allocation.   
Recruitment   Stroke patients recruited from inpatient stroke unit care 
within 30 days of event. 
Exclusion criteria  Exclusion  criteria:  age  less  than  45;  resident  out  with 
area;  terminally  ill;  severe  communication  problems; 
cognitive  impairment;  poor  English  language; 
institutional care; social isolation. 
Inclusion criteria  Inclusion criteria: Confirmed stroke of mild or moderate 
severity; competent to consent. 
Patient 
characteristics 
(n=291, Mean age 70, Male 49%) 
Intervention  Intervention: The intervention was provided by a clinical 
psychologist  or  a  social  worker  who  were  formally 
trained.    The  emphasis  of  the  intervention  was  on 
recruiting  families  and  naturally  occurring  social 
networks  rather  than  formal  or  community care  based 
services.  15 Intervention visits were made according to 
protocol (approximately 90 minutes in duration). 
Comparison  Control:  The  control  group  received  usual  care  (not 
defined).   
Outcome 
assessment 
Outcome assessment was conducted at 3 and 6 months 
by  a  blinded  outcome  assessor.  Patient  outcome 
measures:  These  included  Activities  of  daily  living 
(Barthel,  Instrumental  activities  of  daily  living); 
Dependency (Physical performance test); Mood (Centre 
for  Epidemiological  Studies  Depression  Scale  CESD); 
Cognition (A cognitive summary score); Perceived health 
status (Self rated health and quality of life). 
Carers  Involvement of a carer was not compulsory. 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data obtained. 
Publication 
status 
Published 
   
*Cochrane criteria 
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Table 5.12: Study Characteristics   Bradford 
 
Trial Location  Bradford         
Study 
methodology 
Randomised controlled trial. 
Randomisation  Allocation by random number tables and carried out by 
assistant not connected to study. 
Recruitment   Patients were obtained from hospital and primary care 
within six weeks of stroke (n=240). 
Exclusion 
criteria 
Exclusion criteria: Cognitive impairment; poor prognosis 
or placement in institutional care. 
Inclusion criteria  Inclusion  criteria:  Acute  stroke  with  some  disability; 
aged over 60 and able to give informed consent.   
Patient 
characteristics 
Mean age 73 (SD 7), Male 53%. 
 
Intervention  Intervention:  The intervention was delivered by senior 
nurses who visited 7 times according to a protocol and 
provided information, advice and support. 
Comparison  Control:  The control group received no visits. 
Outcome 
assessment 
The outcomes were assessed at 3, 6 and 12 months. No 
blinding was attempted. 
Patient  outcomes:  Extended  activities  of  daily  living 
(Nottingham  extended  ADL);  Activities  of  daily  living 
(Barthel);  Dependency  (Functional  ambulatory 
category); Subjective health status (Nottingham health 
profile). 
 
Carers  Involvement  of  a  carer  was  not  compulsory.    Carer 
outcomes:  Mental  health  and  Subjective  health  status 
(GHQ28);  Extended  activities  of  daily  living  (Frenchay 
activities index). 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data obtained 
Publication 
status 
Published 
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Table 5.13: Study Characteristics   Edinburgh 
 
Trial Location  Edinburgh 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Allocation  by  remote  computer  generated  random 
numbers. 
Recruitment   Patients  were  recruited  from  both  inpatient  and 
outpatient  settings  within  30  days  of  stroke  onset.  
Patient  blinding  was  achieved  through  a  process  of 
delayed consent. 
Exclusion 
criteria 
 
Inclusion criteria   
Patient 
characteristics 
Number recruited = 417, mean age 68 (SD13), 50% male 
Intervention  Intervention:  The intervention was delivered by a social 
worker, who contacted patients on average four times 
to  provide  social  support,  counselling  and  to  identify 
unmet needs requiring services.   
Comparison  Control:  Control patients received usual care which did 
not include contact with the stroke family care worker 
until  after  final  follow  up  had  been  completed  at  six 
months. 
Outcome 
assessment 
Outcomes  were  recorded  by  a  research  psychologist 
blinded to treatment allocation at six months.  Patient 
outcomes: Extended activities of daily living (Frenchay 
activities index FAI); Activities of daily living (Barthel), 
Dependency  (Oxford  handicap  scale);  Mental  \Health 
(GHQ30, Hospital Anxiety and Depression Scale, Mental 
adjustment  to  stroke  scale,  medical  coping  modes 
questionnaire); Satisfaction (Pound satisfaction scale). 
Carers  Involvement  of  a  carer  was  not  compulsory.    Carer 
outcomes:  Subjective  health  status  (Caregiver  hassles 
scale);  Extended  activities  of  daily  living  (Frenchay 
activities index, social adjustment scale); mental health 
(GHQ28); Satisfaction (Pound satisfaction scale).   
 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data was obtained for most outcomes. 
Publication 
status 
Published 
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Table 5.14: Study Characteristics   Glasgow 
 
Trial Location  Glasgow 
Study 
methodology 
Randomised Controlled Trial. 
 
Randomisation  Allocation  by  remote  random  number  generation  and 
sequentially numbered opaque envelopes. 
Recruitment   Patients  were  recruited  on  discharge  from  outpatient 
clinics and rehabilitation facilities.   
Exclusion 
criteria 
Exclusion:    Major  illness;  cognitive  impairment;  severe 
communication disorder. 
Inclusion criteria  Inclusion  criteria:  Clinical  diagnosis  of  stroke  or  TIA; 
presence of at least one modifiable risk factor; able to 
give informed consent.   
Patient 
characteristics 
Number = 205, mean age = 65 (SD 9), male = 51% 
Intervention  Intervention:    Intervention  patients  received  three 
appointments (30 minutes each) with a nurse to discuss 
lifestyle,  risk  factors  and  recovery  from  stroke.    In 
addition patients were given written information specific 
to them regarding risk factor targets etc. 
Comparison  Control:  Control patients received one meeting with the 
stroke nurse to discuss risk factors prior to recruitment. 
Outcome 
assessment 
Outcomes were assessed at 5 months by a research nurse 
blinded to treatment allocation.  Outcomes:  Cumulative 
risk  factor  control;  individual  risk  factor  control; 
Subjective  health  status  (Euroqol);  mood  (Geriatric 
Depression  Scale)  and  satisfaction  (Pound  satisfaction 
scale). 
Carers  Carers were not involved in this study. 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data. 
Publication 
status 
Published 
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Table 5.15: Study Characteristics   Leeds 
 
Trial Location  Leeds     
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Remote  random  number  sequence  generation  and 
telephone allocation. 
Recruitment   Patients  were  identified  from  admissions  to  hospital 
(n=450).    Consent  was  obtained  after  randomisation.  
Patients  were  blinded  to  other  treatment  or  control 
arms. 
Exclusion 
criteria 
Exclusion  criteria:  Subarachnoid  haemorrhage;  too  ill; 
poor  communication;  poor  English  language  ability; 
cognitive impairment; serious concurrent illness. 
 
Inclusion criteria  Inclusion criteria: First or recurrent stroke, local to area 
and able to give consent. 
 
Patient 
characteristics 
Mean age was 71 (SD 12), 54% male.   
Intervention  The  trial  tested  two  separate  interventions  and  one 
control group.  Psychology Intervention: The psychology 
arm of this trial was delivered by Psychiatric Nurses who 
aimed  to  improve  patient's  problem  solving  skills  by 
working  with  patients  at  fortnightly  visits.    The 
Pyschiatric  Nurses  were  supervised  fortnightly  by  a 
Senior Psychiatrist.  Volunteer  Intervention:  Volunteers 
were  recruited  through  local  charities  and  self  help 
groups.    All  attended  a  training  session  on  the 
consequences of stroke. 
Comparison  Control:  Patients  in  the  control  group  received  usual 
care, although this was not standardised. 
Outcome 
assessment 
Outcomes  were  measured  at  6  and  12  months  by  an 
outcome assessor blinded to patient allocation. 
Carers  Involvement of a carer was not compulsory.   
Allocation 
concealment 
A=adequate* 
Data  Individual patient data obtained from trialists. 
Publication 
status 
This study is published in abstract form only. 
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Table 5.16: Study Characteristics   Liverpool 
Trial Location  Liverpool 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Allocation  by  remote  computer  generated  random 
numbers and telephone randomisation. 
Recruitment   Participants were recruited at discharge from hospital 
following admission with stroke to a larger multi centre 
study (Life after Stroke). 
Exclusion 
criteria 
 
Inclusion criteria   
Patient 
characteristics 
 
Intervention  Three separate interventions were evaluated singly or in 
combination for this study.  They include the evaluation 
of a Stroke Family Support Worker (Social Intervention), 
a  Psychologist  (Psych)  and  an  Occupational  Therapist 
(Physical).    Only  the  social  and  psychological  arms  of 
this  study  have  been  used  for  analysis,  where  these 
were conducted alone and in comparison to the control 
group.  Social Intervention:  This involved the input of a 
Stroke  Family  Support  Worker  to  provide  verbal  and 
written  information,  informal  counselling  and  social 
support  as  well  as  liaison  with  other  services.    On 
average  the  SFSW  made  4  contacts  per  patient  by 
telephone or visit. 
Psychology Intervention: The intervention was delivered 
by a Psychology Assistant, working under the supervision 
of  an  experienced  Clinical  Psychologist.  It  included 
assessing  a  patient’s  mental  and  emotional  state  and 
delivering cognitive behavioural therapy for the patient 
as  well  as  problem  solving  for  the  whole  family.    On 
average the psychologists made 10 visits per patient. 
Comparison  Control group:  The control group received usual care 
which  did  not  include  the  Family  Support  Worker, 
Psychologist or the Occupational Therapist. 
Outcome 
assessment 
Outcomes were assessed at 12 months.  
Carers  Involvement of a carer was not compulsory.   
Allocation 
concealment 
A=adequate* 
Data  Individual patient data obtained. 
Publication 
status 
This study remains unpublished at this time. 
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Table 5.17: Study Characteristics   London 
 
Trial Location  London 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Allocation  by  fax  to  remote  centre  with  computer 
generated random number table. 
Recruitment   Participants were recruited from admissions to hospital 
with first in a lifetime stroke (n=340). 
Exclusion 
criteria 
Exclusion  criteria:  Unable  to  consent  due  to  poor 
prognosis, cognitive impairment or poor communication 
and where assent was not available. 
Inclusion criteria  Inclusion criteria: First stroke and resident in local area.
   
 
Patient 
characteristics 
Mean age was 78 (SD 10), 42% male. 
Intervention  Intervention:  A  Stroke  Association  Family  Support 
Organiser, offering emotional support, information and 
liaison to services and voluntary agencies.  They made 
contact, primarily through visits on average  15 times. 
Comparison  Control:  The control group received no input from the 
Family Support Organiser but could receive usual care 
including other agency involvement. 
Outcome 
assessment 
Outcomes  were  evaluated  at  12  months  by  a  blinded 
outcome assessor.   
Patient  outcomes:    Extended  Activities  of  Daily  Living 
(Frenchay Activities Index); Death; Residence; Activities 
of  daily  living  (Barthel);  Mood  (Hospital  Anxiety  and 
Depression  Scale);  Participation  (Reintegration  to 
Normal  Living  Index);  Satisfaction  (Pound  Satisfaction 
Scale); Hope and Acceptance scale. 
Carers  Involvement of a carer was not compulsory. 
Carer  outcomes:  Subjective  Health  Status  (Caregiver 
Strain  Index);  Extended  activities  of  daily  living 
(Reintegration  to  normal  living  index);  Mental  health 
(Hospital  anxiety  and  depression  scale);  Hope  and 
acceptance. 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data. 
Publication 
status 
Published 
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Table 5.18: Study Characteristics   Mansfield 
 
Trial Location  Mansfield    
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Telephone allocation from remote, computer generated 
list of random numbers. 
Recruitment   Patients  admitted  to  hospital  with  an  acute  stroke 
(n=250).   
 
Exclusion 
criteria 
Exclusion  criteria:  Unconscious  on  admission; 
Institutional  care;  Severe  disability;  Resident  outwith 
local area. 
Inclusion 
criteria 
Inclusion  criteria:  Confirmed  stroke  within  4  weeks  of 
onset. 
Patient 
characteristics 
Mean age 69 (SD 11), 54% male. 
Intervention  Intervention: A Psychologist with training by the Stroke 
Association as a Family Support Organiser delivered an 
information  pack,  and  identified  unmet  information 
needs, concerns and emotional needs.  In addition they 
acted as liaison to the stroke team.  The FSO visited on 
average  twice  with  additional  telephone  liaison.    The 
intervention was provided for up to 9 months. 
Comparison  Control:  Control  group  patients  received  no  contact 
from the Family Support Organiser. 
Outcome 
assessment 
Outcomes were recorded at 4 months and 9 months by 
an independent assessor who was blinded to treatment 
allocation.  Patient outcomes: Subjective health status 
(GHQ12); Extended activities of daily living (Nottingham 
extended  ADL);  Activities  of  daily  living  (Barthel); 
Mental  health  (GHQ12);  Satisfaction  (Modified  Pound 
satisfaction scale). 
Carers  Involvement of a carer was not compulsory. 
Carer outcomes: Subjective health status (Carer strain 
index);  Mental  health  (GHQ12);  Extended  activities  of 
daily living (Nottingham extended ADL). 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data. 
Publication 
status 
Published 
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Table 5.19: Study Characteristics   Melbourne 
 
Trial Location  Melbourne 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Methods  of  allocation  and  randomisation  are  not 
defined. 
Recruitment   Patients  were  recruited  from  a  previous  population 
incidence  study,  two  years  after  the  onset  of  stroke. 
(N=213). 
Exclusion 
criteria 
 
Inclusion 
criteria 
Stroke  (patients  were  recruited  from  a  previous 
population incidence study). 
Patient 
characteristics 
 
Intervention  Intervention:  This was provided by a social worker who 
provided liaison with health and community services and 
social  support.    On  average  seven  visits  to  a  clients 
home were carried out. 
Comparison  Control: The control group had no social work input. 
Outcome 
assessment 
Outcomes were recorded at one year.  No attempt was 
made at blinding outcome assessment. 
Patient  Outcomes:  Death;  Days  in  Institutional  care, 
local,  undefined  measures  of  activities  of  daily  living 
and dependency. 
Carers   
Allocation 
concealment 
B=unclear* 
Data  Published  data  only.    No  successful  contact  could  be 
made with the authors. 
Publication 
status 
Published 
   
*Cochrane criteria 199 
Table 5.20: Study Characteristics – Melbourne (SHIPS) 
 
Trial Location  Melbourne (SHIPS) 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  No  information  was  available  on  methods  of 
randomisation or allocation concealment. 
Recruitment   Patients were recruited from hospital (n=96). 
Exclusion 
criteria 
 
Inclusion criteria   
Patient 
characteristics 
 
Intervention  Intervention: Regular visits and phone calls from a nurse 
who provides support, education and liaison to patients 
and carers. 
Comparison  Control:  Patients  and  caregivers  in  the  control  group 
received no home visits until after the end of the nine 
month trial follow up. 
Outcome 
assessment 
Patient outcomes: Subjective health status (Assessment 
of  quality  of  life  scores);  Activities  of  daily  living 
(Barthel);  Dependency  (Modified  Rankin  score);  health 
service usage. 
Carers  Carer  involvement  does  not  appear  to  have  been 
compulsory. 
Allocation 
concealment 
B=unclear* 
Data   
Publication 
status 
This study finished early due to funding shortages.  No 
individual patient data was available.  This data remains 
unpublished. 
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Table 5.21: Study Characteristics   Oxford 
 
Trial Location  Oxford 
Study 
methodology 
Randomised controlled trial. 
Randomisation  Allocation  by  telephone  randomisation  to  remote 
individual;  with  sequentially  numbered  opaque 
envelopes. 
Recruitment   Patients were recruited from hospital presenting within 
six weeks of  stroke. 
Exclusion 
criteria 
Exclusion criteria: Institutional care, dominant medical 
problems or severe illness. 
Inclusion criteria  Inclusion criteria: Confirmed stroke aged 18 or over local 
in area and with close family carer. 
Patient 
characteristics 
(n=323, mean age = 74 (SD 13), 52% male).   
 
Intervention  Intervention: Patients assigned to the intervention group 
were visited by the Family Support Organiser (trained by 
the Stroke Association) who provided written and verbal 
information  and  advice,  support  and  liaison  with 
services. On average, patients received 2 visits and three 
telephone contacts. 
Comparison  Control:  The  control  group  did  not  receive  any  input 
from the Family Support Organiser. 
Outcome 
assessment 
Outcomes were assessed at six months by a researcher 
blinded  to  treatment  allocation.    Patient  outcomes: 
Subjective  health  status  (Dartmouth  CO OP  chart); 
Death;  Place  of  residence;  Activities  of  daily  living 
(Barthel,  Rivermead  mobility  index);  Dependency 
(London handicap scale); Mental health (Hospital anxiety 
and  depression  scale);  Satisfaction  (Local  satisfaction 
scale). 
Carers  Carer  outcomes:  Subjective  health  status  (Carer  strain 
index,  SF36);  Extended  activities  of  daily  living 
(Frenchay  activities  index);  Mental  health  (GHQ28); 
Satisfaction. 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data. 
Publication 
status 
Published 
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Table 5.22: Study Characteristics – Philadelphia (STAIR) 
 
Trial Location  Philadelphia (STAIR) 
Study 
methodology 
Randomised controlled trial. 
Randomisation  Randomisation by random number table but allocation 
concealment unclear. 
Recruitment   Patients were recruited from in patient wards within 3 
months of stroke onset. 
Exclusion 
criteria 
Exclusion  criteria:    Severe  co morbidity;  cognitive 
impairment;  communication  problems;  institutional 
care. 
Inclusion criteria  Inclusion criteria: Aged over 65; recent stroke; returning 
to  community;  caregiver  identified;  able  to  give 
informed consent.   
Patient 
characteristics 
n=55, 52% Male 
Intervention  Intervention:  Patients  were  assigned  a  case  manager 
who  visited  monthly  and  telephoned  weekly.    They 
provided access to information, identified psychosocial 
stresses and provided liaison to community or hospital 
resources. 
Comparison  Control:  The control group did not receive visits from 
the  case  manager  or  input  from  the  multi disciplinary 
team.  Outcomes  were  recorded  at  12  months  by  a 
researcher blinded to treatment allocation.  
 
Outcome 
assessment 
Patient  outcomes:  Extended  activities  of  daily  living 
(Frenchay  activities  index,  Social  Functioning 
Examination,  Older  American  Resources  and  Services 
Scales Social  Resources  (OARS SR));  Activities  of  daily 
living (FIM, OARS ADL, OARS Physical health, SFE, FAI); 
OARS Economic resources. 
Carers  Carer involvement was necessary for the study.  Carer 
outcomes:  Subjective  health  status  (Questionnaire  on 
resources and stress (QRS)); Mental health (Centre for 
epidemiological studies depression scale (CESD)). 
Allocation 
concealment 
B=unclear* 
Data  Some aggregated data were available in addition to the 
paper, but not individual patient data. 
Publication 
status 
Published 
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Table 5.23: Study Characteristics   Preston 
 
Trial Location  Preston      
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Allocation  by  telephone  to  remote  centre  with 
concealed random number sequence. 
Recruitment   Patients  with  a  clinical  diagnosis  of  stroke  were 
recruited from admission to hospital. 
Exclusion 
criteria 
Exclusion criteria: Depression prior to stroke, cognitive 
impairment, poor prognosis, substance addiction. 
 
Inclusion 
criteria 
Inclusion criteria: clinical diagnosis of stroke. 
Patient 
characteristics 
(n=176), mean age =75 (SD 10), 52% male. 
 
Intervention  Intervention:  Patients  were  visited  by  a  stroke  nurse 
who  visited  on  average  3  times  over  2  months  and 
provided information and advice, emotional support and 
liaison with services. 
Comparison  Control:  The  control  group  received  inpatient  case 
management and multidisciplinary rehabilitation, but no 
home visits on discharge. 
Outcome 
assessment 
Outcomes  were  recorded  at  3  and  12  months  by  a 
researcher  blinded  to  treatment  allocation.  Patient 
outcomes: Subjective health status (Nottingham health 
profile);  Extended  activities  of  daily  living  (Frenchay 
activities  index);  Activities  of  daily  living  (Barthel); 
Mental health (Beck depression inventory). 
 
Carers  Involvement  of  a  carer  was  not  compulsory.  Carer 
outcomes; Subjective health status (Carer strain index). 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data. 
Publication 
status 
Published 
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Table 5.24: Study Characteristics – Rhode Island 
Trial Location  Rhode Island    
Study 
methodology 
Randomised controlled trial.   
 
Randomisation  There  was  no  information  on  the  method  of 
randomisation or allocation concealment. 
Recruitment   Patients and carers were recruited in hospital following 
stroke.   
Exclusion 
criteria 
Exclusion  criteria:  Subarachnoid  haemorrhage; 
Institutional care; no caregiver. 
Inclusion criteria  Inclusion  criteria:  Age  over  35  with  confirmed  stroke, 
competent to consent and caregiver present. 
Patient 
characteristics 
Number = 215, mean age 65(SD 13), 55% male. 
 
Intervention  Intervention: Patients received on average 13 telephone 
calls  (lasting  15 20  minutes)  from  the  stroke  liaison 
worker  who  provided  education,  social  and  emotional 
support and counselling. 
Comparison  Control group: Control group patients were allocated to 
usual care. 
Outcome 
assessment 
Outcomes were recorded at 3, 6, 12 and 18 months by 
staff  blinded  to  treatment  assignment.    Patient 
outcomes:  Subjective  health  status  (SF36);  Extended 
activities of daily living (Frenchay activities index, FIM); 
mental  health  (Geriatric  depression  scale);  Family 
function (Family assessment device). 
 
Carers  Involvement  of  a  carer  was  compulsory.    Carer 
outcomes:  Subjective  health  status  (Caregiver  strain 
index, SF36); Mental health (CES D). 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data. 
Publication 
status 
This trial is unpublished at present. 
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Table 5.25: Study Characteristics – Utrecht (HESTIA) 
Trial Location  Utrecht (HESTIA) 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation  Randomisation was performed by telephone to a remote 
centre. 
Patient blinding was achieved by a process of delayed 
consent. 
Recruitment   Patients  were  recruited  from  12  hospitals  prior  to 
discharge following a first in a lifetime stroke. 
Exclusion 
criteria 
Exclusion criteria: Recurrent stroke; age under 18; poor 
prognosis;  severe  dependency;  lives  out  with  area; 
institutional care. 
Inclusion 
criteria 
Inclusion criteria: Age 18 or over with first ever stroke, 
resident  in  area  with  no  or  only  mild  dependency, 
discharged  to  community  and  expected  to  live  more 
than one year. 
Patient 
characteristics 
n=536, mean age 63 (SD 15), 49% male. 
Intervention  Intervention:  Senior  nurses  made  three  telephone 
contacts and visited the patient in their homes.  They 
provided  information,  support  and  liaison  to  primary 
care. 
 
Comparison  Control group:  The control group received the same in 
patient care but were not contacted on discharge. 
Outcome 
assessment 
Outcomes  were  recorded  at  six  months  by  postal 
questionnaire  and  telephone  interview  by  an  assessor 
blinded  to  treatment  allocation.  Patient  outcomes: 
Subjective health status (SF36); Activities of daily living 
(Barthel); Dependency (Modified rankin scale); Mental 
health (Hospital anxiety and depression scale); Use of 
services;  satisfaction  (Satisfaction With Stroke Care 
questionnaire SASC 19). 
Carers  Involvement  of  a  carer  was  not  compulsory.    Carer 
outcomes: Subjective health status (Carer strain index); 
Extended activities of daily living (Social support list   
discrepancies  (SSL D));  Mental  health  (Sense  of 
competence questionnaire (SCQ)). 
Allocation 
concealment 
A=adequate* 
Data  Individual patient data. 
Publication 
status 
Published 
   
*Cochrane criteria 205 
Table 5.26: Primary Patient Outcomes 
Primary Outcomes 
Study  Subjective Health Status 
  
EADL 
Adelaide  SF36 - physical health   Adelaide Activities Profile  (cumulative) 
Boston (FIRST)    Instrumental Activities of Daily Living  
Bradford  Nottingham Health Profile  Frenchay Activities Index 
Edinburgh  GHQ30  Frenchay Activities Index 
Glasgow  EuroQOL   
Leeds  GHQ  Frenchay Activities Index 
Liverpool  GHQ12  Nottingham Extended ADL 
London    Reintegration to normal living  
Mansfield  GHQ12  Nottingham Extended ADL  
Melbourne    Local tool 
Melbourne (SHIPS)  AQOL  Barthel  
Oxford  COOP  Frenchay Activities Index  
Philadelphia 
(STAIR) 
  Frenchay Activities Index 
Preston  Nottingham Health Profile  Frenchay Activities Index  
Rhode Island  SF36 (general health subsection)  Frenchay Activities Index  
Utrecht  SF36 (general health subsection)  Barthel 
Analysis plan with outcomes for each trial in the categories for the review 
process.206 
Table 5.27: Table of Secondary Outcomes 
Analysis plan with outcomes for each trial in the categories for the review process   
 
 
Secondary Outcomes 
Study  Death  Place  of 
Residence 
ADL  Dependency  Mental  Health  - 
Generic 
Mental  Health  - 
Depression 
Mental  Health  - 
Anxiety 
Knowledge 
about stroke 
Use  of 
Services 
Participation  Other 
Adelaide      Barthel    GDS  GDS  HADS  anx          
Boston (FIRST)      Barthel  Physical 
Performance 
Recovery Efficacy  Recovery 
Efficacy 
      Received  
Social Support 
 
 
Bradford  Yes    Barthel  Functional 
Ambulatory 
Category 
             
Edinburgh  Yes  Yes  Barthel  Modified Rankin   HADS cumulative  HADS dep  HADS  anx     Yes  RLOC  SAS 
Glasgow  Yes        GDS  GDS      Yes     
Leeds  Yes    Barthel    GHQ   GHQ           
Liverpool      Barthel    GHQ12  GHQ12      Yes     
London      Barthel    HADS cumulative  HADS dep  HADS  anx       RNLI   
Mansfield      Barthel          Local       
Melbourne      Local  Local          Yes     
Melbourne (SHIPS)      Barthel                 
Oxford  Yes  Yes  Barthel  London 
Handicap Scale 
HADS cumulative  HADS dep  HADS anx  Local  Yes  London  
Handicap Scale 
 
 
Philadelphia 
(STAIR) 
    FIM            Yes  FAI   
Preston  Yes  Yes  Barthel    Beck  Depression 
Inventory 
Beck  Depression 
Inventory 
         
Rhode Island          GDS  GDS           
Utrecht  Yes    Barthel  Modified Rankin  HADS cumulative  HADS dep  HADS  anx     Yes     207 
Table 5.28: Table of Outcomes for Carers 
 
Analysis plan with outcomes for each trial in the categories for the review 
process
Carer Outcomes - 
Analysis Plan 
Primary Outcomes  Secondary Outcomes 
Study  Subjective Health 
Status 
EADL  Mental Health 
Adelaide  SF36 (physical health)     SF-36 mental 
health 
Boston (FIRST)  Caregiver Burden       
Bradford  GHQ28  Frenchay Activities Index   GHQ28 
Edinburgh  Caregiver Hassles Scale  Frenchay  Activities  Index 
from published medians 
GHQ28 
Glasgow          
Leeds  Carer Strain Index      GHQ28 
Liverpool  Carer Strain Index      GHQ12 
London  Carer Strain Index      HADS  
Mansfield  Carer Strain Index      GHQ12 
Melbourne          
Melbourne (SHIPS)  Carer Strain Index        
Oxford  Carer Strain Index   Frenchay Activities Index   GHQ28 
Philadelphia 
(STAIR) 
Questionnaire and 
Resources 
   CES-D  
Preston  Carer Strain Index        
Rhode Island  Carer Strain Index   Frenchay Activities Index   CES-D 
Utrecht  Carer Strain Index      Sense of 
Competence 208 
 
    Table 5.29: Identifying Relevant Satisfaction Questions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*High score indicates dissatisfaction, †High score indicates satisfactions 
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I  have  been  treated  with  kindness 
and respect by staff at the hospital 
●  ●  ●      ●  ● 
The  staff  attended  well  to  my 
personal needs whilst in hospital 
●  ●  ●      ●  ● 
I was able to talk to the staff about 
any problems I might have had 
●  ●  ●      ●  ● 
I have received all the information I 
want about the causes and nature of 
my illness 
●  ●  ●  ●  ●  ●  ● 
The  doctors  have  done  everything 
they can to make me well again 
●  ●  ●      ●  ● 
I  am  happy  with  the  amount  of 
recovery I have made 
●  ●  ●      ●  ● 
I  am  satisfied  with  the  type  of 
treatment  the  therapists  have  given 
me 
●    ●      ●  ● 
I have had enough therapy  ●          ●  ● 
I  was  given  all  the  information  I 
needed about allowances or services 
I might need after leaving hospital 
●  ●  ●  ●  ●  ●  ● 
Things  were  well  prepared  for  my 
return home 
●    ●      ●  ● 
I  get  all  the  support  I  need  from 
services  such  as  meals  on  wheels, 
home help etc. 
●    ●  ●    ●  ● 
I  am  satisfied  with  the  outpatient 
services provided by the hospital 
●  ●  ●        ● 
I am satisfied with the practical help I 
have received since I left hospital 
●            ● 
I  have  received  enough  information 
about  recovery  and  rehabilitation 
after stroke 
●      ●  ●    ● 
Somebody  has  really  listened  and 
understood my needs and problems 
since I left hospital 
●  ●  ●  ●      ● 
I  have  felt  neglected  since  I  left 
hospital 
●      ●      ● 
I have had enough emotional support 
since I left hospital 
●  ●  ●    ●    ● 
I  have  received  enough  special 
equipment 
●      ●      ● 
I  know  who  to  contact  if  I  have 
problems relating to my stroke 
●  ●    ●      ● 
I think the ambulance service is reliable  ●    ●         
I am satisfied with the amount of contact 
I have had with the hospital since I have 
attended 
  ●        ●   
reducing the risk        ●  ●     
I  am  satisfied  with  the  service  I  have 
received from my GP 
    ●         
I  am  satisfied  that  my  family  were 
encouraged to be involved in my care 
    ●         
I  was  given  enough  information  about 
voluntary organisations 
    ●         
overall satisfaction        ●       
hospital services summary score            ●   
community services summary score            ●   209 
 
Chapter Six:  
Identifying Stroke Liaison Roles in Scotland 
 
Introduction 
As we have seen from Chapter 5, the evidence for Stroke Liaison Workers is 
at the very least complicated and without a clear, simple message.  Despite 
this  lack  of  clear  evidence,  Stroke  Liaison  Worker  roles  have  multiplied 
throughout the United Kingdom including Scotland.  Many of these posts are 
paid for by charities such as the Stroke Association in England and Chest 
Heart and Stroke, Scotland (CHSS).  To some degree this may have been 
driven in the charity sector by a perception that mainstream NHS services 
are  failing  to  provide  for  patients  and  carers  felt  needs  simply  because 
evidence and  cost  effectiveness  cannot  be  easily  demonstrated  for these 
services.  In that respect satisfaction described by patients and carers may 
be felt to be adequate grounding for the provision of such services. 
Some services are part of mainstream NHS provision, but guidance on the 
roll out of services is limited (12;332).  It would appear that in the absence 
of a clear evidence basis or mechanism of effect for SLW like interventions 
that roles and posts have proliferated (stroke nurse website).  What unites 
or  separates  these  roles  currently  is  a  definition  by  title  or  terminology 
without a standardised or agreed definition of job plans for these posts (i.e. 
who does what in what way to whom, when and where).  It is apparent at 
national  forums  (National  Stroke  Forum)  where  these  roles  are  discussed 
that important differences emerge in the provision of input to patients and 
carers. 
Additionally in personal communication with Stroke Liaison Workers and on 
presentation of the evidence in scientific communications to conferences 210 
(333)  it  is  apparent  that  despite  potentially  disappointing  results,  that 
individual Stroke Liaison Workers have a high degree of confidence in the 
effectiveness of their work. 
It  is  therefore  legitimate  to  consider  exploring  two  central  questions  in 
mapping the existing evidence to current health service practice. 
1.  Firstly,  can  current  Liaison  Roles  be  quantified  and  evaluated  in 
Scotland?    Do  they  bear  any  comparison  to  the  interventions 
described in the research or have the roles and services evolved to 
make current evidence invalid for current services? 
2.  Secondly,  what  are  the  beliefs  of  those  who  carry  out  these  roles 
regarding the effectiveness of their work and its applicability to some 
or all patients. 
Answering  these  questions  requires  both  quantitative  data  and  semi 
qualitative data. 
No  central  register exists  within  the  NHS Scotland  to  locate  and  contact 
these  health  workers.    In  addition,  because  many  of  the  services  have 
evolved  from  local  needs  and  local  contexts,  it  was  apparent  that  some 
degree  of  description  and  classification  would  be  required  in  order  to 
identify comparable roles independent of titles and superficial descriptives.  
The Scottish Stroke Nurses Forum (SSNF) was established in 2003 to provide 
a  forum  for  the  professional  development  and  promotion  of  high  quality 
nursing standards and education amongst nursing professionals in Scotland. 
It  is  currently  the  most  comprehensive  network  of  nursing  clinicians  and 
researchers  in  Scotland  and  as  such  provides  a  forum  to  contact  and 
evaluate role development across Scotland. 
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Methods 
 
Questionnaire Development 
No  single  definition  of  a  Stroke  Liaison  Worker  exists  and  no  single  job 
description or profession has been defined by services nationally or locally.  
For this reason identifying and evaluating these roles proves difficult.  In 
practice,  a  number  of  screening  questions  are  likely  to  be  required  to 
identify individuals who work with patients after stroke providing liaison, 
social  support  and  information.    A  questionnaire  was  developed  to  map 
existing services in Scotland and mirror the roles described in the Stroke 
Liaison  Workers  literature.    These  questionnaires  asked  for  information 
under a series of domains including geographic, employment (profession and 
grade),  and  the  scope  of  the  individuals  work  (e.g.  inpatients  only, 
outpatients etc). 
SSNF  members  who  identified  that  they  worked  with  patients  in  the 
community after a stroke were asked a series of further questions.  These 
related  to  the  areas  of  a  Stroke  Liaison  role  as  identified  in  the  review 
process.  Specific questions were asked of the type of social support, liaison 
and information provision provided by each respondent.  Respondents were 
asked to categorise their approach to the individual patient (i.e. proactive 
and structured or reactive and flexible) and their type of interaction with 
the patient or carer (Focussed or Comprehensive).  Definitions were given 
for each of these terms (see Table 5.1, Appendix J) and respondents were 
asked  to  prioritise  their  responses  according  to  which  was  their  most 
common  method  of  approach.    Care  was  taken  to  avoid  pejorative 
terminology that might influence respondents.  Those respondents who were 
identified by screening questions to be in relevant roles were asked their 
personal belief of whether their role was effective for all or only some of 
their clients.  Additional questions allowed respondents to record free text 212 
where they felt important.  Additional questions were asked of respondents 
regarding the three commonest problems they dealt with day to day. 
Questionnaires  were  piloted  with  staff  members  known  to  the  author  to 
work in this type of post.  Following this minor modifications were made to 
the questionnaire to clarify definitions etc.  The questionnaires were then 
sent to all 209 members of the Scottish Stroke Nurses Forum.  In response to 
the initial mailing, 89 questionnaires were returned.  A second mailing was 
therefore carried out, prompting a further 21 responses. 
From all the responses, only initial demographic data were retained for this 
analysis.  Respondents who were identified through the screening question 
to  be  dealing  with  the  relevant  patient  and  carer  group  were  analysed 
separately.  Their results are presented here.   
 
Results 
In  total  110  questionnaires  were  returned  (52.6%),  of  which  58  met  the 
screening criteria for a Stroke Liaison Worker role.   
The regional distribution of respondents is shown in Figure 6.1. 
Quantitative data 
All  respondents  who  identified  themselves  as  potential  Stroke  Liaison 
Workers were from the nursing profession.  Most were from senior nursing 
grades; 35% (n=20) grade F, 28% (n=16) grade G and 16% (n=9) grade H, with 
the  majority  (59%,  n=34)  working  with  both  in patients  and  outpatients, 
implying an immediate role in discharge liaison.  Responders were asked 
who they dealt with.  All 58 respondents identified that they dealt with 
patients, with 97% (57) dealing additionally with carers and families. 213 
Respondents were then asked to identify which aspects of stroke liaison they 
were  involved  in  (education  and  information  provision,  liaison,  social 
support), with 90% identifying themselves as delivering all three roles. 
Respondents were then asked to identify within these general areas, which 
specific areas of information provision they provided, or what form of social 
and  psychological  support  they  provided  and  with  whom  they  regularly 
liaised. 
These  questions  had  been  developed  by  the  author  and  used  within  the 
review  process  described  in  Chapter  Five  to  try  and  classify  the  specific 
types of intervention delivered. 
In general terms, response rates were very high to all questions, with most 
nurses responding to nearly all areas (Table 6.1). 
The Stroke Liaison Worker approach is illustrated in Table 6.2.  Respondents 
were asked to identify their primary mode of approach or interaction with a 
patient  or  carer.    A  number  of  respondents  scored  both  approaches  as 
equal, hence the overlap of statistics. 
Visits  were  primarily  conducted  in  the  community  in  the  patients  homes 
(80%),  with  some  liaison  contacts  additionally  being  made  by  telephone 
(81%) or at visit to the hospital (e.g. at outpatient clinics – 48%). 
Respondents were asked if they believed their role to be effective.  62% (36 
respondents) believed that their role was effective for all their patients.  
22% (13) suggested that their role in their opinion benefited most patients, 
whilst 14% (8) believed that it benefited only some. 
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Qualitative data 
Responses to the questions regarding the three commonest problems dealt 
with by Stroke Liaison Workers were reviewed.  I looked for common threads 
or  themes  that  might  group  the  responses  together.    The  four  dominant 
themes identified were:  
a)  Psychological or emotional issues,  
b)  Informational or educational issues,  
c)  Practical or service related needs and  
d)  Medical or physical needs.   
Other  issues  including  problems  relating  to  service  provision  and  staffing 
issues were grouped under “other responses”.   
A count of the frequency of problems in these five themes was conducted, 
illustrating that the commonest theme was psychological or emotional needs 
(103  responses)  followed  by  informational  and  educational  needs  (30 
responses), practical or service needs (23 responses) and medical or physical 
(20 responses).  13 responses were listed that did not relate to patient care 
or support. 
Psychological or emotional needs 
Responses in this category illustrate a number of separate themes.  These 
include psychological adjustment to the effects of stroke. 
“Helping patients and relatives deal with the life changing events 
of stroke.“                                                                                                                           
“Patient, carer/relative not coming to terms with stroke and its 
effect.”     215 
“Life changes”                                                                                                      
Nurses also identified anxiety and depression as a frequent theme: 
“Patient/carer depression and anxiety”                                                                                    
“Depression”                                                                                                                             
“Fear of re stroke”                                                                                                                    
“Anxiety (especially re recurrence)” 
A number of other issues and themes were also identified as important: 
“Communication problems   social isolation”                                                                                                                             
“Loneliness”                                                                                                                                                                                             
“Physiological issues”                                                                                                                 
“Motivation”                                                                                                                             
“Change in family dynamics”                                                                                                                                                                               
Informational or educational needs 
Respondents  identified  a  number  of  issues  as  having  an  educational  or 
informational  basis.  These  include  behaviour  modification  and  lifestyle 
factors related to reducing risk factors: 
“How to change lifestyle e.g. smoking cessation, exercise and 
diet”                                                                                                                                        
“Secondary prevention e.g. medication compliance and 
understanding”                                                                                                                             216 
“Management of risk factors   especially smoking” 
Other informational needs were more general: 
“Lack of understanding of stroke and recovery” 
“Patients not understanding all the aspects of stroke”                                                                      
“Educating other family members”                                                                                                                             
Specific information needs were also identified in relation to driving and 
returning to work. 
Practical or service needs 
A number of responses indicated a variety of needs relating to support or 
rehabilitation services in the community and problems where nurses were 
clearly being required to provide liaison: 
“Benefits advice”                                                                                                                             
“Problems communicating with GP, social work etc.”                                                                                                                             
“Lack of support for patients from AHPs in community”                                                                                                                             
“Advice re local support services” 
Financial  issues  relating  to  benefits  was  the  most  frequent  single  issue 
identified. 
Medical or Physical needs 
These included issues in relation to physical rehabilitation: 
 “Patients not carrying over their functional level in the home 
setting and physical regression”                                                                                                        217 
“Communication/swallowing”                                                                                                                             
Physical needs:   
“Fatigue”       
“Bowel and bladder problems”                                                                                                                             
“Pressure area problems”                                                                                                                             
“B/P control”                                                                                                                                                         
And issues in relation to specific treatments and treatment modification: 
“Medication problems   e.g. dosage, how long”                                                                                                                            
“Side effects of stroke or medication”                                                                                                                             
Discussion 
 
Overall, 53% of respondents identified themselves as potentially fitting the 
category  of  Stroke  Liaison  Worker.    The  screening  question  appears  to 
correctly identify the nurses who provide the key aspects of Stroke Liaison 
Workers. 
Overall, results from the nurses who responded are broadly similar.  Most 
respondents report that they are offering all three of liaison, education and 
information provision and social support.  Specifically nearly all respondents 
offer a broad range of information and education.  In addition, the nurses 
employ a range of methods of social support to patients and their families, 
with  the  general  exception  of  formal  counselling  methods.    Most 
respondents have a comprehensive role in liaison between the patients and 
other services.  One of the limitations of this patient survey might be its 
lack of definition of the specific differences for example between; informal 218 
emotional  support,  informal  counselling  and  formal  counselling.    The 
questions  were  listed  as  though  to  illustrate  a  continuum  of  different 
methods  of  support,  and  despite  the  lack  of  a  formal  definition,  the 
response  rate  was  high,  and  broadly  similar,  suggesting  that  despite  this 
limitation, nurses appeared to respond in a consistent way. 
Attempts  to  specifically  define  the  intervention  prove  challenging  when 
trying  to  compare  it  to  the  established  literature  in  this  area.    Asking 
respondents  to  identify  their  primary  mode  of  approach  (reactive  or 
proactive)  proved  difficult  with  a  number  of  respondents  rating  both 
approaches as of equal frequency.  There is a risk that the way in which the 
question is constructed implies that one approach sounds more positive (e.g. 
pro active) and another pejorative (reactive).  Attempts were made to avoid 
negative language where possible.  This question attempted to dichotomise 
interventions to mirror some of the trials in the literature that were either 
reactive (76) or proactive (297).  Additional dichotomisation was attempted 
to identify trials that focussed on a specific problem or defined area (e.g. 
risk factor control or mood and emotional health) (279;298) or attempted to 
be comprehensive and cover a broad range of areas (32).  These differences 
become important if evidence suggests that a particular method of working 
as well as role proves to be effective. 
One further area of potential difficulty relates to the team associations that 
the Stroke Liaison Nurses have.  Traditionally Stroke Liaison Nurses have had 
a more independent role, operating between primary and secondary care 
and tending not to be a part of a multidisciplinary team.  Attempting to map 
existing Scottish roles to therapy teams was not clearly distinguished by the 
questionnaire.  Respondents identified that they were related to a hospital 
stroke team (35, 60%), as part of community support teams (12, 21%) or 
other service structures (9, 16%).  Further questions about the nature of the 
team structure and the frequency of team meetings and multidisciplinary 
discussion could have highlighted the degree to which Stroke Liaison Nurses 
were integrated to or independent from multidisciplinary teams. 219 
Scottish  nurses  who  responded  to  this  survey  to  identify  Stroke  Liaison 
Worker roles appear to offer a service comparable to each other in terms of 
the  intervention  delivered.    Minor  differences  appear  in  relation  to  the 
approach taken by Stroke Nurses and their interaction with patients.  The 
roles performed by the nurses appear to compare with those in the original 
trials.  Overall, Scottish Stroke Nurses appear to offer a multifaceted service 
with a high level of confidence that it is effective; that is, that in some way 
their  role  meets  needs  that  would  not  otherwise  be  met.    The  themes 
identified by the Stroke Nurses appear to be broadly consistent with the 
existing literature and primarily identify psychological and emotional issues 
as the dominant ones. 
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Figure 6.1: Region of Stroke Liaison Workers 
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Table 6.1: Specific Interventions Provided by Scottish Stroke Liaison Workers 
 
Specific help  Yes  
n=58 (%) 
Information Provision and Education    
Stroke Information 
(general) 
56 (97) 
Risk Factors  57 (98) 
Stroke consequences and complications  52 (90) 
Stroke services and benefits  50 (86) 
Stroke treatments and therapies  51 (88) 
Social Support   
Informal emotional  56 (97) 
Informal counselling  54 (93) 
Formal counselling  6 (10) 
Family support and problem solving  56 (97) 
Individual problem solving  55 (95) 
Organising other social support  53 (91) 
Liaison   
…with patient  57 (98) 
…with community services  54 (93) 
…with primary care  54 (93) 
…with secondary care  52 (90) 
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    Table 6.2: Scottish Stroke Liaison Workers Primary Approach 
Stroke Liaison Approach and Interaction  Primary (%) 
n=58 
Stroke Liaison Approach   
Pro-active and Structured 
“I tend to seek out to meet or talk with everyone.  I tend to 
bring up subjects even when not brought up by the patient (or 
carer), or I work through a list of potential problem areas.” 
30 (52) 
Reactive and Flexible 
“I  respond  to  patients  needs  and  adjust  my  workload  or 
discussions  around  the  problems  that  they  bring  up.    The 
amount of time or follow-up will depend on need.” 
33 (57) 
   
Stroke Liaison Workers interaction   
Focussed 
“I am quite specific about which areas we talk about (e.g. my 
role is to talk about risk factors or to talk about psychological 
problems etc.)” 
12 (21) 
Comprehensive 
“I cover a broad range of subjects and provide broad support 
for different aspects of living with stroke” 
49 (85) 
Results show the proportion of respondents who identified an approach as their primary approach or interaction with a 
patient.  In some cases, despite being asked to choose only one approach, respondents identified both approaches 
as equal. 223 
Chapter Seven 
 
Conclusions and Recommendations 
We have seen from the existing literature that there is a strong association 
between specific problems post stroke (e.g. social isolation, depression etc.) 
and  poorer  outcomes  for  both  patients  and  their  carers  (e.g.  mortality, 
depression  etc.)    It  seems  legitimate  therefore  to  explore  specific 
interventions that might be seen to buffer these post stroke problems and 
limit  their  consequences.    The  context  therefore  exists  for  trials  of  (for 
example) information provision and social or psychological support. 
In  Chapter  Two,  we  evaluated  the  short  term  outcomes  from  a  brief 
intervention  of  education,  information  provision  and  liaison.    We 
hypothesised that a better informed  and better  supported  stroke  patient 
might take more active control of their risk factors and be more satisfied 
with their care.  This intervention did not appear to improve overall risk 
factor control despite modest effects on systolic blood pressure.   Patients 
did  appear  to  describe  improved  satisfaction  with  some  aspects  of  their 
care.    The  evaluation  in  Chapter  Three  of  the  longer  term  benefits  was 
limited by the significant drop out rate of both the intervention and control 
group  subjects.    Either  for  this  reason,  or  because  the  effects  of  the 
intervention  were  limited,  there  was  no  evidence  of  benefit  from  the 
intervention  described  in  Chapter  Two  at  over  three  years  later.    One 
interesting observation was the relatively high persistence with secondary 
prevention therapy in both groups.  One potential confounding factor in the 
intervening period between Chapters Two and Three is the development of 
a local primary care initiative for Chronic Disease Management.  This is a 
programme that seeks to regularly review patients with Stroke, Ischaemic 
Heart Disease and Diabetes and aim to modify or improve their risk factors.  224 
It  is  possible  to  postulate  that  this  may  have  had  an  effect  on  both 
intervention and control groups.   
The results in Chapters Two and Three could represent a Type II statistical 
error.    Whilst  larger  scale  studies  may  address  this  uncertainty,  meta 
analysis of similar studies can enable meaningful conclusions to be drawn 
from  the  existing  literature.  In  order  to  establish  what  randomised 
controlled trials existed in this area of stroke research and to assess their 
combinability, we needed to develop a descriptive framework that would 
allow  comparability.    In  the  absence  of  an  underpinning  science, 
intervention  characteristics  for  comparison  must  be  based  on  external 
descriptors such as those discussed in Chapters Four and Five. To a great 
extent,  this  is  because  the  Phase  One  modelling  described  in  the  MRC 
framework  (page  67)  has  not  been  carried  out.    This  limits  our 
understanding  of  the  intervention  aims  and  effects  to  external  factors.  
Nevertheless  randomised  trials  currently  exist  evaluating  a  comparable 
group  of  interventions  and  therefore  meta analysis  of  these  trials  was 
warranted despite these limitations.  The process of identifying the current 
evidence  for  possible  comparability  highlighted  an  emerging  group  of 
interventions that have developed in recent years with the sole purpose of 
addressing the needs of carers.  This emerging group of trials merits further 
evaluation, but this is beyond the scope of this thesis.   
 
In attempting to combine appropriate randomised controlled trials for meta 
analysis  we  sought  to  add  to  the  external  descriptives  of  Chapter  Four 
additional information gleaned directly from the trialists.  We hoped that 
this  would  improve  our  accuracy  in  understanding  the  interventions  and 
ensure if they could be appropriately combined and sub grouped.  In many 
respects, given that little was known about how these interventions might 
work, our analysis could be described as exploratory.  For this reason, the 
wide  range  of  outcome  measures  is  appropriate.    Despite  this  broad 
approach, no clear evidence of effectiveness for the current model of Stroke 225 
Liaison Workers appears to emerge.  Interesting and potentially important 
themes do exist however. 
 
Stroke  Liaison  Worker  interventions  result  in  greater  satisfaction  with 
certain  aspects  of  service  provision  (such  as  information  provision  and 
liaison) but do not appear to result in changes to patient subjective health 
status, extended ADL or carer subjective health.  Subgroup analysis suggests 
that patients with mild to moderate dependence in activities of daily living 
may benefit with reductions in dependence as well as improved independent 
survival. 
 
It  would  appear  that  this  complex  intervention  with  its  broad  intentions 
does  not  result  in  significant  benefits  when  applied  to  all  patients  and 
carers.   
Further research in this area may not be warranted on the existing model of 
Stroke Liaison Worker   that is a multidimensional intervention delivered to 
all patients and carers.  Further work to explore alternative interventions 
however  is  urgently  needed.    This  research  and  evaluation  must  include 
where possible, more detailed modelling (or phase one) work and take into 
account the themes emerging from this thesis.  In essence it must consider: 
·  Being more focussed on a specific problem or impairment 
o  E.g. depression 
·  Or focussing on a specific sub group of patients 
o  E.g. mild to moderately dependent patients 
o  Carers 
·   Or working in combination with existing proven interventions 226 
o  E.g. Early supported discharge teams  (Since the development 
of these trials Early Supported Discharge services have become 
more  widespread  and  we  do  not  as  yet  know  the  potential 
interaction between these two interventions.) 
 
What  does  appear  to  emerge  as  a  clear  message  is  that  Stroke  Liaison 
Worker roles as they currently exist do not have an adequate evidence base 
to  justify  their  continued  support.    Despite  this,  as  we  have  seen  from 
Chapter Six, there is a widespread belief in their effectiveness and current 
roles  in  Scotland  appear  to  map  well  to  the  models  of  Stroke  Liaison 
Workers  that  were  evaluated  in  the  trials.    The  research  and  stroke 
community  needs  to  consider  the  significance  of  this  evidence  and  its 
implications for practice. 227 
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Appendix A: Initial Consent and Patient Questionnaire 
 
Enrolment Data set               Page 1 
Please fill in the white boxes. 
 
Date: 
 
1. 
Demographics  Enrolment Number 
Name: 
Address: 
 
Post Code: 
Unit Number: 
D.O.B. 
Sex  Male    1 
  Female    2 
 
2. 
Diagnosis    Tick  Coding 
TIA    1 
CVA    2 
Cerebrovascular 
Disease 
  3 
Other    4 
   
                PLEASE FILL IN 
3. 
 
Risk 
Factors 
  Tick  Coding  CURRENT RISK 
Smoking    1  No per day: 
Hypertension    2  Current BP  Sys  Dia   
NIDDM / IDDM / 
IGT 
  3  Current / Most recent  RBG  HbA1c 
Previous TIA    4   
Previous CVA    5 
AF    6  On Warfarin?  Yes:  No: 
High 
Cholesterol 
  7  Level: 
Alcohol Excess    8  Units per week: 
Obesity    9   
IHD    10 
PVD    11 
Other    12  (Specify) 
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INFORMATION SHEET              Page 2 
 
Patient Number: 
 
Patient's Name: 
Date of Birth: 
Post Code: 
 
THE  IMPACT  OF  A  STROKE  NURSE  SPECIALIST  ON  RISK  FACTOR 
MODIFICATION IN A TIA CLINIC: A RANDOMISED, CONTROLLED TRIAL 
 
You are being invited to enrol in a study that we are currently conducting in our 
"TIA" clinic. 
This study forms part of research we are conducting into the effects of advice 
we give to our patients who are at risk of a stroke. 
 
We hope to find out whether different kinds of approach to advice-giving can 
make a difference to our patients in terms of their health, understanding of their 
illness and satisfaction. 
 
As part of the study patients will be randomly allocated to two different groups.  
One group will receive monthly appointments with our specialist stroke nurse.  
The other group will not receive these appointments.  You will already have 
been allocated to one of these groups.  We are unable to influence which group 
you will have been allocated to.  All patients will be seen in four months time 
when  they  will  be  given  a  further  questionnaire,  have  their  blood  pressure 
measured and blood tests taken.  Many of these blood tests and blood pressure 
measurements may have been necessary as part of your normal care.  For a few 
patients however, these tests will be purely for the purposes of research. 
 
Research in medicine helps us to discover new or better ways of helping patients 
like yourself, and your participation would be greatly appreciated.  Participation 
in the study may be of little or no benefit to you, but the results may help other 
patients in the future. 
 
If  you  do  agree  to  take  part  in  the  research  project,  your  own  General 
Practitioner will be told and will be given details about any care which you are to 
receive. 
 233 
Consent Form                Page 3 
 
Patient's Name: 
Date of Birth: 
Post Code: 
 
Please place your initials in the boxes provided to indicate that you understand the statements 
that are being made. 
 
The Doctor or Sister named below has           
explained the study to me.     
 
I know that I can withdraw from the study          
at any time without having to give a reason. 
 
I know that should I withdraw, this will not          
in any way affect my care.  
 
I consent to take part in this study.            
 
 
Patients Name: 
Address: 
 
Signature: 
Date: 
 
Doctor/Sisters Name: 
Signature: 
Date: 234 
Questionnaire                Page 4 
 
Patient's Name: 
Date of Birth: 
Postcode: 
We would like to know some information about your quality of life at the 
beginning of our study. 
 
1.  Quality of life 
Please tick the box which you think best describes your current state of health. 
Mobility 
 
1.  No problems in walking about          
2.  Some problems in walking about          
3.  Confined to bed              
 
Self-care 
 
1.  No problems with self-care          
2.  Some problems washing or dressing self        
3.  Unable to wash or dress self          
 
Usual Activities 
 
1.  No problems with performing usual activities       
(E.g. work, study, leisure, family etc.) 
2.  Some problems with performing usual activities      
3.  Unable to perform usual activities         
 
Pain/Discomfort 
 
1.  No pain or discomfort            
2.  Moderate pain or discomfort          
3.  Extreme pain or discomfort          
 
Anxiety/Depression 
 
1.  Not anxious or depressed            
2.  Moderately anxious or depressed          
3.  Extremely anxious or depressed       235 
Questionnaire                Page 5 
 
Patient's Name: 
Date of Birth: 
Postcode: 
 
 
   236 
Appendix B: Concluding Data-set and Patient Questionnaire   
   
Concluding Data set                Page 1 
 
Date: 
1. 
Demographics  Enrolment Number  Patient Phone No: 
Name:  GP: 
Address:   
   
Post Code:   
Unit Number:   
D.O.B.   
Sex    Male    1 
    Female    2 
2. 
Diagnosis    Tick  Coding 
TIA    1 
CVA    2 
Cerebrovascular Disease    3 
Other    4 
   
3. 
Risk 
Factors 
  Tick  Coding  CURRENT RISK 
Smoking    1  No per day: 
Hypertension    2  Current BP  Sys  Dia   
NIDDM / IDDM / 
IGT 
  3  Current / Most recent  RBG  HbA1c 
Previous TIA    4   
Previous CVA    5 
AF    6  On Warfarin?  Yes:  No: 
High Cholesterol    7  Level: 
Alcohol Excess    8  Units per week: 
Obesity    9  Weight:  Height: 
IHD    10   
PVD    11 
Other    12  (Specify) 
4. 
  Questionnaire completed?  Bloods taken where indicated? 
Blood Pressure Recorded?  Results available? 
5. 
Clinical 
Data 
Further event not leading to admission? 
Cause?   
Admission to Hospital since enrolment? 
Diagnosis?   
Death? 
Cause?   
Other event? 
Details:   
Key  TIA=1  CVA=2  Other=3 (Please specify) 
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Questionnaire                Page 2 
 
Patient's Name: 
Date of Birth: 
Postcode: 
Now that you have completed your period in the study we would like to know 
some information about your quality of life, medications, mood and satisfaction 
with the service you have received. 
 
2.  Quality of life 
Please tick the box which you think best describes your current state of health. 
Mobility 
 
4.  No problems in walking about          
5.  Some problems in walking about          
6.  Confined to bed              
 
Self-care 
 
4.  No problems with self-care          
5.  Some problems washing or dressing self        
6.  Unable to wash or dress self          
 
Usual Activities 
 
4.  No problems with performing usual activities       
(E.g. work, study, leisure, family etc.) 
5.  Some problems with performing usual activities      
6.  Unable to perform usual activities         
 
Pain/Discomfort 
 
4.  No pain or discomfort            
5.  Moderate pain or discomfort          
6.  Extreme pain or discomfort          
 
Anxiety/Depression 
 
4.  Not anxious or depressed            
5.  Moderately anxious or depressed          
6.  Extremely anxious or depressed       
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Questionnaire                Page 3 
 
Patient's Name: 
Date of Birth: 
Post Code: 
 
2.  Your satisfaction with the service you have received 
 
Please tick the box which best describes how you feel about the statements below: 
  Strongly 
Agree 
Agree  Disagree  Strongly 
Disagree 
I have been treated with kindness and 
respect by staff at the hospital. 
       
The staff attended well to my needs 
when I was at the hospital. 
       
I was able to talk to the staff about any 
problems I might have had. 
       
I have received all the information I want 
about the causes and nature of my illness. 
       
The doctors have done everything they 
can to make me well again. 
       
I am satisfied with the outpatient services 
provided by the hospital. 
       
I have received enough information 
about my risk factors for stroke. 
       
Somebody has really listened and 
understood my needs and problems since 
I attended the hospital. 
       
I am satisfied with the amount of contact 
I have had with the hospital since I have 
attended. 
       
I have had enough emotional support 
since I attended the hospital. 
       
I know who to contact if I have 
problems relating to my TIA/stroke. 
       
I am happy with the amount of recovery 
I have made. 
       
I was given all the information I needed 
about the allowances or services I might 
need. 
       
 
 239 
Questionnaire                Page 4 
 
Patient's Name: 
Date of Birth: 
Post Code: 
3.  Your medications 
Please list in the boxes below all the medications you are taking and how 
frequently. 
E.g. Medicine  E.g. 1 tablet  E.g. 2x per day 
     
     
     
     
     
     
     
     
4.  Your mood 
Please answer the following questions by circling either YES or NO. 
 
1.  Are you basically satisfied with your life?        YES / NO 
2.  Have you dropped many of your activities     
     and interests?              YES / NO 
3.  Do you feel that your life is empty?         YES / NO 
4.  Do you often get bored?            YES / NO 
5.  Are you in good spirits most of the time?        YES / NO 
6.  Are you afraid that something bad is going 
     to happen to you?              YES / NO 
7.  Do you feel happy most of the time?        YES / NO 
8.  Do you often feel helpless?           YES / NO 
9.  Do you prefer to stay at home rather than 
going out and doing new things?          YES / NO 
10. Do you feel you have more problems 
with memory than most?            YES / NO 
11. Do you think it is wonderful to be alive now?      YES / NO 
12. Do you feel pretty worthless the way you are now?    YES / NO 
13. Do you feel full of energy?           YES / NO 
14. Do you feel your situation is hopeless?        YES / NO 
15. Do you think most people are better off 
than you are?                YES / NO 
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Appendix C: Concluding Letter to GP after Final Follow-up 
 
 
 
Date:  
 
 
 
 
Dear Doctor, 
 
Your patient ________________________________has been enrolled in a trial of 
health education in secondary TIA / Stroke prevention. 
 
They have now finished follow up.  Their results are shown below along with our 
recommended targets. 
 
Modifiable Risk Factor  Result  Our Recommendation 
Blood Pressure    <140/85 
Cholesterol    <5.0 
Blood Sugar 
HbA1c 
  Random Blood Glucose <8 
HbA1c <7.5 
Smoking    Cessation 
 
As a secondary preventative measure we would recommend that their risk factors are reduced to 
within these levels.   
 
If you have any questions regarding their treatment or the trial I will be happy to try 
and answer these, as will the trial supervisor, Dr McAlpine. 
 
Yours Sincerely, 
 
 
 
 
 
 
 
Graham Ellis 
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Appendix D: Example of Patient Held Record 
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Appendix E: Examples of Literature Given to Patients 
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Appendix  F:  The  Impact  of  Stroke  Nurse  Specialist  Input  on  Risk 
Factor Modification: A Randomised Controlled Trial – Age & Ageing 
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Appendix G: Meta-Analysis Trial Grid 
  
 
Stroke Liaison Workers Collaborative Review 
 
Trial Details 
Contacts 
Trialists 
   
Year   
Place   
Trial Name   
 
Participants 
Population from 
which patient 
selected 
 
Carers involved?   
Inclusion criteria   
Exclusion Criteria   
Numbers  Patient (Treatment)    Patient (Control)   
Carer (Treatment)       Carer (Control)   
 
Methods 
Method of generating random sequence? 
 
Method of treatment allocation and allocation concealment? 
 
Intention to treat analysis? 
 
Blinding (e.g. patient/healthcare staff/outcome assessor/follow up/single/ 
double/none) 
 
Time from stroke onset to enrolment 
 
Length of follow up 
 
 250 
 
Intervention 
Please indicate which one of the following domains you consider the most key in 
your intervention. 
Education and Information Provision   
Social and Family Support   
Liaison   
 
We have attempted as far as possible to classify the interventions to allow grouping or 
comparisons.  Please indicate which descriptions you feel most fit your trial intervention. (You 
may select as many boxes as you feel appropriate.) 
Education and Information Provision 
Stroke (general)   
Stroke risk factors or preventing another stroke   
Stroke consequences and complications   
Stroke services and available benefits   
Stroke treatment and therapies   
Other (please give details)   
 
Social and Family Support 
Informal and emotional support   
Informal counselling   
Formal counselling   
Family support/problem solving   
Individual support and problem solving   
Organising of other social support   
Other (please give details)   
 
Liaison 
With patient/carer   
With community services   
With primary care   
With secondary care   
Other (please give details)   
 
Mean number of visits/contacts? 
Visits:   
Phone calls:   
 
Background of Stroke Liaison Worker 
Please describe the professional background of the Stroke Liaison Worker(s) 
 
Did the Stroke Liaison Worker receive any formal training? 
 
Any other information you feel relevant regarding the intervention? 
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Outcome Measures 
The following is a list of the main outcome measures of the review.  Please 
indicate which measure you used for each domain, listing them in the order 
of priority. 
Patients 
Primary Outcomes 
Subjective Health Status   
Extended activities of 
daily living 
 
 
Secondary Outcomes 
death  Yes / No 
place of residence  Yes / No 
activities of daily living   
dependency   
mental health (including 
anxiety and depression) 
 
knowledge about stroke   
use of services   
satisfaction with services   
participation   
other   
 
Carers 
Primary Outcomes 
Subjective Health Status 
(including measures of 
carer strain) 
 
 
Secondary Outcomes 
Extended activities of 
daily living  
 
mental health   
knowledge about stroke   
satisfaction with services   
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Data 
I am happy to have my relevant individual patient data used as specified   
I am unhappy to have my relevant individual patient data used as specified   
I am happy to have some of my data used with the following qualifications: 
 
 
 
 
 
NB. If you have used a local outcome questionnaire or instrument, which is not 
widely available (e.g. satisfaction questionnaire) It would be very helpful if you 
were able to forward one to me. 
Data format (e.g. software)   
Please also note if the data labels on your database are not obviously apparent, 
a copy or note of the field labels would be very helpful. 
 
 
Contact details 
I require assistance with travel: 
I require accommodation: 
I am most easily contacted 
at/by: 
(please note email is our 
preferred method of contact) 
Phone 
Email 
Mobile 
Fax 
My most up to date email is:   
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Appendix H: Minutes of Stroke Liaison Workers Collaborative Meeting 
 
Minutes of Stroke Liaison Workers Collaboration 
Royal College of Physicians and Surgeons of Glasgow 
4
th March 2005 
 
Present: J Mant, M Dennis, S O’Rourke, V Miller, N Lincoln, A Forster, C Burton, A 
Sharma, G Ellis, P Langhorne 
 
Apologies: T Hafsteinsdottir, M Clark, J Frayne, and D Bishop 
 
Absent: T Glass, D Christie, and G Goldberg 
 
Presentations: 
Introduction to protocol  (Jonathan Mant) 
 
Literature Search and Taxonomy of Interventions  (Graham Ellis) 
 
There  was  some  brief  discussion  around  the  changes  in  the  protocol  and  the 
exclusion of carer only interventions as well as the appropriate inclusion of TIA 
patients. 
 
Discussion around taxonomy and subgroup classification: 
 
The model proposed by GE was discussed. 
With the breadth of interventions, and in some cases the flexibility required in a 
particular context, these classifications were felt to be somewhat arbitrary. 
It  also  became  clear  that  apparently  similar  trials  had  a  reasonable  degree  of 
variation. 
A further model was proposed, based on whether the intervention was responding 
to individual problems and needs, whether it was relatively fixed and systematic in 
its approach or whether it was theory driven and focussed in a particular area. 
 
These categories would be as follows: 
1.  Proactive and Structured  
a.  Preston 
b.  Bradford 
c.  Utrecht 
d.  Rhode Island 
2.  Reactive and Flexible 
a.  Edinburgh 
b.  Adelaide 
c.  Oxford 
d.  London 
e.  Liverpool 
f.  Nottingham 
g.  Melbourne 
h.  Melbourne (SHIPS) 254 
3.  Proactive and Focused 
a.  Glasgow 
b.  Leeds (Volunteer) 
c.  Leeds (Psychiatric Nurse) 
d.  Boston (FIRST) 
e.  Philadelphia 
 
Other sub-groupings were discussed: 
 
Service related 
1.  According to what intervention or services the control group received 
2.  In-patient versus outpatient (never admitted) 
3.  Related  to  outcome  of  question  (e.g.  Psychological  to  mental  health 
outcomes) 
4.  Prior stroke unit admission versus none 
These were in addition to the previously stated suggestions: 
5.  Intervention characteristics 
6.  Prior  profession  of  Stroke  Liaison  Worker  (and  specialist  versus  non 
specialist) 
7.  Direct versus remote services  
8.  Early  Versus  Late  (Cumulative  add  in  analysis  were  suggested  to  reflect 
range) 
9.  Intensity (Cumulative add in?) 
10. Duration (Cumulative add in?) 
 
 
Patient related 
1.  First Versus Recurrent stroke 
2.  Admitted Versus Never Admitted 
3.  TIAs Versus Stroke 
4.  Prior depression 
These were in addition to previously stated suggestions: 
5.  Prior functional / Baseline functional status 
6.  Age 
7.  Sex 
8.  Carer (or first degree relative?) Versus None (3 Groups – first degree, other 
support, none?) 
 
Outcome measures 
Discussion continued around dichotomisation/continuous data comparisons. 
The possibility of individual patient dichotomisation was discussed, although the 
pragmatics of this seemed challenging. 
Discussion  continued  on  the  theme  of  the  satisfaction  outcomes  and  whether 
these be grouped or taken individually.  In addition there was discussion around 
the use of relevant satisfaction outcomes to appropriate intervention. 
Additional comment was made on the worth of giving mention to the inclusion of 
qualitative data in the review.  
The possibility of combining similar and comparable outcomes was discussed. 
 
Publication and Authorship issues 255 
 
Data Ownership 
There was some discussion around the use of data from unpublished trials. 
It was reiterated that the rights to ownership and use of this data were with the 
individual trialists or group and that we did not intend to jeopardise individual trial 
publication.  For this reason (where timescales are important), it was decided that 
at the point of completion of data analysis, the use of the relevant data would be 
discussed  with  the  individuals  or  groups  concerned.    Where  this  presents  a 
problem, that data would be excluded if requested.  For reasons of efficiency and 
practicality it was requested that data be submitted for analysis now, but on the 
agreement that its public release not be permitted until further discussions take 
place with the trialists affected. 
 
Group Authorship 
It was agreed that where the journals permitted, a group name would be used for 
the primary publication, with recognition of the contribution of individual authors. 
Where  further  subsequent  papers  of  additional  analysis  were  involved,  the 
authorship would be represented by a statement such as: 
Y, Y and Z on behalf of the Stroke Liaison Workers collaboration. 
 
The meeting was concluded with thanks expressed to all for their co-operation 
and helpfulness. 
 
Sweepstake: 
Nadina    Caregiver strain 
Peter      Satisfaction with services 
      Caregiver strain index 
Chris      Satisfaction with Services 
      Caregiver Strain index 
Anne      Caregiver satisfaction 
Anil      Satisfaction with services 
Martin     Caregiver satisfaction 
Jonathan    Caregiver satisfaction with knowledge 
Van      Satisfaction with services 
Suzanne    Patient satisfaction with liaison 256 
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Appendix J: Scottish Stroke Nurse Questionnaire 
 
 Stroke Liaison Worker Questionnaire 
 
My region is: 
Argyll and Clyde    Grampian   
Ayrshire and Arran    Highlands   
Borders    Lanarkshire   
Dumfries and Galloway    Lothian   
Fife    Shetland   
Forth Valley    Tayside   
Glasgow    Western Isles   
Other (please specify below)    Orkney   
 
 
I am a: 
Nurse    Health Visitor   
Volunteer    Social Work   
AHP (please specify)     
Other (please specify)     
 
Grade:   
 
I work with: 
Inpatients only   
Inpatients and outpatients (including ward discharges)   
Only outpatients (including ward discharges)   
Not applicable (e.g. no patient contact)   
 
If your answer above is “inpatients only”, or “not applicable” jump to page 4 
“Questions for everyone” 
 
We are particularly interested in these three areas and in how your role might 
include these aspects of care.  We would like you to try and identify which are 
most relevant to your work. (Tick ALL that apply to you) 
 
My role with patients/carers in the community is: 
Liaison   
(This may mean referring the patient on to appropriate clinicians, or 
simply acting as a point of contact.) 
 
 
Social Support   
(This can be anything from simple support to offering advice about family 
problems or more in depth counselling.) 
Education and Information Provision   
(This could mean anything from giving leaflets to taking seminars with 
patients and carers or counselling about lifestyle and risk factors.) 
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We would like to explore a little more, aspects of your practice with patients or carers.  Which of 
the following apply to your work?  If you wish to add comments at the end, please do so. 
(Please tick ALL  that apply) 
I provide: 
Education and Information provision in the following areas: 
Stroke (general information)   
Stroke risk factors or preventing another stroke   
Stroke consequences and complications   
Stroke services and benefits   
Stroke treatments and therapies   
Other   
Social Support of the following kinds: 
Informal emotional support   
Informal counselling   
Formal counselling (e.g. as a trained counsellor 
using established techniques) 
 
Family support / problem solving   
Individual support / problem solving   
Organising of other social support   
Other   
Liaison: 
With patient / carer   
With community services   
With primary care   
With secondary care   
Other   
Other comments 
 
 
 
 
 
 
 
 
My approach is: 
We would like you to put a 1 in the box that best describes what approach you would use most of 
the time.  If you sometimes use the other approach, put a 2 in the other box.  If you rarely or 
never use the other approach, leave it blank.  
Pro-active and Structured   
I tend to seek out to meet or talk with everyone.  I tend to bring up 
subjects even when not brought up by the patient (or carer), or I work 
through a list of potential problem areas. 
 
Reactive and Flexible   
I respond to patients needs and adjust my workload or discussions around 
the problems that they bring up.  The amount of time or follow-up will 
depend on need. 266 
My interaction and discussions with patients are: 
We would like you to put a 1 in the box that best describes what approach you would use 
most of the time.  If you sometimes use the other approach, put a 2 in the other box.  If you 
rarely or never use the other approach, leave it blank. 
Focussed   
I am quite specific about which areas we talk about (e.g. my role is to talk 
about risk factors or to talk about psychological problems etc.) 
Comprehensive   
I cover a broad range of subjects and provide broad support for different 
aspects of living with stroke. 
 
My involvement with patients is by: 
Tick ALL that apply to your work 
Visit to their home   
Phone   
They come to me at hospital   
Other (please specify)   
 
 
Colleagues: 
Tick ONLY ONE description that sounds closest to your work 
I work in a community support team (such as community 
rehabilitation or discharge support) 
 
I am a member of the hospital stroke team, but not a member of a 
community team as above. 
 
Other   
 
 
I deal with: 
Tick ALL that  apply to your work 
Informal Carers   
Patients   
Families   
Other (specify)   
 
 
Does it work?  
Tick ONLY ONE 
I believe my work has a positive impact on all the patients/carers I see   
I am uncertain if all patients/carers benefit from my work but think that 
most will 
 
I am convinced that some patients benefit from my work.   
I am not sure if my role is beneficial   
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Questions for everyone 
 
I think the following are the most important aspects of my work: 
 
 
 
 
 
 
 
I believe I am most likely to have a beneficial impact on the following 
people: 
 
 
 
 
 
 
The commonest three problems I deal with are: 
 
1______________________________________________________________ 
 
2______________________________________________________________ 
 
3______________________________________________________________ 
 
 
Comments on your role: 
 
 
 
 
 
Other Comments: 
 
 
 
 
 
 
 
If you are willing to be interviewed on your role in stroke care, please contact Louise Craig 
by phone (0141 330 5645) or email (lec5t@clinmed.gla.ac.uk) of by providing contact details 
below. 
Name:         Contact details: 
 
Thank you for your time in completing this questionnaire. 268 
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